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Pre-mRNA splicing by the spliceosome requires the precise and regulated efforts 
of the five snRNAs (U1, U2, U4, U5, and U6) and numerous associated proteins. 
Following assembly and activation of the spliceosome, two consecutive reactions result 
in intron removal and exon ligation from pre-mRNA substrates. It has been established 
that several members of the DExH/D-box family of helicases act transiently on the 
spliceosome prior to the chemical steps to authorize the successive reactions by 
hydrolyzing ATP and consequently inducing structural rearrangements. While it has been 
suggested that these changes produced in the structure of the spliceosome result in 
optimal positioning of the reactive species, the mechanisms and products of these 
reorganizations remain uncharacterized.  
 vii 
The work presented here describes the genetic strategy for accumulating and 
purifying spliceosomes arrested in vivo, during the catalytic steps of the splicing cycle. 
Using these complexes, we have defined the components required to proceed through the 
first and second steps of splicing, in addition to the factors required for the release of the 
spliced message. Analysis of these functional, synchronized particles has also allowed us 
to define a function for Prp2p in initiating the first step of pre-mRNA splicing. Our data 
suggest that Prp2p may act in an ATP-independent manner to remodel the spliceosome 
prior to using its ATPase function to displace the SF3 complex. We propose that the SF3 
complex, in addition to its role in identification of the branchpoint, also acts to sequester 
the reactive 2’OH of the branchpoint adenosine to prevent premature reactivity.  
Following the two catalytic steps of the splicing cycle, the spliceosome must 
disassemble and recycle its snRNPs for further rounds of splicing. The essential U6 
snRNP component Prp24p, mediates one of the early assembly events - the annealing 
between the U4 and U6 snRNAs. We have discovered that although Prp24p is essential 
for viability, its function(s) can be bypassed by overexpressing the U6 snRNA. 
Additionally, biochemical characterizations of various forms of the U4/U6 snRNP 
provide evidence that Prp24p must be released before other components of the U4/U6 
snRNP are permitted to interact and facilitate tri-snRNP formation.
 viii 
 






















































































































































































































































































































































Chapter 1:  Introduction 
1.1 EUKARYOTIC GENE EXPRESSION 
The discovery that eukaryotes carry split genes, in which the coding regions are 
not continuous but interrupted by stretches of non-coding sequences called introns, was 
one of the most important discoveries in molecular biology in the second half of the 20th 
century (Berget et al., 1977; Chow et al., 1977). For proper gene expression, these introns 
must be removed and the blocks of coding sequences, referred to as exons, are joined 
together in a process known as precursor-mRNA (pre-mRNA) splicing. The vast majority 
of human genes contain multiple introns, which are spliced both constitutively and 
alternatively, presenting a clear argument for necessity of regulated and precise 
processing of pre-mRNA.  
From a metabolic standpoint, the purpose of introns is not self-evident, as splicing 
is an energy consuming process (Cooper et al., 2009). However, as the potential for 
splicing events increases, so does the complexity of an organism. For example, roughly 
94% of human genes undergo alternative splicing, and many of these post-transcriptional 
processing events take place in a tissue-, signal-, or developmental stage- specific manner 
(Wang et al., 2008). Along with the conferred advantages of introns and alternative 
splicing comes the responsibility of regulating the machinery that recognizes and 
functions in the removal of introns. With major cellular efforts directed toward precise 
and controlled intron removal, cells become vulnerable to misregulation, which in higher 
eukaryotes often results in disease (Cooper et al., 2009). It has been estimated that ~50% 
of disease causing point mutations within the coding sequences affect splicing (Lopez-
Bigas et al., 2005).  
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The classical representation of gene expression holds that DNA is transcribed into 
RNA, and RNA is translated into proteins. Though this is the foundation for production 
of functional molecules, cells have evolved numerous regulatory steps throughout gene 
expression, and many of these events not only take place at the RNA level, but also 
involve catalytic functions of several classes of RNA. The coding RNAs, known as 
mRNAs, serve as the templates for protein synthesis, while non-coding small nuclear 
RNAs (snRNAs) act in complex with protein to remove the introns from the pre-mRNA. 
snRNAs have also been proposed to play a catalytic role in the maturation of pre-mRNAs 
(Yean et al., 2000). Other non-coding RNAs including, ribosomal RNAs (rRNAs), 
transfer RNAs (tRNAs), small nucleolar RNAs (snoRNAs), and microRNAs (miRNAs), 
are also critical for proper gene expression.  
Pre-mRNA splicing is dependent upon a ribonucleoprotein (RNP) complex 
known as the spliceosome. Within the spliceosome, the coordinated activities of five 
snRNAs and over one hundred proteins recognize splice sites with high fidelity and 
accurately remove introns. This dissertation will specifically focus on the biochemical 
interactions and conformational changes within the spliceosome during the splicing 
cycle. The following introduction will detail the individual components of the splicing 
machinery, their mechanism of action, and the role of splicing regulation in control of 
gene expression.  
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1.1.1 Splicing history  
In 1977, Philip Sharp (Berget et al., 1977) and Richard Roberts (Chow et al., 
1977) suggested a new mechanism for the formation of mRNA upon the observation of 
incomplete hydrogen bonding between an adenovirus RNA transcript and the gene from 
which it was transcribed. Their data led to the “split gene” model in which large 
intervening sequences are removed during the formation of a mature mRNA species. 
Later, Walter Gilbert termed the gene disruptions “introns” and the coding regions which 
ultimately ligate together “exons” (Gilbert, 1978). The discovery of intron removal from 
pre-mRNA begged the questions of how this process occurred and what, if any, cellular 
machinery was required. 
 
1.1.1.1 The discovery of snRNAs  
Even before the discovery of introns, a class of RNAs was identified first in 
metazoan cells, which became known for its unique base composition and termed U-
RNAs (Muramatsu et al., 1966; Okamura and Busch, 1965). From total, purified RNA, 
the U-RNAs sedimented in the 4 – 8S region of a sucrose gradient and were significantly 
different from rRNA and tRNAs (Muramatsu et al., 1966). The first of the U-RNAs to be 
isolated and sequenced were U1, U2 and U3 (Hodnett and Busch, 1968). 
Characterizations of these showed that U1 and U2 were nucleoplasmic while the third, 
U3, was localized to the nucleolus. Eventually three other snRNAs were discovered, each 
of which showed presence within the nucleus. With five of six of the RNAs localizing to 
the nucleus, and each having a notably high uridylic acid content, these RNAs were 
termed the U snRNAs (Busch et al., 1982).  
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Studies directed toward determining the existence of snRNAs in Saccharomyces 
cerevisiae revealed a more perplexing situation, as it seemed that at least 24 different 
snRNAs existed in budding yeast (Riedel et al., 1986; Wise et al., 1983). Further 
experimentation showed that these yeast snRNAs were encoded by single genes and 
existed at ~1/1000 the abundance of their mammalian counterparts (Wise et al., 1983). 
Despite the seemingly large number of snRNAs found in yeast compared to metazoan 
cells, only six of the yeast snRNAs we found to be essential, and these were the RNAs 
orthologous to the metazoan U1 – U6 snRNAs.  
 
1.1.1.2 The discovery of small nuclear ribonucleoproteins (snRNPs) 
Closely trailing the discovery of small nuclear RNAs, came the finding that 
proteins associate specifically with each of these snRNAs. Enger and Walters recognized 
that upon protease treatment, the snRNAs migrated more slowly in glycerol gradients, 
indicating each may be complexed with a number of proteins (Enger and Walters, 1970). 
The first protein components assigned to U1-U5 snRNAs were the Sm core of proteins, 
which is a seven-membered ring that binds a specific sequence in those snRNAs (Lerner 
and Steitz, 1979). Later it was discovered that although U6 does not have a consensus Sm 
binding sequence, it is bound by a “Like Sm” (LSm) core of proteins (Achsel et al., 1999; 
Vidal et al., 1999). The Sm complex has been shown to be required, but not sufficient for 
snRNP biogenesis in the cytoplasm, and the presence of NLS-like motifs in several of the 




1.1.1.3 snRNP discovery in splicing 
In the laboratory of Joan Steitz, a discovery in 1980 suggested that snRNAs were 
involved in splicing (Lerner et al., 1980). This work showed complementarity between 
the 5’ sequence of the U1 snRNA and the consensus sequence of the splice junction, 
leading to the proposal that snRNAs may form base paired interactions in order to 
facilitate splicing of intron-containing transcripts. Later it was discovered by the Guthrie 
laboratory that the U2 snRNP recognizes the branchpoint sequence by base pairing 
interaction (Parker et al., 1987).  
 
1.1.1.4 The splicing mechanism 
Following the discovery of introns, great efforts were dedicated to understanding 
the mechanism by which introns were removed from pre-mRNA substrates. Major 
breakthroughs from the laboratories of John Abelson (Domdey et al., 1984; Lin et al., 
1985), Michael Green (Grabowski et al., 1984; Padgett et al., 1984; Ruskin et al., 1984), 
Philip Sharp (Grabowski et al., 1984; Padgett et al., 1984), and Michael Rosbash 
(Rodriguez et al., 1984) proposed that the splicing reaction proceeds by means of two 
sequential transesterification reactions producing two sets of products, one from each 
reaction (Illustration 1.1).  
In the first reaction, the 2’ hydroxyl from an adenosine residue, termed the 
branchpoint adenosine, found within the conserved intron branchpoint sequence, 
nucleophilically attacks the phosphate preceding the conserved intronic GU at the 5’ 
splice site. This yields the products of the first transesterification: a freed 5’ exon and a 
lariat intermediate. In the second transesterification, the phosphate following the 
conserved intronic AG at the 3’ splice site is attacked by the 3’-OH of the 5’ splice site to 
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ligate the two exons and release the intron in the form of a lariat. Although, intron 
removal from self-splicing group II introns and pre-mRNA substrates is mechanistically 
identical, pre-mRNA intron-containing transcripts lack the extensive secondary and 
tertiary structure that group II introns possess, which allows cleavage in cis. Instead, the 
splicing of pre-mRNA depends upon trans-acting machinery, known as the spliceosome 
(Brody and Abelson, 1985; Lin et al., 1987). 
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Illustration 1.1 Splicing proceeds through two stepwise transesterification reactions. 
This illustration depicts the pre-mRNA, with the intron represented by the black 
line. The consensus 5’ splice site, 3’ splice site and branchpoint sequences are shown for 
Saccharomyces cerevisiae. In the first step of splicing the 2’OH from the branchpoint 
adenosine attacks the 5’ SS to yield the lariat intermediate and the freed 5’ exon. In the 
second catalytic step, the 5’SS attacks the 3’ SS to form the spliced mRNA and the 
cleaved out lariat intron. Following splicing, the mRNA can be exported to the cytoplasm 
where it will be translated by the ribosome into protein.  
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1.1.1.5  The spliceosome  
In humans, introns of up to several hundred kilobases can be processed and 
removed from pre-mRNA efficiently and accurately (Singh and Padgett, 2009). This 
suggests that eukaryotic cells have developed a mechanism for rapid and precise removal 
of introns of any size to ensure proper gene expression. The spliceosome positions the 
chemically reactive species in close enough proximity, overcoming the distances between 
the 5’ splice site and the 3’ splice site. This ribonucleoprotein complex collectively 
contains the five small nuclear RNAs and over one hundred stably-interacting and 
transiently-interacting proteins (Wahl et al., 2009). The yeast spliceosome was first 
characterized by the Abelson laboratory in 1985, when pre-mRNA and its splicing 
products were found to sediment at ~40S region upon glycerol gradient analysis (Brody 
and Abelson, 1985). This work employed yeast whole cell extract with radioactive in 
vitro-transcribed mutant pre-mRNA, and demonstrated splicing intermediate 
sedimentation corresponding to the intermediates produced from the two splicing 
reactions. Not long after the discovery of the spliceosome, it was found that numerous 
proteins, including snRNA-associated proteins, are involved in and required for 
commencement and completion of splicing. Because the spliceosome is a dynamic 
macromolecule, factors are being still identified and characterized to this day.  
 
1.1.2 snRNP biogenesis 
Because splicing is carried out in a cyclic pathway, and each snRNP enters into 
the splicing cycle in a unique manner, it is necessary to understand the origin of the 
snRNAs and their association with their repertoire of proteins.  
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1.1.2.1 U1, U2, U4 and U5 snRNP biogenesis 
Each of the snRNAs is transcribed by RNA polymerase II (RNA Pol II), except 
for U6 snRNA, which is transcribed by RNA Polymerase III (RNA Pol III). Possibly as a 
result of this difference, the biogenesis pathways for U1, U2, U4 and U5 snRNPs also 
differ significantly from that of the U6 snRNP (Kiss, 2004).  
The snRNAs transcribed by RNA Pol II each undergo a number of processing 
events before they may participate in the splicing cycle. Following transcription of these 
snRNAs, the 5’ end is modified with a 7-monomethyl guanosine (m7G) cap. Like the 
other products of RNA Pol II transcription, the pre-snRNAs then interact with of the Cap 
Binding Complex (CBC) (Izaurralde et al., 1994), which acts as the adaptor for 
CRM1/RanGTP dependent nuclear export. An additional factor, Phosphorylated Adapter 
for RNA Export (PHAX), has been characterized as a specific requirement for snRNA 
export (Ohno et al., 2000). Following transport to the cytoplasm by means of the nuclear 
pore complex, the export machinery disassembles as triggered by the dephosphorylation 
of PHAX (Ohno et al., 2000). In higher eukaryotes, the survival of motor neurons (SMN) 
complex acts upon the snRNA by loading the heptameric core of Sm proteins onto the 
conserved binding site of the 3’ end of each of the snRNAs (Massenet et al., 2002; 
Paushkin et al., 2002). The Sm complex, which is conserved from yeast through 
vertebrates, is composed of SmB1p, SmD1p, SmD2p, SmD3p, SmE1p, SmFp and SmGp, 
and is characteristic of each of the RNA Pol II transcribed snRNAs. This complex is 
essential for the subsequent steps of hypermethylation of the 7mG cap by Tgs1p 
methyltransferase and 3’ end cleavage. Hypermethylation of the cap results in a 2,2,7-
trimethylguanosine (TMG) cap, which along with the Sm complex, serves as the nuclear 
localization signal for snRNP reentry into the nucleus. A network of interactions between 
the cap, Snurportin-1 (SPN1), importin β, and a yet to be identified import factor act to 
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import the cytoplasmically processed snRNA (Palacios et al., 1997). Once back in the 
nucleus the snRNPs are further processed in sub-nuclear compartments, known as Cajal 
bodies in animals and plants. Here, the RNA component of the snRNP undergoes site-
specific pseudouridylation and 2’-O-methylation (Sleeman and Lamond, 1999). 
Additionally, the Cajal bodies are also believed to be the sites of snRNP-specific protein 
association (Schaffert et al., 2004).  
 
1.1.2.2 U6 snRNP biogenesis 
The maturation pathway of the most highly conserved snRNA, U6 (Brow and 
Guthrie, 1988), differs significantly from the other snRNP processing events. To begin, 
the U6 snRNA receives a different 5’ end modification with the addition of a γ-
monomethyl cap (Shimba and Reddy, 1994), which probably contributes to U6 nuclear 
retention. As an RNA Pol III product, the U6 snRNA also has a 3’-oligouridine stretch, 
which is addressed by the La protein. The La protein is known to provide stability for the 
nascent transcript (Wolin and Cedervall, 2002).  The 3’ end of U6 eventually also 
possesses a 2’, 3’-cyclic phosphate (Lund and Dahlberg, 1992), which is thought to 
trigger the release of the La protein and recruit the Like Sm (LSm) complex. The LSm 
ring is composed of seven proteins and binds to the 3’ end of U6 as a heptameric ring, in 
a manner analogous to the Sm interaction with U1, U2, U4 and U5 (Achsel et al., 1999; 
Mayes et al., 1999; Seraphin, 1995; Vidal et al., 1999). Once the LSm complex 
associates, U6 snRNA is prevented from entering into the cytoplasm (Spiller et al., 
2007). The LSm complex is also required to localize U6 snRNA to further processing 
within the nucleolus, where snoRNAs mediate the methylation and pseudouridylation of 
the snRNA (Ganot et al., 1999).  Finally, and once again most likely directed by the LSm 
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complex, the U6 snRNA localizes to Cajal bodies (Gerbi and Lange, 2002). Here, U6 is 
thought to bind to its final snRNP protein, p110/SART3, (Stanek et al., 2003), which is 
orthologous to the yeast protein, Prp24p. Prp24p allows the U6 snRNP to form extensive 
base pairing interactions with the U4 snRNA (Shannon and Guthrie, 1991).  
 
1.1.2.3 Characteristic features of snRNP biogenesis in Saccharomyces cerevisiae 
Much less is known about snRNP biogenesis in S. cerevisiae. It remains unclear if 
snRNP maturation events in S. cerevisiae are restricted to the nucleus or, if U1, U2, U4, 
and U5, as in higher eukaryotes, go through a cytoplasmic phase. The Guthrie laboratory 
has identified a factor Brr1p, which shows association to each of the snRNPs and is 
distantly related to a factor contained in mammalian SMN complex (Noble and Guthrie, 
1996). This relationship could imply a mechanism for yeast that is similar to Sm complex 
assembly in higher eukaryotes (Noble and Guthrie, 1996; Will and Luhrmann, 2001). 
Although no import factors analogous to Snurportin or importin β have been identified, 
evidence suggests that putative nuclear localization signals found within the carboxy-
termini of SmB1p and SmD1p could function in recruiting the snRNPs back to the 
nucleus (Bordonne, 2000). Additional data from the Wolin laboratory suggests that the 
yeast homolog of the La protein, Lhp1p, may function not only in U6 stabilization and 
maturation, but also may protect the nascent U1, U2, U4, and U5 transcripts (Xue et al., 
2000).  
Each snRNA interacts with a number of snRNA-specific proteins in addition to 
the Sm complex or the LSm complex. Some of the snRNP-specific factors are found 
associated with their respective snRNAs and the spliceosome throughout the entire 
splicing cycle, while others interact in a more transient manner. In metazoan cells, these 
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factors are shown to load on to their respective snRNPs in Cajal bodies (Schaffert et al., 
2004); however, the precise location of where these interactions initiate is not known in 
yeast and no compartment analogous to the Cajal body has been identified in S. 
cerevisiae.  
 
1.1.3 The splicing cycle 
Unlike most RNPs such as the ribosome, the spliceosome must assemble from its 
building blocks, the snRNPs, for each and every splicing event. As graphically depicted 
in Illustration 1.2, intron removal is executed only once the spliceosome is formed and 
remodeled by the addition and removal of proteins and formation and disruption of RNA-
RNA interactions. Following the second catalytic step of splicing, the spliceosome must 
disassemble to recycle its snRNPs for further rounds of splicing. The dynamic and 
continuous cycle of the RNA-RNA and RNA-protein coordination within the 
spliceosome builds an RNP of unique and particular interest.  
Classically, assembly of the spliceosome has been represented as the stepwise 
addition of snRNPs to the pre-mRNA, where the splice sites of the pre-mRNA recruit 
spliceosomal proteins and form base pairing interactions with snRNAs (Lin et al., 1985). 
This assembly pathway is represented in the assembly events shown in Illustration 1.2. 
Alternatively, the snRNPs have been shown to associate as a holoenzyme termed the 
penta-snRNP, which addresses the substrate only after all five snRNPs associate (Stevens 
et al., 2002). In either case, the snRNPs dynamically rearrange to ultimately interact with 
the substrate to form an active site where chemistry can take place. The beginning of this 
section will describe the traditional model for stepwise assembly of the spliceosome 
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starting with the recognition of the 5’ splice site by the U1 snRNA. Following this 
review, the alternative penta-snRNP model will be presented.  
 14 
 
Illustration 1.2 Pre-mRNA splicing is a dynamic cycle, including assembly, activation, 
catalysis, disassembly, and recycling.  
The pre-mRNA splicing cycle includes numerous dynamic rearrangements within 
the snRNP components, the pre-mRNA, and the assembled spliceosome. Many of the 
rearrangements are ATP-dependent. The yeast enzymes that carry out the ATP-dependent 
steps, termed RNA helicases, are highlighted throughout the cycle. The recycling and 
assembly steps of the splicing cycle are shown with black arrows and are dependent upon 
Prp5p and Sub2p. The activation steps are shown in purple, and are dependent on Brr2p 
and Prp28p. The two chemical steps are shown by blue arrows (flow of electrons in red), 
and are dependent upon Prp2p and Prp16p. The disassembly steps, including the message 
release, are shown with green arrows, and are dependent upon Prp22p, Prp43p and Brr2p. 
Adapted from Scott Stevens.  
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1.1.3.1 Commitment complex 
During transcription, the C-terminal domain (CTD) of RNA Pol II is responsible 
for recruiting the capping enzyme, which caps the 5’ end of the nascent pre-mRNAs with 
a 7-methyl guanosine cap (Cho et al., 1997). Additionally, evidence suggests that the 
CTD is also responsible for co-transcriptional recruitment of the splicing machinery to 
the pre-mRNA (Fong and Bentley, 2001; Listerman et al., 2006). According to the 
stepwise model for spliceosome assembly, as the pre-mRNA is synthesized, the 5’ end of 
the U1 snRNA and snRNP components recognize and interact with the 5’ splice site in a 
ATP-independent manner. In yeast, the 5’ splice site is the conserved dinucleotide, GU, 
at the 5’ border of the intron (Reyes et al., 1996). This interaction forms what is known as 
the commitment complex (Ruby and Abelson, 1988; Seraphin and Rosbash, 1989). The 
RNA-RNA interaction is weak and believed to be aided by U1 snRNP components, likely 
including the following which have been shown to UV crosslink to the 5’ splice site 
region: Snp1p, Yhc1p, Mud15p, Mud10p, SmB1p, SmD1p, and SmD3p (Puig et al., 
1999; Zhang and Rosbash, 1999).  
 
1.1.3.2 Pre-spliceosome formation 
Subsequent to the commitment complex formation, the Branchpoint Binding 
Protein, Bbp1p, recognizes the branchpoint (Berglund et al., 1998). In yeast the 
consensus branchpoint sequence is UACUAAC, where the underlined A is the 
branchpoint nucleotide. The 3’ splice site consensus sequence is YAG, where Y is either 
pyrimidine. The 3’ splice site is a variable distance downstream from the branchpoint 
sequence, but in yeast exists on average 39 nucleotides from of the branchpoint sequence 
(Spingola et al., 1999) and is separated by a polypyrimidine tract of 8-12 nucleotides. 
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This sequence, usually rich in uracil, is recognized by Mud2p (Zavanelli et al., 1994). 
Following the binding of Bbp1p to the branchpoint, the U2 snRNA recognizes and base 
pairs to the branchpoint sequence. It was later discovered that the branchpoint nucleotide 
is the only residue of the branchpoint sequence that does not pair with the U2 snRNA 
(Query et al., 1994), similar to the bulging branchpoint nucleotide of group II introns.  
The ATP-dependent association of the U2 snRNP with the branchpoint requires 
the two DExH/D-box proteins, Sub2p and Prp5p (Fleckner et al., 1997; O'Day et al., 
1996). The action of Sub2p may be required for the release of Bbp1p or Mud2p prior to 
U2 snRNP association with the pre-mRNA (Kistler and Guthrie, 2001), while Prp5p is 
likely involved in rearranging U2 snRNP prior to U2 interaction with the branchpoint 
(Abu Dayyeh et al., 2002). The interaction between the U2 snRNP and the branchpoint is 
dependent upon both the RNA-RNA interactions as well as RNA-protein interactions 
between the U2 snRNP components, SF3a and SF3b which bind upstream of the 
branchpoint and on the branchpoint, respectively (Gozani et al., 1996). The SF3a 
complex is composed of three factors in yeast, Prp9p, Prp11p and Prp21p (Ruby et al., 
1993), while the SF3b complex is made up of six factors: Cus1p, Hsh49p, Hsh155p, 
Rse1p, Ysf3p, and Rds1p. Human pre-spliceosomes contain orthologs of the SF3 
components, in addition to a factor, p14, which directly interacts with the branchpoint 
(Will et al., 2001), and to which there is no obvious yeast counterpart. This second 
recognition event for the branchpoint may be another checkpoint in the splicing cycle 
ensuring correct branchpoint choice. Once U1 and U2 are assembled upon the substrate, 
the spliceosome is termed the A complex.  
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1.1.3.3 U4/U6U5 formation 
According to the traditional stepwise model for assembly, a pathway parallel to 
the pre-spliceosome assembly exists to prepare U4/U6U5, also referred to as tri-snRNP, 
for entry into the spliceosome. The final maturation of the mono-U6 snRNP involves the 
addition of the only mono-U6 snRNP specific protein, Prp24p (Shannon and Guthrie, 
1991). As will be discussed later in detail, Prp24p has been shown to rearrange U6 
snRNA such that U6 snRNA can anneal to U4 snRNA. Following its action, Prp24p 
dissociates, and U4 and U6 form an extensively base paired interaction. As shown in 
Illustration 1.3, this interaction extends the snRNAs into two intermolecular stems with 
one another (Brow and Guthrie, 1988). Additionally, other factors, Snu13p, Prp3p, Prp4p 
and Prp31p are known to bind to the U4/U6 snRNP, and a sequential model for their 
binding to di-snRNP has been suggested from human in vitro studies from the Lührmann 
laboratory (Nottrott et al., 2002). These factors are thought to aid in the stability of di-
snRNP, as well as in the recruitment of mono-U5 to form tri-snRNP. As listed in Table 
1.1, each of these factors is also found to be a component of tri-snRNP, aiding in the 




    
 
 
Illustration 1.3 U4 and U6 snRNAs form an extensive base pairing interaction upon di-
snRNP formation.  
The annealing between the two snRNAs is facilitated by the mono-U6 snRNP 
component, Prp24p. Prp24p likely facilitates this interaction by remodeling the structure 
of U6 snRNA into a conformation in which it can make the correct contacts for forming 
two intermolecular stems with U4 snRNA. U4 and U6 remain base paired throughout 
assembly, and upon activation, U4 snRNA is released from the spliceosome. Adapted 
from Jandrositz and Guthrie (1995) and Dunn and Rader (2010). 
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The core of the mono-U5 snRNP is composed of three large proteins, Brr2p, 
Prp8p and Snu114p, which interact with each other under high-salt conditions even in the 
absence of RNA (Achsel et al., 1998). This heterotrimeric complex likely functions in tri-
snRNP formation, spliceosome formation, and spliceosome function, as it is present in 
the fully assembled spliceosome and subsists throughout the splicing cycle. 
Human studies show how the interaction between U4/U6 and U5 snRNPs may be 
facilitated by interactions between the di-snRNP factors, Prp3p and Prp31p, and the tri-
snRNP and mono-U5 snRNP factor, Prp6p (Liu et al., 2006; Makarova et al., 2002). 
Additionally, data support the tri-snRNP-specific component, Snu66p, may act to bridge 
di-snRNP and to mono-U5 snRNP through its protein-protein interactions with the U5 
snRNP component Brr2p, and the di-snRNP component, Prp3p (Liu et al., 2006). The 
product of the extensive network of interactions between di-snRNP and mono-U5 is the 
formation of U4/U6U5, or tri-snRNP. Tri-snRNP is composed of roughly 30 proteins, 
which are listed in Table 1.1. 
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U1 snRNP U2 snRNP U5 snRNP U6 snRNP U4/U6 snRNP U4/U6U5 
snRNP 
Luc7p Msl1p Prp8p Prp24p LSm2p Prp8p 
Mud1p Lea1p Brr2p LSm2p LSm3p Brr2p 
Nam8p Prp11p Snu114p LSm3p LSm4p Snu114p 
Prp39p Prp21p Snu40p LSm4p LSm5p Prp6p 
Prp40p Prp9p Dib1p LSm5p LSm6p Snu66p 
SmB1p Hsh49p Prp6p LSm6p LSm7p Prp3p 
SmB2p Hsh155p SmB1p LSm7p LSm8p Prp4p 
SmD2p Cus1p SmB2p LSm8p SmB1p Prp31p 
SmD3p Cus2p SmD2p  SmB2p Snu13p 
SmE1p Ist3p SmD3p  SmD2p Dib1p 
SmFp Res1p SmE1p  SmD3p Prp38p 
SmGp Ysf3p SmFp  SmE1p Spp381p 
Snp1p SmB1p SmGp  SmFp Snu23p 
Snu56p SmB2p Prp28p  SmGp SmB1p 
Snu71p SmD2p   Snu13p SmB2p 
Yhc1p SmD3p   Prp3p SmD2p 
Prp42p SmE1p   Prp4p SmD3p 
 SmFp   Prp31p SmE1p 
 SmGp    SmFp 
 Snu17p    SmGp 
     LSm2p 
     LSm3p 
     LSm4p 
     LSm5p 
     LSm6p 
     LSm7p 
     LSm8p 
Table 1.1 snRNP specific proteins  
(Gottschalk et al., 2001a; Neubauer et al., 1997; Stevens and Abelson, 1999; 
Stevens et al., 2001) 
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1.1.3.4 B complex formation  
In the traditional model for assembly of the spliceosome, the B complex is 
defined by the presence of all five snRNAs and a pre-mRNA substrate. The composition 
of purified human B complex has been revealed by 2D gel analysis (Bennett et al., 1992) 
and by mass spectrometry (Makarov et al., 2002; Zhou et al., 2002). Within the B 
complex, RNA-RNA interactions are of considerable interest, as all five snRNAs are 
present. At the point in time when tri-snRNP joins the spliceosome, the 5’ splice site is 
base paired with the U1 snRNA, while the branchpoint sequence is paired to the U2 
snRNA. The U4 snRNA has not been shown known to interact with the pre-mRNA, 
while the U5 snRNP makes contacts with both the 5’ splice site and the 3’ splice site 
(Reyes et al., 1996; Umen and Guthrie, 1995a). The U6 snRNA undergoes extensive 
remodeling upon entry into the spliceosome; however, the significant rearrangements 
likely take place during activation (see 1.1.3.5 below).  
Along with the addition of tri-snRNP to the spliceosome, a number of non-
snRNP-associated proteins also join. Among these factors is the heteromeric Prp19p 
complex, known as the Nineteen Complex (NTC). This complex has been shown to be 
important for U5 snRNP and U6 snRNP stability during activation (Chen et al., 2002) 
and in U5 and U6 snRNA recognition of their respective binding sites in the events 
following activation (Chan and Cheng, 2005). Also known to bind at the time of B 
complex formation is the Retention and Splicing (RES) complex (Dziembowski et al., 
2004). Although the B complex may contain all 5 snRNPs, it is not yet a catalytically 
active spliceosome.  
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 1.1.3.5 Activation of the spliceosome: formation of B* complex 
Further conformational changes and compositional additions and removals are 
required to produce a splicing-competent spliceosome. It is thought that these 
rearrangements include, but are not limited to, the restructuring of the U6 snRNA.  This 
is important to ensure the proper conformation for U6 snRNA and prevent premature 
cleavage of the substrate (Wahl et al., 2009). Activation of the B complex is traditionally 
characterized by the unwinding of U1 and U4 snRNAs from the spliceosome. The action 
on U4 is a result of the ATP-dependent unwinding by the DEID-box protein, Brr2p (Kim 
and Rossi, 1999; Lauber et al., 1996; Xu et al., 1996). Brr2p has multiple roles in 
splicing, and has been shown to be regulated by the GTPase protein Snu114p (Small et 
al., 2006). The ATP-dependent release of U1 is mediated by the DEAD-box factor, 
Prp28p (Staley and Guthrie, 1999). Upon activation, the U6 snRNA, which had 
previously been base paired to U4 snRNA, is now released from its interaction with U4 
and exchanges with U1 snRNA interaction at the 5’ splice site. Additionally, short 
duplexes between U2 snRNA and U6 snRNA are formed, and an intramolecular metal-
binding stem-loop within the U6 snRNA forms (U6-ISL) (Yean et al., 2000). These 
conformational changes likely free residues within U6 that are important for catalysis. 
The remodeling events induced by Prp28p and Brr2p are depicted in Illustration 1.4, and 
specific RNA-RNA disruptions and interactions are highlighted. Prior to the start of this 
dissertation project, the activated “B*” complex had been the final spliceosome 




     
Illustration 1.4 Precatalytic spliceosomes (B complexes) dynamically rearrange to 
activate for catalysis.  
Prp28p is known to unwind U1 snRNA from the 5’ splice site (green), allowing 
for U6 snRNA to base pair to the 5’ splice site (green). Brr2p releases U4 from the 
spliceosome, which results in the reformation of the U6-intra-stemloop (pink), in addition 
to short duplex formations between U2 and U6 (yellow). U2 snRNA remains base paired 
to the branchpoint sequence. Following the remodeling events, the spliceosome is 
activated; however, several other events, which are described in Chapter 3, are required 
before catalysis. Conserved yeast sequences of the pre-mRNA are depicted in dark blue. 
U1 and U6 snRNA/5’ splice site-binding sequences are also shown. Adapted from Wahl 
et al. 2009. 
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1.1.3.6 Transition from the B* complex to the C complex: the first chemical step 
The first step of splicing requires the DEAH-box protein, Prp2p (Chen and Lin, 
1990; King and Beggs, 1990; Roy et al., 1995). Evidence supports a highly transient 
interaction of Prp2p with the spliceosome (King and Beggs, 1990), mediated by the G-
patch protein, Spp2p (Roy et al., 1995). The hydrolysis of ATP by Prp2p is thought to 
cause a conformational rearrangement that results in the optimal positioning of the 
spliceosome around the pre-mRNA, creating an active site (Kim and Lin, 1996). 
However, the resulting structural composition and conformation of the rearrangement 
caused by Prp2p had only been speculated upon prior to this work. Recent work has 
suggested that another factor, Yju2p, acts in an ATP-independent manner after Prp2p 
hydrolysis, and prior to the first chemical step (Liu et al., 2007). Although prior to this 
work, activated B* complexes formed in vivo had not been compositionally defined, in 
vitro data exists to support major reorganizations within the spliceosome following the 
activation event (Makarov et al., 2002). Following these spliceosomal rearrangements, 
the 2’ hydroxyl from the branchpoint adenosine attacks the 5’ splice site to yield the lariat 
intermediate and the freed 5’ exon.     
 
1.1.3.7 The C-complex 
Following the first step of splicing, the spliceosome is not competent for the next 
transesterification until it has undergone at least one more conformational change. To 
prepare for the second chemical step of splicing, the DEAH-box protein, Prp16p, 
hydrolyzes ATP, inducing a remodeling event which positions the reactive species, the 5’ 
splice site and the 3’ splice site, within close proximity (Schwer and Guthrie, 1992). Like 
Prp2p, Prp16p has only a transient interaction with the spliceosome, and following ATP 
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hydrolysis immediately dissociates (Schwer and Guthrie, 1991). Following this 
conformational change, several other factors have been characterized to play a major role 
in the preparation of the spliceosome for the second chemical reaction. These proteins 
include Prp18p and Slu7p, which have been shown to act after Prp16p but upstream of 
the chemical step (James et al., 2002). Additionally, Prp17p, which has been shown to 
join the spliceosome before the first step of chemistry, acts prior to the second step (Sapra 
et al., 2008). Finally the DEAH-box, Prp22p, has been shown to have an ATP-
independent role in the second step of chemistry (Schwer and Gross, 1998). The actions 
of each of these proteins result in an active site where the 5’ splice site can attack the 3’ 
splice site, ligating the two exons and cleaving out the intron in the form of a lariat RNA. 
 
1.1.3.8 Post-catalysis 
Following the second chemical step of splicing, the spliceosome now contains the 
spliced mRNA and the lariat intron. Both of these RNAs are removed from the 
spliceosome by the actions of two DEAH-box factors. Prp22p, uses its ATP-dependent 
function to unwind the spliced message from the spliceosome (Schwer and Gross, 1998), 
while Prp43p is required to disassemble the post-splicing spliceosome, including the 
release of the lariat intron (Martin et al., 2002). The lariat is then debranched by Dbr1p 
(Chapman and Boeke, 1991) and is later degraded.  
 
 26 
1.1.3.9 Preformed model for assembly 
Though strong evidence exists for the classical model for spliceosome assembly 
taking place in a stepwise manner, purifications of the snRNPs under physiological salt 
conditions suggest an alternative model for spliceosome formation. 
 In 1999, Stevens and Abelson characterized a 25S tri-snRNP particle under a salt 
concentration of 250 mM (Stevens and Abelson, 1999). Although tri-snRNP was isolated 
from cells and stable at 250 mM salt, the authors observed that when the salt 
concentration was lowered to 150 mM, U2 snRNP associated with the purified 30S 
particle, indicating the presence of a tetra-snRNP. The results were consistent with 
spliceosomes formed from human extracts conditions containing U2, U4, U5 and U6 
(Konarska and Sharp, 1988). Konarska named the tetra-snRNP a pseudospliceosome and 
used the model to describe spliceosome formation as being a network of snRNP-snRNP 
interactions. Next, Stevens et al. lowered the salt to 50 mM, or conditions required for in 
vitro pre-mRNA splicing (Lin et al., 1985) and observed that all five snRNAs co-purified 
in a 45S particle in the absence of a pre-mRNA (Stevens et al., 2002). The presence of all 
five snRNPs and the absence of the pre-mRNA led to the alternative proposal that 
spliceosome assembly is carried out when the 45S “holo-enzyme” binds to a substrate, 
rather than assembled by discrete integrations of snRNPs upon a substrate. This model is 
outlined in Illustration 1.5.  
The penta-snRNP model for assembly specifies that the U1 snRNA base pairs 
with the 5’ splice site of the pre-mRNA and the branchpoint is base paired to the U2 
snRNA all in the context of the other snRNPs. Furthermore, the data support that in some 
events, U1 snRNP commits to the pre-mRNA in the absence of the other snRNPs. As 
shown in Illustration 1.5, the tetra-snRNP, containing U2, U4, U5, and U6, is then 
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recruited. In this event, the U1 snRNP may be “marking” the 5’ splice site to ensure 
proper processing of the substrate. In either case, the recruitment of a penta-snRNP to the 
substrate would be a kinetic advantage to gene expression. Finally, it is important to note 
the rearrangements required to produce a splicing competent spliceosome all take place in 
the context of the penta-snRNP, as all proteins previously described during spliceosome 
assembly were identified in the penta-snRNP, and in vitro splicing reactions confirmed 







Illustration 1.5 The preformed model of spliceosome assembly states that a penta-snRNP 
contacts the pre-mRNA.  
In the penta-snRNP model for assembly, all five snRNPs associate in the absence 
of pre-mRNA, as opposed to the stepwise addition of the snRNPs in assembly. In some 
cases U1 snRNP identifies the 5’ splice site and then recruits the tetra-snRNP. In either 
case, the result is a B complex spliceosome, containing an unspliced pre-mRNA and all 
five snRNPs. In both models for assembly, the remodeling events are required to activate 





 Following the characterization of the yeast penta-snRNP, mammalian data was 
produced that supported the penta-snRNP assembly model (Azubel et al., 2004; Malca et 
al., 2003). Further work in human and chicken cells has described the existence of a 
supraspliceosome, where four penta-snRNPs associate upon a single substrate pre-mRNA 
(Azubel et al., 2006; Chen et al., 2007).  
It is important to note that much of the data supporting stepwise assembly have 
been acquired from in vitro reconstitutions of the spliceosome or spliceosome assembly 
intermediates. In light of the salt-sensitivity of spliceosome precursors, one could argue 
that in vitro-reconstituted particles may not necessarily be authentic representations of the 
on-pathway intermediates of the splicing cycle. Additionally, in vitro assembly of the 
spliceosome produces ensemble populations, which are not well coordinated and which 
contain significant proportions of off-pathway, dead-end particles. Since the splicing 
cycle is just that, a cycle, purifications of particles arrested at specific steps in vivo may 
provide a more accurate description of the spliceosomal complexes that exist during the 
assembly, activation, catalysis, disassembly, and recycling.  
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1.2  DYNAMIC REARRANGEMENTS IN THE SPLICING CYCLE 
 Self-splicing group II introns depend on extensive secondary and tertiary 
structures within the intron to facilitate their intron removal (Boudvillain et al., 2000). 
Although pre-mRNA splicing uses the identical chemical mechanism for removal of 
introns, pre-mRNAs lack the intramolecular interactions and conserved sequences that 
group II introns employ to catalyze their intron removal. Instead pre-mRNAs depend on 
the actions of the snRNAs and proteins of the spliceosome to position the intron into a 
configuration where intron removal is achievable. This leads to the important question of 
how the dynamic changes within the spliceosome occur to promote spliceosome 
assembly, activation, catalysis and disassembly, all in a forward direction. The major 
contributors to this critical element of pre-mRNA processing are members of the 
DExH/D-box family of RNA helicases.  
 
1.2.1 RNA helicases 
RNA helicases are characterized by the presence of at least eleven identified 
conserved sequence motifs, which are involved in binding an NTP and coupling energy 
released by NTP hydrolysis to unwind double stranded RNA (de la Cruz et al., 1999). 
However, some RNA helicases have been implicated in other energy-dependent 
processes, which do not involve an unwinding event, but instead, an RNA-protein 
disruption or rearrangement (Jankowsky et al., 2001; Linder, 2006; Schwer, 2001). The 
family of RNA helicases that is responsible for most RNP modifications is known as the 
DExH/D-box helicases. The conserved sequences of DExH/D-box factors are depicted in 
Illustration 1.6. These factors have a unique sequence in motif II (DEAD or DEAH) of 
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the conserved helicase domain, for which they are named (Linder et al., 1989). DExH/D-
box proteins have been implicated in almost all gene expression events, including 
transcription (Nakajima et al., 1997; Venema and Tollervey, 1999), ribosome biogenesis 
(Venema and Tollervey, 1999), pre-mRNA splicing (Staley and Guthrie, 1998), mRNA 
nuclear export (Schmitt et al., 1999), translation (Svitkin et al., 2001; Weng et al., 1996) 
and RNA degradation (Weng et al., 1996).  
The differences between DEAD- and DEAH-box factors extend beyond their 
sequences in motif II. Although both are stimulated to hydrolyze an NTP by binding 
RNA, DEAD-box proteins use ATP exclusively, while DEAH-box factors may use any 
NTP (Tanaka and Schwer, 2005; Tanner et al., 2003). Additionally, DEAD-box factors 
contain two conserved sequences C-terminal to the DEAD-box domain (Cordin et al., 
2004), while DEAH-box factors generally have longer conserved motifs within the 






Illustration 1.6 Conserved motifs of DExH/D box proteins.  
DExH/D-box proteins are defined by eight conserved motifs. Motifs I, II and VI 
are known to participate in ATP binding and hydrolysis, while motifs Ia, Ib, IV and V 
facilitate RNA binding. The DEAD-box motifs are typically shorter stretches of 
conserved sequences compared that of to DEAH-box proteins.  
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1.2.2 DExH/D-box helicases in splicing 
The major conformational changes within the spliceosome are triggered by 
members of the DExH/D-box family. In the yeast splicing cycle, three DEAD-box factors 
are required in an ATP-dependent manner during spliceosome assembly: Sub2p (Kistler 
and Guthrie, 2001), Prp5p (Ruby et al., 1993), and Prp28p (Noble and Guthrie, 1996; 
Staley and Guthrie, 1999). In addition to these factors, there are four ATP-dependent 
steps during the catalytic and disassembly phases of the splicing cycle where DEAH-box 
proteins act sequentially to induce remodeling events. These factors include Prp2p, which 
is required before the first step of chemistry (King and Beggs, 1990; Schwer and Guthrie, 
1991); Prp16p, which induces a rearrangement after the first step of chemistry but before 
the second step of chemistry (Schwer and Gross, 1998; Schwer and Guthrie, 1991); 
Prp22p, which uses its ATP-dependent function to release the spliced message from the 
spliceosome (Martin et al., 2002; Schwer and Gross, 1998); and Prp43p which 
disassembles the spliceosome after catalysis (Martin et al., 2002). Prp43p also functions 
in ribosome biogenesis (Combs et al., 2006; Lebaron et al., 2005; Leeds et al., 2006; 
Tanaka and Schwer, 2006). Additionally, Brr2p, which has two RNA helicase cores 
making it a hybrid between DEAD- and DExH-box families, has been shown to act in 
both activation (Raghunathan and Guthrie, 1998a) and disassembly of the spliceosome 
(Small et al., 2006). It is interesting to note that the helicases, which are required for 
catalysis during the splicing cycle are DEAH-box factors, while the assembly steps are 
promoted by DEAD-box proteins.  
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1.2.3 DEAH-box specificity 
Although, most of the DExH/D-box factors have been shown to function in 
particular events, the specific targets of only three DExH/D-box factors have been 
determined (Guenther and Jankowsky, 2009). Among these, the specificity for only one 
splicing helicase, Prp22p, has been identified (Schwer, 2008). It is presumed that the 
reason for this paucity of information regarding helicase target sites is due to the innate 
dynamic characteristics of the helicases, creating an experimentally challenging problem. 
Many helicases, such as Prp2p and Prp16p, interact with their substrates in a transient 
manner probably to limit activity in time and space (Linder, 2006), thus making it 
difficult to determine interaction specificity. A recent biochemical strategy, Crosslinking 
analysis of cDNA (CRAC) (Granneman et al., 2009), which stems from Crosslinking 
Immunoprecipitation (CLIP) (Jensen and Darnell, 2008), has made it possible to identify 
the site on an RNA where an interacting protein binds. This strategy has already proven 
useful in identifying the interaction sites of RNA binding proteins (Bohnsack et al., 
2009); however, it will be challenging for those helicases that interact only transiently in 
nature. Work in Chapter 2 and insights in Chapter 5 will elaborate upon strategies to 
identify binding sites for dynamically interacting RNA helicases. 
 
1.2.4 DEAH-box-induced rearrangements  
Each of the NTPase activities of DEAH-box factors has been shown to be 
stimulated by RNA binding. Recent work has revealed the first structure of the DEAH-
box protein, Prp43p (He et al., 2010; Walbott et al., 2010). Structural work has revealed a 
β-hairpin between motifs V and VI, which the authors have proposed plays an important 
role in RNA unwinding or RNP remodeling. When bound by ADP, the β-hairpin of 
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Prp43p blocks access of an RNA substrate, indicating that hydrolysis of ATP or Pi release 
triggers of remodeling by Prp43p (He et al., 2010). This finding may apply for the other 
DEAH-box factors as well, as many may process, translocate, or dissociate from their 
substrates concomitantly with ATP hydrolysis. The data also provide a consistent view of 
how structural rearrangements induced by the DEAH-box helicases are unidirectional. 
Unfortunately, it is still unclear exactly how DEAH-box proteins induce 
remodeling events within RNPs; however, the evidence for DEAH-box stimulated RNA 
disassembly stands strong (Chen et al., 2001; Jankowsky et al., 2001; Kistler and 
Guthrie, 2001; Lardelli et al., 2010; Schwer, 2008). There are several proposed 
mechanisms for RNA helicase function, based on in vitro studies (Jankowsky et al., 
2001), including a promising model where the helicase tracks processively along a single 
stranded RNA, displacing RNAs in its path. In the event that the helicase is less 
processive, RNP disruption may be a result of a force exerted by the helicase to disrupt 
an interaction between a protein and an RNA, and this single breakage may lead to a 
destabilization of a larger complex from the RNA (Jankowsky and Bowers, 2006). 
Furthermore, it has been demonstrated that DEAD-box binding of ATP can induce short 
RNA duplex unwinding, likely by inducing formation of a conformation of the DEAD-
box protein favorable for strand separation (Chen et al., 2008). It is also possible that a 
conformational change upon ATP hydrolysis could lead to a physical interaction between 
protein and DExH/D-box factor serving to create the disruption. In any case, the 
consequences of the actions of DExH/D-box factors in splicing lead to conformational 




1.3 SACCHAROMYCES CEREVISIAE AND SPLICING 
In 1996, Goffeau et al. published the sequence of the first eukaryotic genome 
(Goffeau et al., 1996). This genome, belonging to the eukaryotic single cellular organism, 
S. cerevisiae, is comprised of roughly 6000 genes. Of these, 5885 genes are protein 
encoding, while 140 code for ribosomal RNAs, 40 for small nuclear RNAs, and 275 code 
for transfer RNAs (Goffeau et al., 1996). Interestingly, of the protein encoding genes, 
only ~5% contain introns, and the vast majority of these genes contain only a single 
intron. It has been shown that roughly one third of these introns are not essential and have 
only minor effects on cell growth (Parenteau et al., 2008). Meanwhile, the genomes of 
complex eukaryotes are mostly comprised of genes with at least one intron, and nine on 
average (Lander et al., 2001).  
Despite the relatively low levels of genes carrying introns in S. cerevisiae, the 
introns that do exist are mostly found in genes that are highly expressed. The genes 
containing introns actually make up close to one third of all cellular transcripts (Ares et 
al., 1999), and it has been shown that introns actually increase the yield of both 
transcriptional and translational products (Juneau et al., 2006). Additionally, roughly 
75% of all genes encoding ribosomal proteins contain introns, while introns are also 
found frequently in genes encoding secretion and meiosis factors (Juneau et al., 2006). It 
is interesting to note that ribosomal genes seem to have longer introns when compared to 
other classes of intron-containing genes (Spingola et al., 1999). These non-random 
characteristics of introns in S. cerevisiae build an intriguing, simplified model organism 
for the study of splicing.  
The splice site sequences in yeast pre-mRNA are more highly conserved than 
those in higher eukaryotes (Meyer and Vilardell, 2009). The lack of defined splice sites in 
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complex eukaryotes is thought to be predominantly due to the need for alternative usage 
of splice sites in alternative splicing. With the conserved GUAUGU at the 5’ splice site 
and the conserved branchpoint sequence of UACUAAC, yeast provide a defined system 
for studying the fundamentals of splicing, pertinent to all eukaryotic organisms.  
Higher eukaryotes have the means by which a gene product can be alternatively 
spliced. The ability of higher eukaryotes to splice pre-mRNA along multiple pathways 
likely plays an important role in the evolution of their complexity; or perhaps it is 
evolution that allows them the adaptation to alternatively splice (Cooper et al., 2009). On 
the other hand, there are very few reports of alternative splice site selection in S. 
cerevisiae (Davis et al., 2000). Despite the substantial difference between S. cerevisiae 
and higher eukaryotes when it comes to alternative splicing, the splicing machinery and 
regulation for the splicing process include the same basic foundation (Meyer and 
Vilardell, 2009). 
In addition to alternative splicing, the metazoan system has another layer of 
complexity, with the existence of a second “minor” spliceosome (Tarn and Steitz, 1997). 
This spliceosome uses similar principles in assembly and splicing mechanism; however, 
splicing of minor class introns operates on different platform. The minor spliceosome is 
composed U11 and U12, which are analogous to U1 and U2 in the major spliceosome, 
and U4ATAC and U6ATAC, which act in place of U4 and U6. The fifth snRNA 
involved in minor class splicing is the U5 snRNA, which is shared between the major and 
minor spliceosomes (Luo et al., 1999). Though yeast lacks this second spliceosome 
entirely, the splicing of both major and minor class introns relies on fundamentals, which 
have been shown and continue to be studied in S. cerevisiae.    
Because it seems introns are the rule in higher eukaryotes rather than the 
exception, complex eukaryotic cells must accommodate by having high levels of the 
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machinery required for this process. Similarly, S. cerevisiae also proportionally 
accommodates the intronic levels within the cell with splicing machinery. This makes the 
isolation and characterization during biochemical studies of spliceosomal intermediates 
in yeast challenging, requiring nothing short of large-scale cellular growth.  
The simplified splicing system of S. cerevisiae offers a number of other 
advantages as a model organism. First, yeast replicate rapidly, with wildtype doubling 
times of roughly 90 minutes (Botstein and Fink, 1988). Secondly, yeast readily undergo 
homologous recombination, making genetic manipulation, including insertions, deletions 
and integrative disruptions, possible and tractable (Botstein and Fink, 1988). The 
screening of either temperature sensitive mutant collections (Blanton et al., 1992; 
Lockhart and Rymond, 1994; Rosbash et al., 1981; Vijayraghavan et al., 1989) or cold 
sensitive mutant collections (Noble and Guthrie, 1996) for mutants who have splicing 
defects when subjected to non-permissive temperatures, have provided a means by which 
a substantial number of splicing factors have been discovered. Interestingly, many of the 
cold sensitive conditional splicing mutants prove very useful for biochemical analysis. 
This will be discussed in more detail in Chapter 2.   
While S. cerevisiae is optimal for studying basic cellular processing events 
because of its simplicity, it is obviously a limited model, lacking the machinery that 
would likely develop the organism into a more complex eukaryote.  Even so this 
organism provides an excellent system to study the foundation of what has proven to be a 




1.4 DISSERTATION OBJECTIVES 
When my dissertation work began, the current understanding of the catalytic steps 
of the splicing cycle was limited to characterizations of particles that were reconstituted 
upon in vitro transcribed substrates. Although these particles provide a foundation from 
which the knowledge of splicing can be expanded, these particles do not necessarily 
represent authentic on-pathway intermediates of the splicing cycle because they are not 
necessarily functional intermediates. In addition, assembly upon a single transcript does 
not represent spliceosomal particles assembled upon the entire collection of yeast intron-
containing transcripts. Because of the dynamic nature of the spliceosome, in vivo 
analyses are difficult, yet necessary from a biochemical standpoint. Accumulating 
homogenous spliceosomal particles at a level high enough to molecularly analyze is 
another challenging problem.  
 With my dissertation work, I intended to employ the power of yeast genetics to 
arrest spliceosomes in vivo and isolate the normally transiently occurring spliceosomal 
intermediates. My intention was to compositionally characterize in vivo purified particles. 
Compositional comparisons between particles made the characterization more interesting, 
as striking changes between spliceosomal intermediates became apparent. Because the 
particles were arrested at a non-permissive temperature some of the analysis allowed 
functional follow-up by incubating the purified particles under the proper conditions at 
permissive temperature.   
 This dissertation is divided into five chapters. Chapter one includes the discovery 
and history of the spliceosome and its constituents, and a detailed report of the splicing 
reaction in the context of the splicing cycle. This is followed by a review of the current 
understanding of the protein factors that are thought to affect the conformational 
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rearrangements within the spliceosome and permit the forward progress of the splicing 
cycle. Finally, this chapter provides a line of reasoning for using S. cerevisiae as a model 
organism to study splicing.  
 The second chapter outlines the first part of my dissertation project. In this 
chapter, the methods for arresting and isolating functional spliceosomes assembled in 
vivo will be introduced. Spliceosomes arrested before the first step of catalysis, before the 
second step of catalysis, and before the message is released from the spliceosome will be 
presented, and a compositional analysis and comparison of these isolated particles is 
provided.  
 Though the original goal of this project was to compare the components of 
catalytically arrested spliceosomes, the compositions of each spliceosome led to the 
hypothesis that a large complex of proteins, known as the SF3 complex, is released 
following one of the DExH/D-box remodeling events. Chapter 3 details functional testing 
of first-step arrested particles, and how a chase from an arrested particle through a single 
catalytic step provided insights a novel ATP-independent conformation change, in 
addition to the ATP-dependent release of the SF3 complex from the branchpoint 
sequence. 
 After the spliceosome has completed a round of splicing, it must disassemble into 
its snRNP components and reassemble. This recycling of snRNPs requires at least one 
ATP-independent rearrangement of U6 snRNA prior to its entry into the splicing cycle. 
Following the remodeling, U6 snRNA can base pair with U4 snRNA. These events are 
facilitated by an essential RNA binding protein, Prp24p. Chapter four details the genetic 
analysis of the essential nature of Prp24p and biochemical experiments on in vivo 
purified particles that led to a model where Prp24p may also be required for events 
following di-snRNP assembly in splicing cycle.  
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 The major theme of my dissertation work has been isolating and characterizing 
dynamic spliceosomal particles using genetic strategies. By employing cold-sensitive 
mutant proteins, this work has demonstrated the purification and characterization of the 
major intermediates in the splicing cycle, in addition to previously uncharacterized 
assembly intermediates. These particles have been arrested in vivo, purified, 
compositionally defined, and functionally tested to reveal novel mechanistic information 
regarding pre-mRNA splicing and the recycling of snRNPs.  
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Chapter 2: In vivo characterization of catalytic splicing intermediates 
2.1 THE CATALYTIC STEPS OF THE SPLICING CYCLE 
To fully appreciate and understand the spliceosome, it is crucial to define the 
mechanisms underlying its assembly, the authorization for initiating the two chemical 
steps and the proofreading of the splice sites. Although both pre-mRNA introns and 
group II introns possess a conserved 5’ splice site, 3’ splice site and branchpoint 
sequence, spliceosomal introns lack the sequences and structures that group II introns 
rely on to self-catalyze their intron removal. Instead, intron removal from pre-mRNAs 
depends on the regulated and coordinated efforts of over one hundred snRNP-associated 
and non-snRNP associated splicing factors. These factors contribute to the proper 
assembly of the substrate, the precise formation of the spliceosome and dynamic 
rearrangements within the catalytic core of the spliceosome. Among these factors are 
eight highly conserved RNA helicase-like proteins of the DExH/D-box family (Staley 
and Guthrie, 1998), and three of these, all DEAH factors, play a critical role during 
catalysis (Illustration 2.1). Prp2p is required in an ATP-dependent manner for the first 
chemical step (Chen and Lin, 1990; King and Beggs, 1990), while Prp16p uses ATP to 
permit the second chemical step (Schwer and Guthrie, 1991). Following catalysis the 
ATP- dependent function of Prp22p is required to release the spliced message (Company 
et al., 1991). Downstream of the conserved DEAH box domain, each of these proteins 
share a homologous C-terminal domain (Burgess et al., 1990; Chen and Lin, 1990; 
Vijayraghavan et al., 1989), which is important for interaction with the spliceosome 
(Edwalds-Gilbert et al., 2004) and for function (Schneider and Schwer, 2001). Although 
these factors have been assigned to particular events, the exact nature of the molecular 






Illustration 2.1 DEAH-box proteins permit forward process during the catalytic steps of 
splicing. 
Prp2p induces an ATP-dependent conformational rearrangement prior to the first 
step of splicing. Prp16p is required in an ATP-dependent manner to induce a 
rearrangement before the second chemical step. Prp22p acts in an ATP-independent 
manner in the second step of chemistry and is required to promote the release of the 
spliced message using its ATP-dependent function.  
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2.1.1 The first step of splicing 
The first chemical step of splicing occurs when the 2’-OH of the intron 
branchpoint adenosine attacks the phosphodiester bond of the 5’ splice site, releasing the 
5’ exon and forming a branched lariat intermediate RNA (Padgett et al., 1984; Ruskin et 
al., 1984). This reaction takes place in the active site of the spliceosome, and while 
studies focused on the second step of splicing have revealed active site components, the 
first-step factors and their role in catalysis have remained elusive.  
Prp2p was implicated in splicing based on the finding that when mutant prp2 heat 
inactivated extract was subjected to splicing conditions, pre-mRNA in the context of the 
40S spliceosome accumulated (Lin et al., 1987). This result was followed up by 
complementing the extracts with wildtype extract containing elevated levels of Prp2p, 
and by adding ATP. This effectively chased the pre-mRNA into the products of the first 
reaction (Lin et al., 1987), implying a function for Prp2p in the first step. Later, the 
specific ATP requirement in the first step was demonstrated to be that of Prp2p, as this 
factor showed an RNA-dependent ATPase function specifically associated with the first 
step of splicing (Kim and Lin, 1993; Kim et al., 1992).  
Further studies have shown that Prp2p only transiently interacts with the 
spliceosome, binding in the absence of ATP, and exiting upon ATP hydrolysis (Kim and 
Lin, 1993; King and Beggs, 1990). Upon ATP hydrolysis, Prp2p is thought to induce a 
conformational change in the spliceosome, which permits the second step of splicing 
(Kim and Lin, 1993; Kim and Lin, 1996). Evidence suggests that ATP hydrolysis by 
Prp2p is tightly linked to the first step of splicing; however, uncoupling these events 
presents a challenge.  
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2.1.2 The second step of splicing 
The second step of the splicing reaction occurs when the 3’-OH of the 5’ exon 
attacks the phosphodiester bond at the 3’ splice site, joining the exons and liberating the 
intron lariat RNA. A number of protein factors, including Prp18p, Slu7p, Prp17p, and 
Prp22p have been characterized to participate in the second step in an ATP-independent 
manner. On the other hand, ATP hydrolysis by Prp16p is required prior to the second step 
of chemistry.  
It has been proposed that the spliceosome resulting from Prp16p action prepares 
an active site for the second step chemistry (Umen and Guthrie, 1995c).  Like Prp2p, 
ATP hydrolysis by Prp16p is an RNA-dependent reaction; however, purified Prp16p does 
not have RNA helicase capabilities (Schwer and Guthrie, 1991), suggesting its role is not 
in unwinding RNA. Instead, Prp16p is thought to carry out a conformational change that 
results in the correct positioning of the substrate for second step catalysis. Upon 
interaction with the spliceosome, Prp16p has been found to interact with the intron 3’ 
splice site by crosslinking studies. Following hydrolysis Prp16p leaves the spliceosome 
(Schwer and Guthrie, 1991), showing a transient interaction prior to the second step 
analogous to the transient interaction of Prp2p before the first step of catalysis. This 
Prp16p-induced conformational rearrangement results in protection of the 3’ splice site 
from oligonucleotide-directed RNase H cleavage (Schwer and Guthrie, 1992), implying 
that an active site may be forming around the second step nucleophile. Following this 
rearrangement, the second step factors Slu7p and Prp8p have been shown to crosslink at 
the 3’ splice site, and to act just before the chemical reaction (Umen and Guthrie, 1995b).  
The action of Prp16p is required for the second step of catalysis to proceed; 
however, ATPase-deficient mutant alleles of prp16 are suppressed by branchpoint 
mutants. This is thought to occur not by kinetically increasing the rate of the second step, 
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but instead by inhibiting the degradation of the mutant lariats (Burgess and Guthrie, 
1993), thus assigning a proofreading mechanism to Prp16p in the second step of splicing.  
 
2.1.3 Message release  
An ATP-independent role has been assigned to Prp22p in the second catalytic 
step; however, this role is only essential for introns containing large distances between 
the branchpoint and the 3’ splice site (Schwer and Gross, 1998). On the other hand, 
Prp22p is essential for the ATP-dependent dissociation of the mRNA from the 
spliceosome (Company et al., 1991). In mRNA displacement, Prp22p has been proposed 
to bind downstream of the 3’ splice site and act to disrupt the mRNA/U5 snRNP contacts 
using 3’ →5’ helicase activity (Schwer, 2008).  
 
2.1.4 Characterizations of dynamic intermediates of splicing 
The dynamic nature of the spliceosome, especially during the catalytic stages of 
the splicing cycle makes studying splicing intermediates a major challenge. Previous 
reports have focused their efforts upon the analysis of spliceosomes assembled from 
extracts on in vitro transcribed substrates. Experimental approaches include 
immunodepleting an essential factor (Chiu et al., 2009; Liu et al., 2007) or using 
transcripts with mutations in the conserved splice sites or branchpoint sequences 
(Bessonov et al., 2008; Fabrizio et al., 2009). A recent study, published while this 
dissertation work was under review, inactivated splicing in extracts made from 
temperature sensitive prp2 strain (Warkocki et al., 2009). Though these strategies provide 
a foundation for analyzing splicing intermediates, particles assembled from extracts do 
not necessarily represent authentic, on-pathway, functional intermediates from the 
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splicing cycle.  Additionally, the characterization of these intermediates is limited to 
complexes assembled upon a single pre-mRNA transcript.  
Though the dynamic process of splicing creates a hurdle for understanding the 
role of the spliceosome in splicing, it is also critical to understand how the splicing 
machinery acts in concert with pre-mRNA to catalyze intron removal from spliceosomes 
assembled during normal cellular activity. This chapter described a genetic strategy, 
which allows for biochemical purification of functional, synchronized spliceosomes from 
yeast, assembled in vivo. Spliceosomes were genetically arrested at three critical 
checkpoints, namely, spliceosomes arrested before the first and second steps of splicing 
and spliceosomes arrested post-catalysis, to enrich for on-pathway, functional complexes. 
This chapter describes the characterized components of these spliceosomes, accounting 
for the snRNA, protein and pre-mRNA content. These compositional studies provide the 
first study of in vivo assembled spliceosomes during the catalytic stages of splicing 





2.2 MATERIALS AND METHODS 
2.2.1 Tagging vectors  
Vector Purpose Selectable marker 
pJPS1162 TAP tagging KANr (Kanamycin 
resistance) 
pBS1539 TAP tagging URA 








SS1347 a ura3, leu2, trp1, his3, lys2, prp2::TRP, pRS415-PRP2-TAP::URA3  
SS1348 a ura3, leu2, trp1, his3, lys2, prp2::TRP, pRS415-prp2G551N-TAP::URA3  
SS492 a hisΔ200, leu2Δ0, met15Δ0, trp1Δ63, ura3Δ0, PRP16-TAP::TRP1 
SS1316 a ade2, his3, leu2, lys2, trp1, ura3, prp16::LYS pSE358-prp16-302-TAP::URA3  
SS1311 α gal-, mal-, his4-619, prp16R456K-TAP::KAN (parent DBY4406) 
SS1330 α gal-, mal-, his4-619, prp22D613Q-TAP::KAN (parent DBY4172) 
SS1332 α gal-, mal-, his4-619, prp22-G394R, D613Q-TAP::KAN (DBY4423) 
SS481 a PRP22-TAP::URA3 
Table 2.2 Yeast strains used in Chapter 2.  
 49 
2.2.3 Oligos 

























U1 probe 5’GAATGGAAACGTCAGCAAACAC3’ 
U2 probe 5’AAGAACAGATACTACACTTGA3’ 
U4 probe 5’ACCATGAGGAGACGGTCTGG3’ 
U5 probe 5’ATGTTCGTTATAAGTTCTATAGGC’3 
U6 probe 5’AGGGGAACTGCTGATC3’ 
RPP1B ex1SS5 5’ATTGACTATCACCAAGGCCGC3’ 
RPP1B ex2-3 5’GTGACGCTGCTGCTGAAGAAGAAA3’ 
YFL039C_1_p_F 5’AGGGGCTTGAAATTTGGAAAAA 3’ 
YFL039C_1_L_R 5’GCAAGCGCTAGAACATACATAGTACA3’ 
YFL039C_1_I_F 5’TTGCTTCATTCTTTTTGTTGCT3’ 




PRP22seq4 5’AGGTGACAGCATCGGCGAATTAC 3 
PRP22seq5 5’CACGCTCTTTATTGTCATCTGTTG3’ 
PRP16seq1 5’GGTGCCTGAACCTCTGTCTGAATT 3’ 










Table 2.3 Oligos used for PCR generation of tags, Northern blotting, RT-PCR, and 
sequencing in Chapter 2.  
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2.2.4 Creation of yeast strains  
Yeast strains listed in section 2.2.2 were created by through use of a PCR-
generated fragment with arms of homology to the region in which the tag was to be 
knocked in, followed by a selectable marker, URA3 for TAP tags generated from 
pBS1539, or KANr (Kanamycin resistance) for TAP fragments generated from 
pJPS1162. Fragments were transformed in using the lithium acetate transformation 
method (Gietz and Woods, 2002). Colonies that grew on synthetic media lacking URA or  
on rich media containing Geneticin (Gibco BRL Life Technologies, Inc.), were screened 
for presence of a functional TAP tag by western blotting. In brief, whole cell extract was 
subjected to SDS-PAGE, transferred to nitrocellulose (Bio-Rad) overnight at 4°C (in 
20% methanol, 0.001% SDS, 386 mM glycine, 48 mM Tris base), blocked with 
BLOTTO (PBST + 5% SDS), washed twice in PBST for 5 minutes each, incubated with 
a 1:1000 dilution of the peroxidase anti-peroxidase antibody (Rockland) for 1 hour, 
washed with PBST 4 times for 15 minutes each, subjected to Chemiluminescent detection 
(Perkin Elmer), and exposed to film.  
 
2.2.5 Mapping helicase mutations 
To map the mutations in the prp16 and prp22 genes in the DBY strains, the entire 
open reading frame was PCR-amplified from the respective strains. The prp16 mutation 
contained in DBY4406 is Arg 456 to Lys, located just downstream from motif Ib. The 
mutation in prp22 contained in DBY4172 is Asp 613 to Gln, a charge reversal located 
just after the DEAH-box (motif II). The mutation in prp22 contained in DBY4423 is Gly 
394 to Arg, as well as the same Asp 613 to Gln also found in DBY4172. The 
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characterized prp2 mutation Gly 551 to Asn is accompanied by an additional previously 
uncharacterized mutation: Asp 547 to Glu, which suppresses the dominant negative 
phenotype reported by Lin and colleagues (Edwalds-Gilbert et al., 2000). 
 
2.2.6 Cell growth and temperature shifts 
Wildtype strains were grown in YPD at 31°C to OD (A600) = 1.5 before 
harvesting. Mutant strains were grown at PT (prp2G551N strains at 37°C; prp16 and 
prp22 strains at 31°C) to OD (A600) = 1.0 and then shifted to NPT (prp2G551N strains at 
25°C; prp16 and prp22 strains at 16°C) for 45 minutes. Cells were harvested by 
centrifugation, washed in cold water, washed in buffer A (10mM HEPES, pH 7.9, 200 
mM KCl, 1.5 mM MgCl2, 8% glycerol), and resuspended in one volume (w:v) buffer A 
before freezing dropwise in liquid nitrogen.  
 
2.2.7 Isolation of arrested spliceosomes 
The Tandem Affinity Purification (TAP) tag provides a method for two-step 
purifications of complexes assembled in vivo (Rigaut et al., 1999). The TAP tag 
combines two affinity tags, separated by a Tobacco Etch Virus (TEV) cleavage site 
(Dougherty et al., 1989)(see Illustration 2.2). With a Protein-A domain at the C-terminus, 
the complex of interest is captured on IgG antibody-conjugated beads. Following washes, 
the Protein A tag can be cleaved from the complex, and left on the column through of the 
TEV protease cleavage site, which lies in between the protein-A tag and the Calmodulin 
binding domain. The complex can then be affinity purified to a further extent by using the 
Calmodulin resin, and eluting with EGTA (Niggli et al., 1979). The affinity steps in this 
dissertation employ the use of only the Protein-A tag and the TEV cleavage site of the 
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TAP tag. As described below, glycerol gradient sedimentation serves a second and size 
separating purification step following the initial affinity purification, which keeps the in 





Illustration 2.2 The TAP tag can be used for two-step affinity purification of native in 
vivo assembled complexes.  
An IgG affinity column captures the Protein-A tag at the C-terminus of a protein 
contained within the complex of interest. The Protein-A tag can be cleaved by TEV 
protease, leaving the complex of interest with a C-terminal Calmodulin binding domain. 
This can be used  in a secondary purification step. 
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Frozen cells were milled using a Retsch mixer mill (Mayas et al., 2006) with 50 
mL canisters immersed in liquid nitrogen. Briefly, cells were disrupted by shaking at 10 
Hz for 5 cycles of 3 minutes each. ATP was depleted by addition of glucose to 2 mM. 
Whole cell extract was prepared as described (Stevens and Abelson, 2002). Briefly, the 
pulverate was thawed, and allowed to extract for 30 minutes by gentle rotation at 4°C in 
the presence of 5 μM Leupeptin, 3 μM Pepstatin, 0.4 mM PMSF, and 1 mM DTT. 
Extract was cleared by centrifugation at 30,000 x g for 30 minutes at 4°C, and then 
100,000 x g for 1 hour at 4°C. The middle third of the cleared extract was gently removed 
following the second centrifugation step, and allowed to dialyze in Buffer D-Lite 
(containing 8% glycerol, 150 mM KCl, 1.5 mM MgCl2, 20 mM HEPES, pH 7.9) for 2 x 1 
hour. Extract (~40 mL) was incubated with IgG sepharose (400 μL) for 1 hour at 4°C 
with rotation to allow binding of the TAP tag to IgG. The resin was washed with 40 mL 
of IPP150 (10 mM Tris, pH 8.0, 150 mM NaCl, 0.1% NP-40, 1.5 mM MgCl2, 8% 
glycerol, 1 mM DTT), and then resuspended in IPP150 (1.2 mL). Bound material was 
incubated for 1 hour at 16°C with TEV protease to cleave the TAP tag and RNase 
Inhibitor (Invitrogen). The eluted material was layered onto 10-30% glycerol gradients 
(made with 20 mM HEPES, pH 7.9, 150 mM KCl, 1.5 mM MgCl2, 0.2% NP-40, 1 mM 
DTT, 0.2 mM PMSF), and the gradients were centrifuged for 10 hours at 29,000 RPM in 
an SW41 rotor at 4°C. Fractions were phenol/chloroform extracted, and protein and RNA 
were precipitated (Stevens and Abelson, 2002).  
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2.2.8 Northern blot analysis 
RNA was precipitated by adding 2.5 volumes of ethanol, and incubating 
overnight at -20°C. RNA was pelleted by centrifugation and washed with 70% ethanol. 
Following drying the pellet, the RNA was resuspended in formamide loading buffer 
(80% formamide, 10mM EDTA pH 8.0, xylene cyanol, bromophenol blue), heated for 10 
minutes at 65°C and then separated by electrophoresis on a 7% 19:1 polyacrylamide gel, 
containing 8M urea and 1x TBE, for 1 hour and 45 minutes at 25 mA/gel. Gels were 
transferred to nylon membrane (Whatman) overnight at 0.5 A in 25 mM  Na2HPO4, pH 
7.0 buffer at 4°C. The RNA was crosslinked to the membrane by exposing the membrane 
to UV (254 nm) light for 1 minute, prior to pre-hybridization incubation at 42°C in 
Church buffer (500 mM Na2HPO4 pH 7.0, 7% SDS, 1 mM EDTA)(Church and Gilbert, 
1984). Hybridization with γ 32P radiolabeled oligonucleotides was performed overnight at 
42°C. The membrane was then washed briefly in 6x SSC, 2 times with 2x SSC + 0.5% 
SDS for 15 minutes each at 42°C, and once more briefly with 6x SSC. The membranes 
were then exposed to a phosphorimaging screen (Bio-Rad), and developed in a 
phosphorimager (GE Healthcare Typhoon).  
 
2.2.9 RNA quantitiation and normalization 
Quantitation of snRNAs was performed by phosphorimaging analysis using the 
Quantity One suite of software (Bio-Rad). Values for each band within the Northern blot 
were quantitated using identically sized analysis frames. Background levels were 
subtracted from each of the values using an identically sized analysis frame in a region of 
the Northern blot that contained no signal. Background-subtracted RNA signals from 
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each glycerol gradient fraction were normalized against the lane with the most intense 




Peak fractions from the glycerol gradients were treated with DNase I (Promega) 
and RNase inhibitor (Invitrogen) for 15 minutes at 37°C. RNA was phenol/chloroform 
extracted, precipitated, and reverse transcribed with AMV reverse transcriptase 
(Promega) using an oligonucleotide primer specific to the RPP1B ex2-3 oligo for full 
length transcripts or YFL039C_1_L_R (ACT1) for lariat or YFL039C_1_I_R (ACT1) for 
the 3’ splice site (J. Beggs and D. Barrass, personal communication). PCR on cDNA was 
performed using Pfu DNA polymerase using the above primers with RPP1B ex1SS5, 
YFL039C_1_p_F or  YFL039C_1_I_F, respectively, to detect the species of interest.  
 
2.2.11 Mass spectrometry analysis 
Mass spectrometry analysis of proteins isolated from glycerol gradient fractions 
corresponding to the spliceosome peaks was carried out by James Thompson in the Yates 
laboratory at The Scripps Research Institute. A detailed description of the materials and 
methods can be found in (Lardelli et al., 2010) and is provided in Appendix I.  
In brief, lyophilized protein samples were re-solubilized, reduced with TCEP and 
alkylated with iodoacetamide prior to tryptic digests. Samples were desalted and 
separated by a modified six-step HPLC protocol with a two-dimensional conjugated 
C18/strong cation exchange column. Peptides were eluted and electrosprayed into a two-
dimensional ion trap mass spectrometer (ThermoFinnigan). Eight data-dependent MS/MS 
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spectra were taken and analyzed using SEQUEST algorithm (Eng et al., 1994) against the 
Saccharomyces cerevisiae genome database (SGD).  
Parameters for inclusion in the data presented in Tables 2.4, 2.5 and 2.6 include: 
sequence confirmation of >5% of protein and absence from the mock purification 
MS/MS data. Mock purification was performed identically to that of the experimental 
samples from a nontagged strain of yeast. Polypeptides identified in this mock analysis 
are presented in Appendix II, and contaminants identified in the prp2, prp16 and prp22 




2.3.1 Arresting first step-blocked spliceosomes 
Prp2p acts almost immediately upstream of the first step of pre-mRNA splicing; 
therefore, we isolated spliceosomes from S. cerevisiae arrested prior to Prp2p function. 
Prp2p-associated material was affinity purified from cells containing a C-terminal TAP-
tag (Puig et al., 2001; Rigaut et al., 1999) at the PRP2 locus in a wild-type strain. Prp2p-
associated complexes were layered onto a glycerol velocity gradient suitable for 
spliceosome sedimentation (Stevens et al., 2002). Northern blot analysis of snRNAs in 
the even fractions from this gradient shows that Prp2p does not stably interact with 
significant levels of endogenous spliceosomal snRNAs, as represented by the lack of U2, 
U5 and U6 in the glycerol gradient (Figure 2.1A).  As Prp2p is a transiently interacting 
factor (King and Beggs, 1990), we did not expect this strategy to yield spliceosomes, but 
instead to serve as a control.  
To accumulate spliceosomes which have Prp2p stably associated we used a cold 
sensitive (cs) prp2 that interacts with spliceosome. A yeast strain containing the severely 
cold sensitive G551N mutation of Prp2p (Edwalds-Gilbert et al., 2000), which is 
defective ATP hydrolysis and release from the spliceosome, was C-terminally TAP-
tagged at the prp2 locus. Cells were shifted to the NPT of 25°C prior to harvesting, 
trapping endogenous pre-mRNAs in a first step-arrested spliceosome. ATP depleted, 
affinity-purified prp2G551Np-associated material was layered onto a glycerol velocity 
gradient for spliceosome isolation. A significant peak of U2, U5 and U6 snRNAs at ~40S 
is seen in these gradients (Figure 2.1B) corresponding to size of the yeast spliceosome 
(Brody and Abelson, 1985).  
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Figure 2.1 prp2G551Np mutant yeast accumulate snRNAs in the ~40S region of the 
glycerol gradient. 
A. Prp2p-TAP affinity purified, glycerol gradient-separated material 
contains no significant accumulation of snRNAs in the ~40S region of 
the glycerol gradient, after Northern blotting for all five snRNAs, 
indicating the absence of associated spliceosome.  
B. prp2G551Np-TAP-associated material was Northern blotted for 
spliceosomal snRNAs. Splicing complexes, as indicated by the 
presence of U2, U5 and U6 are seen in the ~40S region of the glycerol 
gradient. The arrow indicates the direction of sedimentation, and 
positions of U1, U2, U4, U5 and U6 snRNAs are shown.  
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2.3.2 Determination of pre-mRNA splicing status within prp2-arrested particle 
RNA from the peak fraction of the 40S spliceosome sized particle was subjected 
to RT-PCR with primers against an intron-containing transcript, RPP1B. Figure 2.2 
shows that the intron-containing transcript, RPP1B pre-mRNA is fully unspliced at this 
point in the splicing cycle, implying that the purified spliceosome is indeed arrested at the 
first chemical step.  Functional characterization of this transcript included incubation at 
permissive temperature (PT) or 37°C in the presence of ATP for 20 minutes. 
Interestingly, the data indicates that RPP1B can be functionally chased through both steps 
of splicing, indicating one of two possibilities: either the proteins present are sufficient to 
proceed through both steps of splicing, or there is a minute presence of second step 





Figure 2.2 prp2-arrested spliceosome contain pre-mRNA, which can be chased to a 
spliced message as determined by RT-PCR.  
RT-PCR of an intron-containing transcript was used to assess the splicing status 
of the intron within the prp2-arrested particle. At NPT, RPP1B is unspliced. After 
incubating the particle at PT in the presence of ATP for 20 minutes, the pre-mRNA is 





2.3.3 Compositional characterization of first step-arrested spliceosomes 
To compositionally define the first step-arrested spliceosome, we performed 
MudPIT mass spectrometry analysis of the associated polypeptides (Washburn et al., 
2001) from the fractions of the glycerol gradient corresponding to the spliceosome sized 
particle. Table 2.4 lists the components of the first step-arrested spliceosomes. Notably, 
all but three tri-snRNP components are absent in the prp2-arrested spliceosome. 
Additionally, the first step-arrested spliceosome contains all of the known yeast SF3 
components (Dziembowski et al., 2004) and the U2 core proteins Lea1p and Msl1p 
(U2A’ and U2B”, respectively in human) (Caspary and Seraphin, 1998). Also present in 
the first step blocked spliceosome are the Sm core proteins of the U2 and U5 snRNPs 
(Seraphin, 1995). It is also worth mentioning that the U6-specific LSm proteins (Achsel 
et al., 1999) are absent, which is consistent with their destabilization during spliceosome 
activation (Chan et al., 2003). The entire Prp19p complex (NTC) is also present, as 
expected from the reported role of the NTC in stabilization of U5 and U6 in the events 
leading up to the first step of splicing (Tarn et al., 1994). Consistent with a recent report, 
the second step factor, Prp17p, is also detected prior to the first step (Sapra et al., 2008). 
Two pre-mRNA binding proteins (Sto1p and Cbc2p) comprising the cap-binding 
complex (Colot et al., 1996; Fortes et al., 1999; Lewis et al., 1996) are detected. As 
shown in Table 2.4, a number of other spliceosome-associated proteins are also present in 
the protein sample representing the first step-arrested spliceosomes.  
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snRNP or complex 
association 
Protein # of peptides identified/percentage 
polypeptide 





























2nd step factors Prp17p 15/28.4% 

















Table 2.4 Mass spectrometry analysis of proteins associated with the first step-arrested 
spliceosome from peak fraction of Figure 2.1B.  
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2.3.4 Second step-arrested spliceosome characterization 
After the first step of splicing, Prp16p is required to proceed through the second 
step. Prp16p was TAP-tagged in three strains: BY4741 (wild-type PRP16), prp16-302 
(prp16R456K, G691R) (Madhani and Guthrie, 1994), and the allele of prp16 in strain 
DBY4406 (prp16R456K; (Noble and Guthrie, 1996). Consistent with its transient 
interaction with the spliceosome and similar to wildtype Prp2p-TAP (Figure 2.1A), 
affinity-purified, wildtype Prp16p-TAP is not associated with significant levels of 
spliceosomal snRNAs in any region of the glycerol gradient (Figure 2.3A). Spliceosomes 
purified from both cold sensitive prp16 strains grown at NPT are associated with U2, U5 
and U6 snRNAs in the ~40S region of the glycerol gradient (Figure 2.3B). 
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Figure 2.3 Cold-sensitive prp16 alleles, accumulate spliceosome in the ~40S region of 
the glycerol gradient. 
A. Prp16p-TAP affinity-purified, size-separated material contains no 
significant accumulation of snRNAs, after Northern blotting for all five 
snRNAs across the glycerol gradient.  
B. prp16-R456K, G691Rp-TAP-associated, size separated material was 
Northern blotted for spliceosomal snRNAs. Splicing complexes, as 
indicated by the presence of U2, U5 and U6, are seen in the ~40S 
region of the glycerol gradient. The arrow indicates the direction of 
sedimentation, and positions of U1, U2, U4, U5 and U6 snRNAs are 
shown.  
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2.3.5 Pre-mRNA characterization of second step-arrested particle 
RT-PCR analysis of the mRNA/pre-mRNA/lariat contained in the peak fractions 
from the second step-arrested particle was performed. Using reverse transcriptase primers 
that anneal to the 3’ exon of RPP1B, the 3’ exon of ACT1, or the branched sequence of 
the lariat of ACT1, primer extension was conducted. The RT products were then 
subjected to PCR using the following primers pairs: a 5’ primer that anneals to the 5’ 
exon of RPP1B and the 3’ primer annealing to the 3’ exon of RPP1B to detect full length 
substrate; a 5’ primer that anneals to the intron just downstream of the branch sequence 
of ACT1 and 3’ primer that anneals to the 3’ exon of ACT1 to detect 3’ splice site; or a 5’ 
primer within the lariat of ACT1 and the 3’ primer annealing to the branched sequence of 
ACT1 lariat to detect the lariat structure. As shown in Figure 2.4, the particle contains no 
pre-mRNA, but does contain the 3’ splice site junction and the lariat RNA, indicative of 
the products of the first step of splicing. This confirms the isolation of a C-complex.  
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Figure 2.4 Purified prp16-arrested particles contain lariat intermediate as determined by 
RT-PCR. 
RT-PCR of intron-containing transcripts was used to assess the splicing status of 
the intron within the prp16-arrested particle at NPT. The first set of primers anneal to the 
exons of RPP1B, and the lack of a band indicates there is neither pre-mRNA nor spliced 
message. Primers annealing to the ACT1 intron and the 3’ exon reveal the presence of a 
3’ splice site, which in the absence of pre-mRNA suggests the presence of lariat 
intermediate. Finally, primers that are designed to amplify a lariat structure of the ACT1 
intron show the presence of a lariat. Together, these finding confirm that the first step of 
splicing, but not the second step, has been completed in the arrested particles. 
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2.3.6 Compositional definition of the second step-arrested particle 
Protein fractions corresponding to the second step-blocked particles were 
analyzed by MudPIT mass spectrometry analysis. Table 2.5 lists the protein components  
of the spliceosome prior to the second chemical step of splicing (Figure 2.3B). Unlike the 
first step step-arrested spliceosome (Figure 2.1B), the second step-arrested spliceosome is 
devoid of all SF3 components. This independently supports that both SF3a and SF3b are 
displaced from the spliceosome between these steps. Other differences include the 
dissociation of the Retention and Splicing complex (RES) complex (Dziembowski et al., 
2004). Additionally, we note the presence of the proposed first step factors, Yju2p and 
Cwc25p, only after the first step of splicing has taken place, which is consistent with their 
assigned roles in the first step of chemistry after Prp2p ATP hydrolysis (Chiu et al., 2009; 
Liu et al., 2007). The disassembly factor, Prp43p (Martin et al., 2002), is added prior to 
the second chemical step.  
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snRNP or complex 
association 
Protein # of peptides identified/ 
% polypeptide 







































Ubp3p 4/6.1% Novel 
Bre5p 8/25.8% 
Table 2.5 Mass spectrometry analysis of proteins associated at the 2nd step of splicing 
from Figure 2.3B.  
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2.3.7 Sedimentation comparison between the first step-arrested spliceosome and the 
second step arrested spliceosome 
The difference in sedimentation behavior between the first step-arrested and 
second step-arrested spliceosomes was measured as represented by the quantitation of U6 
snRNA throughout the glycerol gradient fractions (Figure 2.5). Despite the loss of more 
than 500 kDa with the absence of SF3, the prp16-arrested spliceosomes do not sediment 
significantly differently than spliceosomes arrested in the first step. This is likely due to 
the added polypeptide mass of Prp16p, Prp22p, Prp43p, and others, which in total are 
similar to the mass of the displaced SF3 complex and other first-step components (Figure 
2.3). The similarity in mass and co-sedimentation suggest that apart from the 
compositional changes described above there is not a dramatic conformational change 





Figure 2.5 First and second step-arrested spliceosomes do not show significant 
differences in sedimentation.  
U6 snRNA was quantitated as a representative of the second step-arrested 
spliceosome and measured against the sedimentation of the first step-arrested particle. 
The two particles do not sediment significantly differently. 
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2.3.8 Post-splicing prp22-arrested spliceosome characterization 
After the second step, the spliced mRNA and the intron are retained within the 
spliceosome until the ATP-dependent function of the DEAH-box protein Prp22p releases 
the mRNA (Company et al., 1991; Schwer, 2008). To complete the DEAH-box-arrested 
pre-mRNA-, pre-mRNA intermediate-, or mRNA-containing spliceosome purifications 
spliceosomes arrested after the second step, but prior to the release of mRNA were 
purified using the same TAP-tagging strategy with two cold-sensitive alleles of prp22 
(DBY4172 – prp22D613Q and DBY4423 – prp22G394R, D613Q)(Noble and Guthrie, 
1996). Similar to the wildtype Prp2p (Figure 2.1A) and Prp16p (Figure 2.3A) 
purifications, Prp22p was not associated with significant levels of snRNAs (Figure 2.6A) 
following affinity purification and size separation by glycerol gradient sedimentation. 
Spliceosomes arrested with the prp22 cold-sensitive alleles at the Prp22p mRNA release 
step were affinity purified and sedimented through a glycerol velocity gradient. RNA 
extracted from the gradient fractions was Northern blotted for snRNAs (Figure 2.6B). 
The presence of U2, U5 and U6 snRNAs at ~40S of the glycerol gradient indicates the 




Figure 2.6 Cold-sensitive alleles of prp22 accumulate spliceosome in the ~40S region of 
the glycerol gradient. 
A. Prp22p-TAP affinity-purified material shows no significant 
accumulation of snRNAs in the glycerol gradient, after Northern 
blotting for all five snRNAs.  
B. prp16-D613N-TAP-associated material was Northern blotted for 
spliceosomal snRNAs. Splicing complexes, as indicated by the 
presence of U2, U5 and U6, are seen in the ~40S region of the glycerol 
gradient. The arrow indicates the direction of sedimentation, and 
positions of U1, U2, U4, U5 and U6 snRNAs are shown.  
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2.3.9 Pre-mRNA characterization of a message release-arrested particle 
RT-PCR analysis of the mRNA/pre-mRNA/lariat presence within the prp22-
arrested particle was carried out as described in 2.3.5. This analysis revealed the presence 
of only mRNA and lariat intron, consistent with the products of the second step of 
splicing (Figure 2.7). No 3’ splice site was detected supporting the completion of both 
steps of splicing, and confirming the purification of a spliceosome arrested at the release 
step of the splicing cycle.  
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Figure 2.7 prp22-arrested particles contain spliced message and lariat intron as 
determined by RT-PCR. 
RT-PCR of intron-containing transcripts was used to assess the splicing status of 
the intron within the prp22-arrested particle at NPT. The first set of primers, which 
anneal to the exons of RPP1B, show the presence of spliced message. Primers annealing 
to the ACT1 intron and the 3’ exon reveal the absence of a 3’ splice site, which suggests 
both steps of splicing have come to completion. Finally, primers that are designed to 
amplify a lariat structure of the ACT1 intron show that there is a lariat contained in the 




2.3.10 Compositional characterization of the message release-stalled particle 
MudPIT mass spectrometry analysis was once again employed to determine the 
composition of the arrested particle. The prp22-stalled particle contained a strikingly 
similar composition to the prp16-arrested spliceosome (Table 2.5). Interestingly, the 
second step-specific factors, Slu7p and Prp18p, were present in the message release 
mutant particle, consistent with their action after the Prp16p step, but prior to the second 
chemical step (Umen and Guthrie, 1995b). Also notable is the more complete presence of 
the THO/TREX complex, which is consistent with data showing that the THO/TREX 
complex loads late during transcription on most intron-containing transcripts, after 
spliceosome assembly (Abruzzi et al., 2004). Additionally, Yju2p and Cwc25p are absent 
after Prp16p action and prior to dissociation of the spliceosome. Interestingly, the 
presence of a deubiquitinase, Ubp3p, and its interaction partner, Bre5p, were present in 
both the prp16- and prp22- arrested spliceosomes. Although no published work has 
demonstrated a function for these proteins in pre-mRNA splicing, these factors have also 




snRNP or complex 
association 
Protein # of peptides identified/percentage 
polypeptide 




















2nd step factors 
Slu7p 13/28.3% 


















Ubp3p 16/30.6% Novel 
Bre5p 13/36.7% 
Table 2.6 Mass spectrometry analysis of the associated proteins from message release-
arrested spliceosomes from Figure 2.6B.  
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2.3.11 Sedimentation comparison between the first step-arrested spliceosome, the 
second step-arrested spliceosome, and the message release-arrested spliceosome 
Quantitation of U6 snRNA from each of the fraction of the arrested spliceosome 
purifications (Figure 2.1B, 2.3B, and 2.6B) was performed and plotted across the glycerol 
gradients. The post-splicing, prp22-arrested spliceosomes reproducibly sedimented three 
fractions higher in the gradient than either the prp2- and prp16-arrested spliceosomes 
(Figure 2.8). Because the protein composition of this particle is similar to that of the 
prp16-arrested particle, this repeatable, significant shift in spliceosome sedimentation 
indicates a conformation change following the second step of chemistry, resulting in a 





Figure 2.8 The sedimentation pattern of prp2-, prp16- and prp22-arrested spliceosomes 
was compared and suggests a measureable conformation change after the 
second step of splicing. 
U6 snRNA was quantitated as a representative of the arrested spliceosomes and 
measured for sedimentation through a glycerol gradient. Although prp2- and prp16-
arrested particles do not sediment significantly different, prp16-arrested spliceosomes 
sediment approximately 3 fractions removed compared to the prp22-arrested particle, 





Many important discoveries in the field of pre-mRNA splicing have resulted from 
compositional comparison of (1) constituent parts of the spliceosome (Caspary and 
Seraphin, 1998; Caspary et al., 1999; Neubauer et al., 1997; Stevens and Abelson, 1999; 
Stevens et al., 2001; Stevens et al., 2002), (2) assembled or partially assembled 
functional complexes (Bessonov et al., 2008; Chen et al., 2007; Hartmuth et al., 2002; 
Jurica and Moore, 2002; Zhou et al., 2002), and (3) products of the reaction (Makarov et 
al., 2002). In this dissertation work, spliceosomes arrested in vivo at three helicase 
checkpoints during the catalytic phase of the splicing cycle have been purified using 
gentle, but stringent affinity chromatography techniques. Due to the differences likely to 
be encountered throughout the assembly of the spliceosome in vitro upon a single 
transcript versus the co-transcriptional assembly of the spliceosome in vivo, we believe 
that the data presented here accurately represent the composition and functionality of 
these complexes.  
Our mass spectrometry data from each of the first step-, second step- and message 
release-arrested spliceosomes (as shown side-by-side in Table 2.7) show that one striking 
feature among each of the arrested spliceosomes is the absence of tri-snRNP-associated 
factors, with the exceptions of the Sm core, Prp8p, Brr2p and Snu114p, which are present 
throughout the assembly and splicing. Our data show that the majority of the tri-snRNP 
associated factors are dispensable during the catalytic steps of splicing. This result differs 
slightly from that of the activated human spliceosomes (Makarov et al., 2002), in which 
other tri-snRNP components were detected. This discrepancy may be due to the 
operational differences in purifying synchronized splicing complexes formed in vivo 
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versus those formed in vitro, or less likely, might reflect functional differences in the two 
systems.  
More striking is that the SF3a and SF3b components are completely absent after 
the first step. Other differences between prp2- and prp16-arrested spliceosomes include 
the addition of factors known to participate in the second step of splicing (e.g. Prp16p, 
Prp22p), and others that have been implicated in pre-mRNA splicing by association with 
spliceosomes (e.g. several Cwc proteins), but for which there are not yet data 
demonstrating a function in splicing. Interestingly, THO/TREX complex components 
appear only after the first step of splicing and persist through the second step. This 
temporal difference is consistent with data showing that the THO/TREX complex loads 
onto intron-containing transcripts subsequent to assembly events (Abruzzi et al., 2004).  
We also note that the entire RES complex is absent after the first step of splicing. 
The heterotrimer has been implicated in the retention of unspliced pre-mRNA in the 
nucleus and indeed, tagged RES components only co-purify radiolabeled pre-mRNA and 
no other pre-mRNA splicing intermediates (Dziembowski et al., 2004), consistent with 
our mass spectrometry results. How the RES complex might enforce a nuclear retention 
phenotype when it is only associated prior to the first step is not currently understood. 
Other differences between the prp2- and prp16-arrested spliceosomes include the 
addition of the post-splicing Prp43p helicase (Arenas and Abelson, 1997). While Prp43p 
is not known to be required for the second step of for mRNA release, its presence 
indicates that it may either have an unknown role at these steps, or that its presence is 
required or tolerated without playing a catalytic role.  
Compositional differences between the prp16- and prp22-arrested spliceosomes 
are relatively minimal; however, they are consistent with previous reports. These include 
the addition of Prp18p and Slu7p in the prp22-arrested spliceosome, which is consistent 
 82 
with the proposed role for these second step factors. Both have been shown to bind and 
function after the ATPase-dependent function of Prp16p (Jones et al., 1995; Umen and 
Guthrie, 1995b). In addition, Prp17p, is present throughout the splicing cycle according 
to our data and data from the Vijayraghavan laboratory (Sapra et al., 2008). Several 
THO/TREX complex components are stably bound after the second step; however, none 
of the isolated spliceosome contains the largest THO/TREX component, Tho2p.  
Other differences include the addition of Yju2p and Cwc25p after the Prp2p step, 
and their removal after the second step. Previous work from the Cheng and colleagues 
show these factors function prior to the first step (Chiu et al., 2009; Liu et al., 2007). 
Other recent data from the Lührmann laboratory show the stimulatory effect of Cwc25p 
during the first step of splicing (Warkocki et al., 2009). Our data demonstrates that in 
vivo-assembled first step-arrested spliceosomes do not contain these proteins suggesting 
that these factors are added after the Prp2p step or that they are only required for splicing 





Table 2.7 Compositional comparison between arrested spliceosomes. 
MudPIT mass spectrometry analysis of first step (prp2)-arrested, second step 
(prp16)-arrested and message release (prp22)-arrested spliceosomes. The most striking 
difference between the three purified catalytically blocked spliceosomes is the lack of 
SF3a and SF3b complexes following the Prp2p step. Other notable features include the 
lack of tri-snRNP proteins other than Brr2p, Prp8p and Snu114p, and the specific 
presence of Yju2p and Cwc25p only before the second chemical step.  
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These data represent the first purification of catalytically synchronized, arrested 
particles. Using the cold-sensitive nature of the three DEAH box factors required for the 
catalytic steps of splicing and the release of the spliced message, we have accumulated 
spliceosomes, which exist only in a transient nature under wildtype conditions. Upon 
shift of the cold-sensitive strains to non-permissive temperatures, the mutant DEAH-box 
proteins are prevented from carrying out their required functions, thus arresting growth of 
cells, and presenting a means by which the particles can be biochemically characterized. 
In addition, we have shown that the defect in the first step-arrested particle is reversible 
and rescued by raising the temperature to where prp2G551Np is functional and adding 
ATP. This presents the opportunity for functional characterization of the first step of 
splicing through “chasing” the particle through the first step of splicing. The following 
chapter will elaborate on the compositional differences observed between the first step- 
and second step-arrested spliceosomes by functional testing.  
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Chapter 3: Removal of the SF3 complex initiates the first step of 
splicing  
3.1 BACKGROUND: AUTHORIZATION FOR THE FIRST STEP OF SPLICING 
3.1.1 Spliceosome assembly around the branchpoint sequence 
One of the earliest events in spliceosome assembly includes the association of the 
U2 snRNA with the branchpoint sequence of the pre-mRNA (Parker et al., 1987) (see 
Illustration 3.1). The conserved uridine residue of the U2 snRNA that is situated across 
from a dinucleotide of adenosine residues of the branchpoint sequence (see Illustration 
3.1) is modified to a pseudouridine in all eukaryotes (Patton et al., 1994; Yu et al., 1998). 
This modification is thought to position the 2’-OH of the branchpoint adenosine 
accessibly for nucleophilic attack (Newby and Greenbaum, 2002). This is consistent with 
the idea that the branchpoint nucleophile is activated by being bulged from the U2 
snRNA/pre-mRNA duplex (Query et al., 1994). Furthermore, in the absence of a 
conserved 5’ splice site, the branchpoint nucleophile has been shown to attack the 
branchpoint binding sequence of the U2 snRNA, demonstrating the highly reactive nature 
of the nucleophile (Smith et al., 2007) most likely due to its position within the active site 
of the spliceosome. The accessibility and presumably early “activation” of the 
branchpoint adenosine suggest that a mechanism must serve to prevent premature attack 







        
Illustration 3.1 U2 snRNA base pairs with the pre-mRNA early in spliceosome assembly.  
The conserved uridine residue, underlined in the illustration, is modified to 
pseudouridine, which is thought to assist in positioning, or bulging, the branchpoint 




Formation of the duplex between the U2 snRNA and the branchpoint sequence 
occurs concomitantly with the joining of the U2 snRNP-associated proteins, contained 
within two subcomplexes known as SF3a (Brosi et al., 1993a; Brosi et al., 1993b) and 
SF3b (Will et al., 2002). These complexes interact upstream of and on the branchpoint 
sequence, respectively, and are thought to anchor the U2 snRNP to the pre-mRNA 
(Gozani et al., 1996; Ruby et al., 1993). These factors are classically known for their 
identification of and interaction with the branchpoint, as the U2 snRNP contacts the pre-
mRNA in spliceosome assembly; however, they remain part of the spliceosome 
throughout activation. Their purpose in events following spliceosome assembly had not 
been hypothesized upon or investigated prior to this work. 
 
3.1.2 Uncoupling Prp2p function from the first step of splicing   
As described in Chapter 2, Prp2p produces an ATP-dependent rearrangement that 
is required for the first step of catalysis; however, this remodeling event has been 
demonstrated to be followed up by the actions of at least two other factors, which are 
proposed to also act prior to the first chemical step of splicing. Recent in vitro 
reconstitution studies from the Cheng laboratory have suggested two novel factors in the 
first step of splicing. They propose that Yju2p acts in an ATP-independent, Prp2p-
independent manner to promote the first step of splicing after Prp2p function (Liu et al., 
2007), while Cwc25p relies on the functional rearrangement by Prp2p and the presence of 
Yju2p to elicit function (Chiu et al., 2009). The Lührmann laboratory has also recently 
demonstrated the functioning of Cwc25p in stimulating the first step of 
splicing(Warkocki et al., 2009), however, their results do not conclusively identify 
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Cwc25p as essential in the first step. Though in vitro studies have placed the novel 
factors as acting in the first step of splicing, their mechanisms of action have not been 
determined. 
Our in vivo-arrested first step particles (as described in Chapter 2) provided a 
system by which we can functionally analyze the first step of splicing. We found that 
Prp2p functions in an ATP-dependent manner to remove the SF3 complex from the 
U2/pre-mRNA duplex, only after an ATP-independent step induces a conformational 
rearrangement. We propose that this ATP-independent conformational restructuring 
results in a spliceosomal configuration, which is optimal for the chemistry of the first step 
of splicing. Prp2p then induces an ATP-dependent release of the complex that has been 
previously shown to intimately interact with the branchpoint sequence, likely serving to 
sequester the highly reactive nucleophile from premature attack. The evidence from our 
functional analysis of in vivo purified spliceosomes construct a model, which includes 
these mechanistic events in the initiation of the first step of splicing.  
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3.2 MATERIALS AND METHODS 
3.2.1 Tagging vectors 
Vector Purpose Marker 
pFA6a-13Myc-His3MX6 myc tagging HIS3 
pFA6a-kanMX6-PGAL-3HA N-terminal HA tag, galactose 
inducible promoter  
KANr 
Table 3.1 Vectors used for creating C-terminal tags in Chapter 3.  
 
 




SS1353 a ura3, leu2, trp1, his3, lys2, prp2::TRP, pRS415-PRP2-TAP::URA3, 
PRP9MYC::HIS3 
SS1354 a ura3, leu2, trp1, his3, lys2, prp2::TRP, pRS415-prp2G551N-TAP::URA3, 
HSH155MYC::HIS3 
SS1357 a ura3, leu2, trp1, his3, lys2, prp2::TRP, pRS415-PRP2-TAP::URA3, 
PRP9MYC::HIS3, KAN::GAL-HA-YJU2 
SS1358 a ura3, leu2, trp1, his3, lys2, prp2::TRP, pRS415-PRP2-TAP::URA3, 
HSH155MYC::HIS3, KAN::GAL-HA-YJU2 





















U1 probe 5’GAATGGAAACGTCAGCAAACAC3’ 
U2 probe 5’AAGAACAGATACTACACTTGA3’ 
U4 probe 5’ACCATGAGGAGACGGTCTGG3’ 
U5 probe 5’ATGTTCGTTATAAGTTCTATAGGC’3 
U6 probe 5’AGGGGAACTGCTGATC3’ 
RPP1B ex1SS5 5’ATTGACTATCACCAAGGCCGC3’ 
RPP1B ex2-3 5’GTGACGCTGCTGCTGAAGAAGAAA3’ 
YFL039C_1_p_F 5’AGGGGCTTGAAATTTGGAAAAA 3’ 
YFL039C_1_L_R 5’GCAAGCGCTAGAACATACATAGTACA3’ 
YFL039C_1_I_F 5’TTGCTTCATTCTTTTTGTTGCT3’ 
YFL039C_1_I_R  5’GCAAAACCGGCTTTACACAT3’ 
 
Table 3.3 Oligos used for PCR of tags, Northern blotting, and RT-PCR in Chapter 3.  
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3.2.4 Strain creation 
Strains listed in Table 3.2 were created using the PCR generated fragment 
strategy described in Chapter 2, section 2.2.4. For C-terminal myc tags, the tag was 
amplified from pFA6a-13Myc-His3MX6, which contains a HIS selectable marker. For N-
terminal, Galactose drive, HA-tags, fragments were amplified from pFA6a-kanMX6-
PGAL-3HA, which has a KANr selectable marker 5’ to the tag.  
Transformants were screened, as described in Chapter 2, section 2.2.4, except 
using antibodies to recognize the myc tag. Whole cell extract was then separated by 
polyacrylamide gel electrophoresis, and transferred to nitrocellulose (Bio-Rad) 
membrane overnight at 25V at 4°C in transfer buffer (20% methanol, 0.001% SDS, 386 
mM glycine, 48 mM Tris base). The membrane was then subjected to Western blotting 
for the myc tag as follows: the membrane was blocked for 1 hour at room temperature in 
BLOTTO, washed twice for 5 minutes each in PBST, incubated for 1 hour in BLOTTO 
plus a 1:5000 dilution of primary antibody (mouse α-myc) or a 1:1000 dilution of anti-
HA (Covance), washed 4x for 5 minutes in PBST, then incubated in BLOTTO plus a 
1:5000 dilution of goat-α-mouse HRP-conjugated secondary (Rockland) for both the HA 
and the myc Westerns for 1 hour, and finally washed four times for fifteen minutes each 
in PBST. Chemiluminescent detection was performed to detect the western blot signal 
(Perkin Elmer).  
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3.2.5 Metabolic depletion of YJU2  
Strains containing a metabolically depletable YJU2 gene were grown in YP + 2% 
galactose at permissive temperature (PT) to OD (A600) = 0.5, washed in prewarmed YPD, 
resuspended in fresh YPD, and allowed to grow for 3 hours at PT. Cell were then shifted 
to 25°C for 45 minutes before harvesting. Cells were harvested as described in Chapter 2, 
section 2.2.6.  
 
3.2.6 Functional analysis of arrested spliceosomes 
Arrested spliceosomes were purified, as described in section 2.2.7. Following 
eluting with TEV protease, purified material was divided into 4 equal aliquots and treated 
for 20 minutes under the following conditions (Stevens and Abelson, 2002):  
1. 60 mM KH2PO4, 3.2 mM MgCl2, 3% PEG-5000, 1 mM spermidine at PT in 
the presence of ATP  
2. 60 mM KH2PO4,, 3.2 mM MgCl2, 3% PEG-5000, 1 mM spermidine at PT in 
the absence of ATP 
3. 60 mM KH2PO4,, 3.2 mM MgCl2, 3% PEG-5000, 1 mM spermidine on ice in 
the absence of ATP 
4. 60 mM KH2PO4,, 3.2 mM MgCl2, 3% PEG-5000, 1 mM spermidine on ice in 
the presence of the non-hydrolyzable substrate, AMP-PNP 
Splicing reactions were layered on 10-30% glycerol gradients and centrifuged as 
described in Chapter 2, section 2.2.7.  
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3.2.7 Western blotting for MYC tag across the glycerol gradients 
Proteins from even fractions of the glycerol gradient were phenol/chloroform 
extracted and precipitated in the presence of 10 μg of BSA (NEB). Protein was separated 
by SDS-PAGE, transferred, and Western blotting for the myc tag was conducted as 
described in section 3.2.4. 
 
3.2.8 Northern blotting for snRNAs  
RNA extracted from the glycerol gradients was precipitated and analyzed by 
Northern blotting for all five spliceosomal snRNAs as described in Chapter 2, section 
2.2.8.  
 
3.2.9 RNA quantitation and normalization 
 Quantitation of U6 snRNA in each Northern blot was performed as described in 
Chapter 2, section 2.2.9.  
 
3.2.10 Native gel electrophoresis of splicing reactions 
Native gel electrophoresis of splicing reactions using affinity-purified 
spliceosomes was performed using 20 cm X 20 cm X 0.75 mm gels (0.5X TAE and 4% 
80:1 polyacrylamide). RNA was separated by gel electrophoresis at 250 V for 11.75 
hours in 0.5X TAE running buffer at 4°C, with recirculating buffer. Gels were transferred 
to nylon membrane and analyzed by Northern blotting for U6 snRNA as described in 
Chapter 2, section 2.2.8.  
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3.2.11 Spliceosome pelleting experiment 
TEV elutions from purifications of arrested first-step spliceosomes were layered 
on 10-30% glycerol gradients under conditions described in Chapter 2, section 2.2.7. The 
peak spliceosome fraction from the glycerol gradient was split into three equal samples 
and treated for 20 minutes as follows: 
1. 1 M NaCl 
2. 60 mM KH2PO4,, 3.2 mM MgCl2, 3% PEG-5000, 1 mM spermidine on ice in the 
absence of ATP 
3. 60 mM KH2PO4,, 3.2 mM MgCl2, 3% PEG-5000, 1 mM spermidine at PT in the 
presence of ATP 
Samples were layered onto a 30% glycerol cushion containing 20 mM HEPES, pH 7.9, 
150 mM KCl, 1.5 mM MgCl2, 0.1% NP-40, 1 mM DTT, 0.2 mM PMSF, and centrifuged 
at 80,000 RPM for 80 minutes in a TLA 100.3 rotor at 4°C. The supernatant was 
removed and the pellet was resuspended. Extracted protein was analyzed by Western 
blotting for the myc tag (as described in Chapter 3, section 3.2.4) 
 
3.2.12 Protein quantitation 
Quantitation of proteins in Western blots was performed using a NightOWL II LB 
983 (Berthold Technologies) by ultracold-CCD camera detection. Signal intensities were 
integrated over the lanes of the Western blot and values for each glycerol gradient 
fraction was normalized against the lane with the most intense signal, which was give a 
value of 1. Automatic average background subtraction was performed for each Western 




Extracted and precipitated RNA from each of the splicing reactions (described in 
Chapter3, section 3.2.6, samples 1-3) was subjected to RT-PCR (as described in Chapter 





3.3.1 In vivo depletion of Yju2p 
Although Prp2p function initiates the first step of splicing, the recently described 
factor Yju2p was reported to be required after Prp2p function but prior to chemistry (Liu 
et al., 2007).  Yju2p is not detectable by mass spectrometry in prp2-arrested particles 
(Table 2.4); however to ensure that we could confidently distinguish between the 
function of Prp2p and Yju2p in the arrested spliceosomes, we metabolically depleted 
Yju2p from prp2G55Np-TAP cells by repressing the GAL-driven, HA-tagged Yju2p. As 






Figure 3.1 Yju2p can be metabolically depleted from prp2G551Np-TAP cells.  
Western blot analysis of GAL-HA-Yju2p through a time course in galactose (left) 
or after shift to dextrose (right) shows that Yju2p is not detectable after 90 minutes in 
media containing the repressive carbon source, dextrose.  
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3.3.2 Functional analysis of prp2-arrested spliceosomes by Northern blotting 
First step-arrested spliceosomes, from cells depleted of Yju2p and containing a 
MYC tag on Prp9p, were isolated by affinity chromatography using the TAP tag on 
prp2G551Np. Prp9p is the yeast homolog of the mammalian SF3a60 factor, which is a 
component of the U2 snRNP-associated trimeric SF3a complex. Purified, arrested 
spliceosomes were incubated under splicing conditions at NPT with no ATP treatment, 
under splicing conditions at PT with no ATP treatment, under splicing conditions at PT 
with AMP-PNP treatment, or under splicing conditions at PT with ATP. After incubation, 
the reactions were centrifuged through spliceosome-resolving glycerol velocity gradients, 
as described in Chapter 2, section 2.2.6. Following fractionation, the RNA from the even 
fractions from the glycerol gradients was subjected to Northern blot analysis to detect 
spliceosomal snRNAs. Quantitation of U6 snRNA from each of the particle treatments is 
shown in Figure 3.2.  
Spliceosomes incubated at NPT (Figure 3.2) sedimented identically to those from 
an untreated sample in which Yju2p was not depleted (Figure 2.1B). In samples treated at 
PT without ATP, the peak of the U6 snRNA signal was shifted three fractions higher in 
the gradient (Figure 3.2), indicating a substantial change in shape or in composition. This 
suggests that a novel ATP-independent event may be catalyzed by Prp2p itself and 
represents a conformational change. This evidence is corroborated by the treatment of the 
particle at PT with the non-hydrolyzable substrate, AMP-PNP, which shows the same 
shift in sedimentation as seen in the absence of ATP. Furthermore, incubation at PT in 
the presence of ATP shows no additional shift in glycerol gradient sedimentation of the 
spliceosome, which suggests there are no further significantly detectable changes in 





Figure 3.2 Spliceosome sedimentation, as quantitated by U6 snRNA, suggests an ATP-
independent role for Prp2p.  
RNA from glycerol gradients was subject to Northern blot analysis for 
spliceosomal RNAs. U6 was quantitated and normalized. Upon treatment at PT for the 
prp2 mutant allele, spliceosomal sedimentation is shifted three fractions higher in the 
glycerol gradient, suggesting an ATP-independent role for Prp2p.  
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3.3.3 Functional analysis of prp2-arrested spliceosomes by Western blotting for the 
Prp9-myc 
Protein was precipitated following treatment as described in 3.2.6 and glycerol 
gradient sedimentation as described in Chapter 2, section 2.2.7, and subjected to Western 
blot analysis to detect Prp9p-myc. Treatment at NPT in the absence of ATP demonstrates 
that Prp9p cosediments with the spliceosome (Figure 3.3A and E and Figure 3.2). 
Similarly, upon treatment at PT in the absence of ATP (Figure 3.3B) or the presence of 
the AMP-PNP at PT (Figure 3.3C and E and Figure 3.2), Prp9p remains in spliceosome-
sized fractions. However, when incubated at PT in the presence of ATP, Prp9p-myc is 
detected near the top of the gradient (Figure 3.3D and E and 3.2), suggesting Prp9p is 
displaced from the spliceosome upon ATP hydrolysis by Prp2p. A quantitative analysis 
of the sedimentation behavior of SF3 (Figure 3.3E) and spliceosomes from Figure 3.2, 
reveals that the displacement of SF3 from the spliceosome does not affect the 





Figure 3.3 Upon ATP treatment, the SF3 complex is displaced from the spliceosome.  
First step-arrested spliceosomes were treated at NPT in the absence of ATP (A), 
PT in the absence of ATP (B), PT in the presence of AMP-PNP (C), or PT in the 
presence of ATP (D). As shown in D and E, Prp9p is displaced from the spliceosome 
upon treatment with ATP implicating a role for ATP-hydrolysis by Prp2p in removal of 
SF3. 
 102 
3.3.4 Native gel electrophoresis of treated first step spliceosomes 
To further demonstrate that the shifts in glycerol gradient sedimentation seen for 
first step-arrested spliceosomes treated at PT correspond to authentic changes in shape, 
native gel electrophoresis of the treated particles was performed (Figure 3.4). Upon 
treatment at PT with no ATP (lane 2), treatment at PT with ATP (lane 3), and treatment 
at PT with AMP-PNP (lane 4) the migration of spliceosomes is faster than the 
spliceosomes treated at NPT (lane 1). This migration difference corresponds to the 
sedimentation shift seen in Figure 3.2, where spliceosomes treated at PT run three 
fractions higher in the glycerol gradient than those incubated at NPT. Thus, the migration 
difference is dependent upon raising the arrested prp2 particle to permissive 
temperatures, suggesting a conformational change is induced by Prp2p. The results from 
both Figures 3.2 and 3.4  are consistent with an ATP-independent conformational change 
occurring concurrently with relieving the cold-sensitive prp2 defect, and suggest a 
conformational rearrangement is induced by Prp2p. 
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Figure 3.4 Native gel electrophoresis of treated particles from affinity purified prp2-
arrested spliceosomes confirms the size shift, suggesting a conformational 
change upon treatment of the particle at PT.  
Affinity elutions were split into four samples and treated as indicated. 
Comparison of the migrations between the untreated spliceosome (lane 1) and the 
samples treated at PT (lanes 2, 3, and 4) show the shift in spliceosome size, suggesting an 
ATP-independent conformational change.  
 104 
3.3.5 Characterization of pre-mRNA within functional 1st step spliceosomes 
To demonstrate the functionality of the arrested spliceosomes, RT-PCR was 
performed on RNAs contained in representative peak fractions from the glycerol 
gradients of the affinity-purified, treated spliceosomes (Figure 3.2). Using the strategy 
described in Chapter 2, sections 2.3.5 and 2.3.9, to detect pre-mRNA/mRNA, the 3’ 
splice site, and the lariat structure, RT-PCR analysis conclusively demonstrates the 
functionality of the first-step arrested spliceosomes.  
Pre-mRNA is exclusively found in the untreated, arrested spliceosomes, as seen in 
lane 4 in Figure 3.5. This is confirmed by the presence of the 3’ splice site, as shown in 
lane 5, and the absence of the lariat, shown in lane 6. Upon treatment of the arrested 
spliceosome at PT in the absence of ATP pre-mRNA is exclusively found (lane 1), 
corroborated by the presence of 3’ splice site (lane 2) and absence of lariat (lane 3). 
Finally, RT-PCR analysis of the spliceosome at PT in the presence of ATP confirms that 
the presence of ATP drives the first chemical step, as seen by the absence of pre-mRNA 
or mRNA (lane 7), the presence of the 3’ splice site (lane 8) and the presence of the lariat 
structure (lane 9). The band corresponding to the 3’ splice site (lane 8) and the lariat 
structure (lane 9) in addition to the absence of pre-mRNA (lane 7) indicates the products 
of the first step of chemistry. These data confirm the functionality of the prp2-arrested 
particle, and demonstrate that the first step of splicing is dependent upon the presence of 
ATP, which as described in the previous sections is concurrent with SF3 displacement.  
The lack of first step products seen following treatment of the particle at 
permissive temperature also indicates that the ATP-independent conformational change is 
not coincident with or sufficient to promote the first chemical step. In the presence of 
ATP at PT and in the absence of Yju2p, the vast majority of pre-mRNA was chased to 
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lariat intermediate, demonstrating that even if Yju2p is required for the first step of 
splicing for a subset of introns, it is not required for the displacement of SF3 under these 
conditions, as SF3 is not spliceosome associated after Prp2p function (Table 2.5 and 




Figure 3.5 prp2-arrested particles are functional, and upon treatment with ATP, can be 
chased through the first step of splicing. 
When affinity purified prp2-arrested spliceosomes were left untreated, presence 
of pre-mRNA (lane 4), presence of 3’ splice site (lane 5), and absence of lariat structure 
(lane 6) indicate a first step chemical block. Upon elevating the temperature of the 
spliceosome to PT, presence of pre-mRNA (lane 1), presence of 3’ splice site (lane 2) and 
absence of lariat structure once again confirm a first step block. Treatment with ATP at 
PT chases the pre-mRNA to the products of the first chemical reaction, as shown by the 
absence of pre-mRNA (lane 7), presence of 3’ splice site (lane 8) and presence of the 
lariat structure (lane 9). 
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3.3.6 SF3b displacement is independent of Yju2p 
SF3a and SF3b are both present in the assembled, prp2-arrested spliceosomes 
(Table 2.4); however, since each subcomplex can be isolated independently they may 
behave very differently in terms of their release from the spliceosome. To test for the 
displacement of both SF3a and SF3b, a glycerol-cushion pelleting assay to test for SF3 
release was employed. Conditions designed to pellet intact spliceosomes, but incapable of 
pelleting displaced SF3a or SF3b were used. First step-arrested spliceosomes containing 
either Prp9p-myc (SF3a component) or Hsh155p-myc (SF3b component) were affinity 
purified. To enrich for homogeneous populations, spliceosomes were further purified by 
glycerol velocity gradient sedimentation, as described in Chapter 2, section 2.2.7. The 
peak fraction of spliceosome particles from the glycerol gradient was evenly divided into 
three equal samples and treated for 20 minutes either under splicing conditions at NPT in 
the absence of ATP, under splicing conditions at PT in the presence of ATP, or with 1 M 
NaCl. The reactions were sedimented through a glycerol cushion to separate the 
spliceosome from released factors. Proteins extracted from the supernatant and the pellet 
were analyzed for the presence of the myc tag by Western blotting. The SF3a and SF3b 
complexes are known to be sensitive to elevated salt levels (Behrens et al., 1993; 
Bessonov et al., 2008); thus, the salt-treated samples serve as a control for displacement 
of SF3 from the purified spliceosome (Figures 3.6A and B, lanes 7 and 8). At NPT, they 
are found exclusively in the pellet (Figures 3.6A and B, lanes 3 and 4). Both SF3a and 
SF3b are displaced from the conditions, as shown by the presence of Prp9p-myc and 
Hsh155p-myc in the supernatant (Figures 3.6A and B, lanes 5 and 6).  
Furthermore, to ensure that Yju2p is not responsible for the displacement of SF3a 
and SF3b, Yju2p was metabolically depleted from cells prior to temperature shift, 
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harvest, affinity purification and treatment. The above strategy was used for analysis of 
the Yju2p depleted spliceosome containing Hsh155p-myc. Yju2p, which has been 
proposed to act downstream from Prp2p in the splicing cycle, is not required for the 
displacement of SF3b, as Hsh155p is found in the supernatant (Figure3.6C, lanes 5 and 
6), indicating it is released upon the action of Prp2p even in the absence of Yju2p.  
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Figure 3.6 SF3 complexes are released from the spliceosome upon Prp2p function.  
Affinity-purified spliceosomes were pelleted through glycerol cushions following, 
treatment at NPT in the absence of ATP, treatment at PT in the presence of ATP or with 
1 M NaCl. Total proteins from supernatant and pellet fractions were Western blotting for 
the MYC tag. The presence of a band in supernatant of the sample treated at PT with 
ATP indicates that Prp9p (A, lane 5) and Hsh155p (B, lane 5) have been displaced upon 
Prp2p function. The same experiment was performed in cells depleted of Yju2p. The 
presence of Hsh155p in the supernatant of the sample treated at PT in the presence of 
ATP (C, lane 5) supports a role for Prp2p in displacement of SF3 from the spliceosome. 
Controls include 2% of the total affinity elution and the 10% of peak fraction 18 (f18, 
lane 2) of the proportion of the particle left untreated as a control.  
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3.4 DISCUSSION 
The pre-mRNA splicing machinery and the mechanism of splicing have been 
extensively studied by both genetic and biochemical means for many years. Although the 
basic chemical mechanism of the two transesterification reactions of pre-mRNA splicing 
was proposed 25 years ago (Domdey et al., 1984; Padgett et al., 1984; Ruskin et al., 
1984; Will et al., 1993), the specific molecular means by which the chemical steps of 
splicing are authorized and promoted remain unknown. A general mechanism for the 
function of the DEAH-box protein Prp16p was first proposed by Guthrie and colleagues 
(Burgess et al., 1990). Work by Query and Konarska (Query and Konarska, 2004) has 
further shaped this model for Prp16p, U6 and Prp8p in the first to second step transition; 
however, specific functions for both Prp2p and Prp16p in the first and second step, 
respectively, have best been described as enigmatic rearrangements.  
This work illustrates the mechanism for initiating the attack of the branchpoint 
adenosine on the 5’ splice site involves the removal of SF3 from the spliceosome at the 
time of Prp2p action, thus unsheathing the pre-mRNA brachpoint/U2 snRNA duplex. 
This data evidences a model in which the U2-associated SF3a and SF3b protein 





Illustration 3.2 The model for the activation of the first chemical step of pre-mRNA 
splicing includes an ATP independent conformational rearrangement 
and the ATP-dependent removal of SF3a and SF3b. 
The SF3b complex resides on the branchpoint/U2 snRNA duplex, while SF3a 
resides just upstream of the branchpoint adenosine during spliceosome assembly, and 
remains until the ATP-dependent action of Prp2p. Following interaction of Prp2p with 
the spliceosome, an ATP-independent rearrangement concomitant with a structural 
rearrangement occurs. Upon ATP hydrolysis by Prp2p, the SF3a and SF3b components 
are displaced from the pre-mRNA, uncovering the branchpoint adenosine hydroxyl, 
which is now properly positioned for in-line attack of the 5’ splice site. This 
transesterification releases exon 1 and the lariat intermediate, formed by the 2’-5’ linkage 
between the branchpoint and the 5’ splice site.  
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As described in Chapter 2, compositional analysis of first step- and second step-
arrested spliceosomes identified the U2 snRNP subcomplexes, SF3a and SF3b, prior to 
the first step of splicing (Table 2.4), but indicated the absence of these factors after the 
first step of splicing (Table 2.5), suggesting that these factors are displaced sometime 
between the Prp2p action and Prp16p function. Functionally testing this on in vivo-
purified first step-arrested spliceosomes demonstrates the release of SF3a and SF3b upon 
ATP treatment, and the removal of these factors is preceded by an ATP-independent 
spliceosomal rearrangement.  
The ATP-independent structural rearrangement occurs upon raising the prp2-
isolated spliceosome to permissive temperature. Since the arrest of the spliceosome was 
dependent upon a shift to non-permissive temperatures, the conformational change, as 
measured by sedimentation through a glycerol gradient and migration in a native gel 
(Figures 3.2 and 3.4), is proposed to be a result of Prp2p function. This change in the 
spliceosome may result from a repositioning of a snRNP, the pre-mRNA, or both to favor 
the arrangement of the reactive sites for the first step (Konarska et al., 2006). Upon ATP 
treatment, SF3a and SF3b are quantitatively removed from spliceosomes (Figures 3.3, 
and 3.6), and pre-mRNA is chased into the first step products (Figure 3.5) demonstrating 
that the prp2-arrested spliceosomes are functional and are not defective, off-pathway 
intermediates. The spliceosomes purified in this work were prepared under moderately 
stringent conditions, and corresponding mass spectrometry data indicates the presence of 
all expected first step factors and the absence of most second step-specific factors 
(Chapter 2, Table 2.4), suggesting that the particles purified contain all components 
sufficient to proceed through the first step of splicing and not the second step of splicing.  
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Several DExH/D-box proteins have been reported to have both ATP-dependent 
and ATP-independent functions, including Prp5p during spliceosome assembly 
(Newnham and Query, 2001; Perriman et al., 2003) and Prp22p, which has an ATP-
independent role in the second step of splicing (Schwer and Gross, 1998) prior to its 
ATP-dependent role in displacing the spliceosome from the spliced mRNA (Company et 
al., 1991; Schwer, 2008). Similarly, we have shown a parallel ATP-independent 
rearrangement at the time of Prp2p function, and defined an ATP-dependent role for 
Prp2p in initiating the first step of pre-mRNA splicing. Although we cannot yet say 
definitively that Prp2p is required for the ATP-independent step, the inability to proceed 
through this step using a prp2 mutant at non-permissive temperatures strongly suggests 
that Prp2p plays a role.  
The mass spectrometry results presented in Chapter 2 also reveal that the first step 
factors, Yju2p and Cwc25p are not found in in vivo purified first step-arrested 
spliceosomes. Previous work from the Cheng laboratory and the Lührmann laboratory on 
in vitro transcribed pre-mRNA propose that these two factors act prior to the first step 
(Chiu et al., 2009; Liu et al., 2007; Warkocki et al., 2009). Our data demonstrate that in 
vivo-assembled spliceosomes do not require Yju2p for the first step, at least for the pre-
mRNA tested (Figure 3.5), and that Prp2p-initiated removal of SF3a and SF3b is not 
dependent upon these factors. However, our data cannot rule out that Yju2p joins after 
Prp2p and prior to the first step. One possibility for this difference is that Yju2p may be 
required for the splicing of only a subset of introns in yeast. This seems to be a probable 
answer to the discrepancy between in vivo and in vitro data, and indeed, intron 
microarray analysis has revealed vast differences in splicing efficiency between different 
splicing factor mutants (Pleiss et al., 2007). Another possibility is that the difference 
between our in vivo-assembled spliceosomes and those formed in vitro using Yju2p-
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depleted extracts reflect pathway-specific differences resulting from transcription-
coupled pre-mRNA processing versus those assembled in vitro.  We note that SF3a and 
SF3b displacement is quantitative under these conditions, independent of the presence of 
Yju2p in the spliceosomes.  
Structural analysis of the human SF3b complex demonstrated that the SF3b14a 
protein, which crosslinks to the branchpoint adenosine (MacMillan et al., 1994) and the 
U2 snRNA (Dybkov et al., 2006), resides in a cleft through which the pre-mRNA has 
been predicted to thread (Golas et al., 2005). Although yeast SF3b does not contain an 
ortholog of SF3b14a, the high degree of conservation of the other SF3b subunits suggests 
that the U2 snRNA/intron branchpoint duplex is sequestered within SF3b in a protective 
manner.  
Others have shown that early in spliceosome assembly, the branchpoint adenosine 
is arranged in such a way as to expose the reactive 2’-OH upon base pairing to the U2 
snRNA (Newby and Greenbaum, 2002). The importance of restraining this highly 
reactive nucleophile was highlighted in work showing that, in the presence of a defective 
5’ splice site, the branchpoint can attack the U2 snRNA itself (Smith et al., 2007). In our 
model, SF3b provides a temporal steric barrier prior to the activation of the first step of 
splicing (Illustration 3.2). Physically obscuring the branchpoint region at the time of base 
pairing with the U2-associated SF3b complex allows the numerous rearrangements 
required to proceed through spliceosome assembly to occur without premature 
branchpoint reactivity. When the spliceosome achieves the proper conformation, an ATP-
independent rearrangement occurs. Although we do not have direct evidence for the 
participation of Prp2p in the ATP-independent event, the block induced by the 
prp2G551Np at non-permissive temperature suggests that Prp2p plays a role in this 
process. Prp2p then induces an ATP-dependent change that destabilizes both SF3b from 
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the branchpoint region, and SF3a from the region upstream of the branchpoint. This 
unleashes the branchpoint 2’-OH, which is now positioned for the proper in-line attack at 
the 5’splice site to free the 5’ exon and form the lariat intermediate. With this work a 
mechanistic role is described to Prp2p. In addition, this work provides a system by which 




Chapter 4: Prp24p is not essential for U4/U6 annealing in the presence 
of high levels of U6 or for activation of the spliceosome. 
4.1 SNRNP RECYCLING AND REASSEMBLY 
Following mRNA release by Prp22p, the spliceosome must be disassembled so 
the individual snRNPs can be recycled for further rounds of splicing. Prp43p and Brr2p 
are responsible for disassembly of the post-splicing spliceosome in an energy dependent 
manner (Martin et al., 2002; Small et al., 2006). Upon release from the spliceosome, U2, 
U5, and U6 undergo snRNP-recycling events, which prepare them for reentry into the 
splicing cycle.  
4.1.1 U6 snRNA 
Though all 5 snRNAs are essential for viability and for splicing in yeast, U6 has 
been regarded as the central snRNA in the splicing cycle and is the most conserved 
snRNA, with close ~75% identity to its human counterpart (Brow and Guthrie, 1988). 
The U6 snRNA differs significantly in its biogenesis from the other spliceosomal 
snRNAs. U6 is transcribed by RNA Pol III, while the other spliceosomal snRNAs are 
transcribed from RNA Pol II (Kunkel et al., 1986). Perhaps as a result of being the only 
snRNA transcribed by RNA Pol III, the 5’ end of U6 is capped with a γ-monomethyl 
phosphate, as opposed to the 5’-methylguanosine cap that protects the 5’ ends of the 
other snRNAs (Singh and Reddy, 1989). 
The U6 snRNA plays a major role in each of the assembly, splicing, and post-
splicing events. As the spliceosome must adopt conformations that favor the chemical 
reactions of splicing to take place, U6 must also be reconfigured within the spliceosome.   
Thus, U6 snRNA is highly dynamic during the splicing cycle, changing conformations, 
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possibly even triggering the splicing cycle to continue. Chemical probing experiments 
have traced the secondary structure of the “naked” U6 snRNA, U6 within its mono-
snRNP, and its structure within the U4/U6 di-snRNP (Jandrositz and Guthrie, 1995). 
Though these structures have provided much insight into the secondary structure of the 
U6 mono-snRNP, the dynamic nature of U6 snRNA has made the subject a source of 
further analysis and debate (Dunn and Rader, 2010; Fortner et al., 1994; Karaduman et 
al., 2006; Vidaver et al., 1999). 
 
4.1.2 U6 snRNP 
The recycling pathway for the U6 snRNP includes the binding of snRNP 
components in addition to at least one structural rearrangement, which is thought to be 
facilitated by Prp24p. Prp24p is an RNA binding protein, which contains four consensus 
RNA recognition motifs (RRMs), and is found only to co-immunoprecipitate with U6 
snRNA, making it part of the U6 snRNP (Shannon and Guthrie, 1991). Unlike the U1, 
U2, U4, and U5 snRNAs, which are bound by the Sm complex, the 3’ end of the U6 
snRNA interacts with a heptameric ring of LSm (Like Sm) proteins. All together the U6 
mono-snRNP contains eight proteins: Prp24p and the seven LSm proteins.  
Interestingly, the binding of the LSm proteins to U6 does not seem to affect the 
secondary structure of U6 to a great degree (Fortner et al., 1994; Jandrositz and Guthrie, 
1995); however, interactions between Prp24p and the LSm ring have been shown to be 
critical in the formation of the U6 snRNP and further downstream events (Rader and 
Guthrie, 2002). In addition, recent NMR studies have demonstrated the binding of RRM2 
of Prp24p to a short stretch of nucleotides within the stem of the U6 snRNA (Martin-
Tumasz et al., 2010). This binding is thought to recognize the RNA while the stem is 
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breathing and position RRM1 of Prp24p against U6 to “capture” the upstream sequence 
of nucleotides, leaving U6 nucleotides unprotected, and available to anneal with U4.  
 
4.1.3 U4/U6 annealing 
Sequence analysis of U4 and U6 showed extensive complementarity between the 
two snRNAs, suggesting that they may form two intermolecular stems (Brow and 
Guthrie, 1988). The duplex was found to have a uniquely high melting temperature of 
53°C (Brow and Guthrie, 1988; Siliciano et al., 1987). This extensive intermolecular base 
pairing was further characterized as dependent upon the action of the U6 snRNP 
component, Prp24p (Jandrositz and Guthrie, 1995; Raghunathan and Guthrie, 1998a; 
Shannon and Guthrie, 1991). As a result of this, Prp24p has for many years been the 
subject of structural analysis aimed at understanding how exactly Prp24p facilitates this 
annealing event (Bae et al., 2007; Kwan and Brow, 2005; Martin-Tumasz and Butcher, 
2009; Martin-Tumasz et al., 2010). Though it is still unclear exactly how Prp24p 
mediates the interaction between U4 and U6, it is known that upon binding, Prp24p alters 
the secondary structure of U6, likely making U4 annealing sites available.  
Previous reports have established that Prp24p is not a stable component of the 
U4/U6 annealed di-snRNP (Gottschalk et al., 2001b; Stevens and Abelson, 1999); 
however, a cold-sensitive point mutation in the U4 snRNA arrests a particle containing 
U4, U6, and Prp24p (Shannon and Guthrie, 1991). Within this stalled particle the melting 
temperature of the U4/U6 interaction is ~37°C, or 16°C lower than the wildtype melting 
temperature, indicating that U4 and U6 are not stably base paired in the presence of 




4.1.4 Prp24p as an antagonist to the U4/U6 interaction 
Genetic approaches have been used to further characterize the mechanism of 
function of Prp24p in respect to di-snRNP. Evidence from these studies suggest that 
Prp24p acts as an antagonist of the U4/U6 base pairing interaction prior to or 
immediately upon full annealing between the snRNAs (Ghetti et al., 1995; Vidaver et al., 
1999). This had led several laboratories to propose a role for Prp24p in U4 unwinding 
during spliceosome activation (Ghetti et al., 1995; Strauss and Guthrie, 1994; Vidaver et 
al., 1999). As U4 is unwound from the spliceosome, the U6 ISL is reformed, in addition 
to several short duplexes between U6 and U2 (see Illustration 1.4). Specifically, the Brow 
laboratory has characterized a cold-sensitive version of U6 in which the ISL of U6 is 
hyperstabilized, preventing melting of the region important for binding U4 during U4/U6 
annealing (Vidaver et al., 1999), resulting in severely reduced levels of the U4/U6 base 
pairing interaction. Suppressors of this annealing defect have been mapped to the Prp24p; 
however, these Prp24p mutants fail to suppress the cold-sensitive phenotype, which 
points toward an additional role for Prp24p. Because the ISL seems to be stabilized by 
Prp24p, it is possible that Prp24p facilitates the stabilization of the reformed U6 ISL 
during activation, resulting destabilization of U4 snRNA (Vidaver et al., 1999). While 
strong genetic evidence exists for Prp24p function in activation, biochemical data has yet 
to support this hypothesis.  
 
4.1.5 Other di-snRNP components  
 The levels of U6 in a yeast cell are roughly five times higher than the levels of U4 
within the cell (Li and Brow, 1993). Because of this and the energetically favorable 
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U4/U6 base paired conformation, levels of free U4 snRNP are undetectable in wildtype 
yeast cells. Thus it has been challenging to determine the protein contribution from U4 
snRNP to di-snRNP. Several factors have been characterized as di-snRNP proteins, but 
the exact timing of their entrance into the yeast di-snRNP remains to be determined. 
These include Snu13p, Prp4p, Prp31p, and Prp3p (Anthony et al., 1997; Banroques and 
Abelson, 1989; Weidenhammer et al., 1997). Each of these components has also been 
characterized among the tri-snRNP components.  
Snu13p was initially discovered as an essential tri-snRNP component (Gottschalk 
et al., 1999; Stevens and Abelson, 1999) required for proper splicing. Soon after, Snu13p 
was also shown to play a role in ribosome biogenesis as a component of the box C/D 
snoRNA complex, which is known to 2’ O-methylate rRNA during processing (Watkins 
et al., 2000). Snu13p shows remarkable conservation from S. cerevisiae to humans, and 
the human homolog, 15.5K has been shown to bind a kink-turn in the U4 snRNA 
intramolecular stem loop of U4 in the U4/U6 snRNP and then recruit the human 
counterpart of Prp31p as well as the heterodimer of hPrp3p and hPrp4p (Nottrott et al., 
1999). A similar process is suggested to take place in yeast, where Snu13p binding to U4 
snRNA precedes the entry of other di-snRNP factors, serving to recruit them to di-snRNP 
(Oruganti et al., 2005).  
While in vivo data from human cell culture indicates that the human homolog of 
Prp31p forms an essential interaction with the U5 snRNP factor, Prp6p, in the formation 
of tri-snRNP (Schaffert et al., 2004), studies in yeast suggest that Prp31p serves as a 
stabilization factor during tri-snRNP integration into the spliceosome and may actually 
exist both in the spliceosome and in tri-snRNP (Weidenhammer et al., 1997). In both 
systems, Prp31p is essential for splicing, like the other di-snRNP components. Prp31p 
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requires Snu13p to assemble into di-snRNP; however, it is not known if Prp3p and Prp4p 
are also required for this interaction. 
Prp4p was also discovered in S. cerevisiae as a stable component of both di-
snRNP and tri-snRNP (Banroques and Abelson, 1989; Bjorn et al., 1989). It was found 
that under low salt conditions Prp4p immunoprecipitated U4/U6•U5 and under even 
lower salt, B complex spliceosomes. Similar to Prp4p, Prp3p was discovered as an 
essential component of both di-snRNP and tri-snRNP. Conditional mutants of Prp3p 
show a severe assembly defect of U4/U6U5 into spliceosomes with no effect on levels 
of U4/U6, suggesting that Prp3p may be required for stabilization of U4/U6 and 
integration of U4/U6U5 into spliceosomes (Anthony et al., 1997) 
Prp3p and Prp4p have been shown to form a direct and stable interaction prior to 
joining the U4/U6 snRNP (Ayadi et al., 1998). The two proteins have significant genetic 
interactions and extensive physical interactions. In addition, Prp4p belongs to the WD-
protein family, which is characterized by 4 to 10 WD repeats. This structural motif forms 
an interface for protein-protein interactions (Neer et al., 1994), which in the case of 
Prp4p, could serve to form a scaffolding surface for the assembly of tri-snRNP, or more 
simply, could serve as an interface for interaction with Prp3p (Ayadi et al., 1998). In 
addition, the 5’ end of the U4 snRNA has been shown to interact with Prp4p, and this 
interaction plays a critical role in incorporation of U4/U6 into higher order snRNP 
complexes (Bordonne et al., 1990; Xu et al., 1990).  
Taken together, the Lührmann laboratory has proposed a hierarchical assembly 
pathway for the di-snRNP components in humans (Nottrott et al., 2002), beginning with 
binding of 15.5K (Snu13p) to the 5’ stem loop of the U4 snRNA in the U4/U6 complex. 
Following this binding event, other components including Prp31p, Prp3p and Prp4p can 
assemble and serve to stabilize the di-snRNP while U4/U6 joins U5 to form tri-snRNP. 
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Note that SART3, the human ortholog of Prp24p is not included in this schematic, as it 
has likely exited the complex. 
Finally each of these di-snRNP/tri-snRNP components is also incorporated into 
spliceosomes (C complex). However, none of the factors is found in complexes 
succeeding the activated spliceosome (B* complex), indicating they have been 
destabilized at or around the time of U4 release and spliceosome activation. It has been 
suggested by Reinhard Lührmann and colleagues that the human homologues of Prp3p 
and Prp4p, along with another protein that has no known ortholog in yeast, act in 
stabilizing stem II of the U4/U6 interaction while stem I is reversibly unwound. 
Furthermore, they also suggest that this could be a mechanism of proofreading (Nottrott 
et al., 2002).  
 
4.1.6 Tri-snRNP formation 
Following maturation, the U4/U6 snRNP can then interact with the U5 snRNP to 
form U4/U6U5 snRNP. The joining between the two snRNPs is based on protein-
protein interactions between U4/U6 snRNP components and U5 snRNP components. 
Specifically, human Prp31p has been shown to play an important role in contacting the 
U5 snRNP factor; Prp6p, however other contacts are also likely responsible for this salt-
stable association.    
 The role of Prp24p has been well defined as essential for both splicing and cell 
viability; however, it remains unclear when and how Prp24p is released from the U6 
snRNA. While structural analyses and immunoprecipitations suggest that Prp24p binds 
only U6, it is possible that a U4/U6Prp24p complex exists in a transient state prior to the 
subsequent assembly events. Furthermore, the temporal association of the U4/U6 snRNP 
 123 
components into the snRNP remains elusive. This study serves to gain further knowledge 
on assembly pathway in yeast spliceosomes beginning with the assembly of the U4/U6 
snRNP and the following U4/U6U5 formation.  
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4.2 MATERIALS AND METHODS 
4.2.1 Plasmids  
Plasmid Purpose Marker 
pRS415 Control/serial dilutions LEU2 
pRS425 Control/serial dilutions LEU2 
pRS415-SNR6 Control/serial dilutions LEU2 
pRS425-SNR6 Experimental/serial dilutions LEU2 
pRS425-SNR14 Experimental/serial dilutions LEU2 
yCP50-SNR14 Strain creation URA3 
pSE-snr14-G14C Cold-sensitive  HIS3 
pBS1539 TAP tagging URA3 
pFA6a-His3MX6-PGAL-
3HA  
N-terminal HA tag, galactose inducible 
promoter  
HIS3 
Table 4.1 Plasmids used in Chapter 4 for tagging or serial dilutions. 
 




SS330 a  leu2Δ1, his3Δ1, ura3Δ0, prp24::KAN, pRS416-PRP24 
SS1100 a  leu2Δ1, his3Δ1, ura3Δ0, prp24::KAN, pRS416-PRP24, pRS425  
SS1101 a  leu2Δ1, his3Δ1, ura3Δ0, prp24::KAN, pRS416-PRP24, pRS425-SNR6 
SS1102 a leu2Δ1, his3Δ1, ura3Δ0, prp24::KAN, pRS416-PRP24, pRS415-SNR6 
SS1106 a  leu2Δ1, his3Δ1, ura3Δ0, prp24::KAN, pRS416-PRP24, pRS425-SNR14 
SS1103 a  leu2Δ1, his3Δ1, ura3Δ0, prp24::KAN, pRS425-SNR6 
SS1104 a  leu2Δ1, his3Δ1, ura3Δ0, prp24::KAN, pRS425-SNR6, LSM8TAPa::URA3 
SS419 α  leu2Δ0, his3Δ200, ura3Δ0, met15Δ0, trp1Δ63 LSM8TAPA ::URA3 
SS1394 α  leu2Δ0, his3Δ200, ura3Δ0, met15Δ0, trp1Δ63 LSM8TAPA::URA3 TRP::GAL-
HA-PRP24 
SS1160 a trp1, his3, ura3, ade2, lys2, snr14::TRP1, YCp50-SNR14 (URA) (Shannon and 
Guthrie, 1991) 
SS1161 a trp1, his3, ura3, ade2, lys2, snr14::TRP1, pSE-snr14-G14C  (Shannon and 
Guthrie, 1991) 
SS1162 a trp1, his3, ura3, ade2, lys2, snr14::TRP1, pSE-snr14-G14C, PRP3TAP::URA3 
SS1163 a trp1, his3, ura3, ade2, lys2, snr14::TRP1, pSE-snr14-G14C, PRP24TAP::URA3 
SS1167 a leu2Δ0, his3Δ200, ura3Δ0, met15Δ0, trp1Δ63, PRP3TAP::URA3  
Table 4.2 Yeast strains used in Chapter 4.  
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4.2.3 Oligos  

















U1 probe 5’GAATGGAAACGTCAGCAAACAC3’ 
U2 probe 5’AAGAACAGATACTACACTTGA3’ 
U4 probe 5’ACCATGAGGAGACGGTCTGG3’ 
U5 probe 5’ATGTTCGTTATAAGTTCTATAGGC’3 
U6 probe 5’AGGGGAACTGCTGATC3’ 
U3 probe 5’TGATCCTACTGTAGAATGTGTTAGTCAAAA3’  
Table 4.3 Oligos used in Chapter 4 for tagging or Northern blotting.  
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4.2.4 Strain construction 
Yeast strains listed in Table 4.3 were created by the lithium acetate transformation 
method (Gietz and Woods, 2002). Plasmids were transformed into to parent strains and 
selection was maintained. Strain SS1161 was created by transforming with and selecting 
for pSE-snr14-G14C. To screen for colonies that lost the wildtype copy of SNR14, cells 
were dilution plated onto minimal media (lacking HIS) and then plated on 5’FOA, which 
kills cells containing the product of the URA3 gene.  
C-terminally tagged strains were created through use of a PCR-generated 
fragment with arms of homology to the region in which the tag was to be knocked in, 
followed by a selectable marker, URA3. Colonies that grew on synthetic media were 
screened for presence of a functional TAP tag by western blotting with the peroxidase 
anti-peroxidase antibody (Rockland) (see Chapter 2, section 2.2.4). N-terminal HA tags 
under a galactose inducible promoter were created through use of the same PCR-based 
system, using arms of homology upstream of the gene being tagged, and transformants 
were tested for presence of a function HA tag, as described in Chapter 3, section 3.2.4. 
 
4.2.5 Serial streaking and dilutions 
Following transformation of plasmids into the parent strain, transformants were 
streaked out on SD-LEU for the strains containing one of the following vectors: pRS425, 
pRS425-SNR14, pRS425-SNR6. Cells were restreaked on SD-LEU two times, and then 
streaked onto SD-LEU, SD-URA or SD-LEU + 5’FOA at 31°C. For serial dilutions, 
single colonies were grown in liquid minimal medium. OD’s were normalized to one 
optical density (OD) unit and dilutions were made. 3μl of each dilution was plated on 
SD-LEU, SD-URA, or SD-LEU + 5’FOA at 31°C. 
 127 
 
4.2.6 Native total RNA extraction 
Native RNA was extracted from strains in which base pairing was to be tested. 
Native RNA was harvested according to the guanidium thiocyanate (GTC) method, as 
described by Wise et al. (Wise et al., 1983). Briefly, cells were harvested and washed 
once in diethylpyrocarbonate (DEPC) treated water. One cell volume of RNase free 
beads was added to the cells followed by one cell-volume of GTC. The mixture was 
vortexed for 45 seconds followed by a 15 second ice incubation. This was repeated 4 
times. Ten cell volumes of DEPC water was added, followed by ten cell volumes of DNA 
phenol. The mixture was vortexed two times with a one-minute incubation on ice in 
between vortexing. The extraction was then centrifuged at 4.4 x g for 5 minutes at room 
temperature. The aqueous layer was removed and extracted 3 more times. To the final 
extracted aqueous layer, 10% volume of 3 M sodium acetate, pH 5.3 and 2.5 volumes of 
ice-cold ethanol were added. RNA was precipitated overnight at -20°C.  
 
4.2.7 Non-denaturing gel electrophoresis 
Native-extracted RNA samples were collected after precipitation by 
centrifugation and were then resuspended in DEPC water. Separation was conducted by 
electrophoresis through a 20 x 16 x 0.75 mm gel containing 9% 19:1 acrylamide: bis-
acrylamide, 1xTBE gel. The gel was run in 1xTBE running buffer at 25 mA for 2.5 hours 
at 4°C. Following electrophoresis, the gel was transferred to nylon membrane for 
Northern blotting.  
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4.2.8 Northern blotting 
Gels were either transferred to nylon membrane (Whatman) at 10V overnight at 
4°C or at 0.75 A for 3 hours at 4°C in an electroblotting apparatus (Bio-Rad) in 25 mM 
sodium phosphate, pH 7.0. RNA was crosslinked to the membrane by exposure to 254 
nm UV light for 1 minute. Northern blotting was conducted as described in Chapter 2, 
section 2.2.8.  
 
4.2.9 Psoralen crosslinking of U4/U6 
Psoralen crosslinking was performed as previously described (Wassarman, 1993) 
using the psoralen derivative: aminomethyltrioxsalen (AMT). A 400μl glycerol gradient 
fraction was split into four equal fractions. Samples were treated as follows:  
 1. no 365 nm UV light and no AMT 
 2. no 365 nm UV light and + 20 μg/μl AMT 
 3. +365 nm light and no AMT 
 4. +365 nm light and + 20 μg/μl AMT. Samples exposed to UV light were 
incubated at a distance of ~2 cm from the light for 20 minutes. Samples not exposed to 
UV light were left on ice. The samples were then phenol/chloroform extracted and 
precipitated using 2.5 times the volume of ethanol. Samples were separated on a 
denaturing gel (7% 19:1 acrylamide: bisacrylamide, 1x TBE, 8 M urea) at 25 mA/gel for 
1 hour and 45 minutes. The gel was transferred to nylon and Northern blotted with 
radiolabeled oligonucleotides designed to recognize U6 snRNA.  
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4.2.10 Prp24p depletion 
To deplete Prp24p from SS1394, cells were grown in rich media (Hong et al.) 
containing 2% galactose to an OD of 0.5. Cells were harvested by centrifugation at 4.4 x 
g for 5 minutes at room temperature, and washed with pre-warmed YP containing 2% 
dextrose, and then centrifuged again. Cells were then resuspended in YPD, and grown for 
24 hours, and cells were maintained under an OD of 1.0. Aliquots were taken every 1.5 
hours. These aliquots were used for extraction of native RNA as well as protein 
preparation for Western blot analysis. Western blot analysis was conducted as described 
in Chapter 3, using the α-HA antibody at a 1:1000 dilution in BLOTTO, and the goat-α-
mouse, HRP conjugated secondary antibody. 
 
4.2.11 Extract preparation 
Whole-cell extract was prepared according to the following protocol. First, cells 
were grown to an OD (A600) of ~1.5. At this point, cells were harvested, washed with ice-
cold water, washed with AGK buffer (10 mM HEPES, pH 7.9, 1.5 mM MgCl2, 200 mM 
KCl, 8% glycerol). Cells were then resuspended in 1 mL AGK per 1 g of cells and flash 
frozen in pellets by dropping into liquid nitrogen. Next cells were disrupted by ball-
milling in a Retsch MM300 mixer mill with 50 mL canisters immersed in liquid nitrogen. 
Briefly, cells were disrupted by shaking at 10 Hz for 5 cycles of 3 minutes each. 
Canisters were dipped into liquid nitrogen in between each cycle. The pulverate was then 
thawed, and allowed to extract for 30 minutes by gentle rotation at 4°C in the presence of 
5 μM Leupeptin, 3 μM Pepstatin, 0.4 mM PMSF and 1mM DTT.  Extract was cleared by 
centrifugation at 30,000 x g for 30 minutes at 4°C, and then 100,000 x g for 1 hour at 
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4°C. The middle third of the cleared extract was gently removed following the second 
centrifugation step, and allowed to dialyze in Buffer D (20% glycerol, 20 mM HEPES, 
pH 7.9, 50 mM KCl, 0.5 mM DTT, 1.5 mM MgCl2) twice for 2 hours at 4°C. After 
dialysis, the extract was centrifuged at 20,817 x g for 10 minutes at 4°C. The extract was 
frozen in liquid nitrogen and stored at -80°C. 
 
4.2.12 Native gel analysis of splicing complexes 
Electrophoresis was used to separate splicing complexes from 4 μL of extract (as 
prepared in 4.2.7). Complexes were run on a 20 cm x 16 cm x 1.5 mm gel with a 
composition of 4% 80:1 acrylamide: bisacrylamide, 1 x TGM buffer (50 mM Tris base, 
50 mM glycine, 2 mM MgCl2) at 160V for 6 hours at 4°C with recirculating buffer 
(Raghunathan and Guthrie, 1998b). The gel was then transferred to nylon or 
nitrocellulose for Northern blotting or western blotting, respectively.  
 
4.2.13 Affinity purification of di-snRNP and tri-snRNP  
Cells were harvested, disrupted, and extracted as described in Chapter 2, section 
2.2.7. Affinity purifications were carried out as described in Chapter 2, section 2.2.7. 
Following TEV cleavage, the elution was layered onto a 10-30% glycerol gradient (for 
tri-snRNP) or a 10-20% glycerol gradient (for di-snRNP) with a composition of 20 mM 
HEPES, pH 7.9, 1.5 mM MgCl2, 0.02% NP-40, 150 mM KCl, 1 mM DTT, 0.4mM 
PMSF. Gradients were centrifuged at 29,000 rpm for 16 hours at 4°C for tri-snRNP 
separation and 36,000 rpm for 20 hours at 4°C for di-snRNP separation in an SW-41 
rotor at 4°C. Fractions were phenol/chloroform extracted, and RNA was precipitated in 
the presence of 20 μg of glycogen (Roche) and 0.1% 3 M sodium acetate, pH 5.3 with 2.5 
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times ice-cold ethanol. RNA was analyzed by native and/or denaturing gel 
electrophoresis as described in section 4.2.7 and Chapter 2, section 2.2.8, respectively.  
 
4.2.14 Mass spectrometry analysis 
Proteins corresponding to the peak fractions of spliceosomal assembly 
intermediates were precipitated, pooled, and lyophilized. Protein digest with trypsin was 
carried out as described in Appendix IV by Michelle Gadush, and liquid chromatography 
separation and mass spectrometry analysis was performed as described in Appendix IV 
by Dr. Maria Person in the Protein Microanalysis Facility at University of Texas, Austin.  
 
4.2.15 Duplex melting  
Glycerol gradient particles were brought to room temperature and incubated with 
1% SDS and 1 mg/mL proteinase K for 1.5 hours. Particles were diluted 1:5 in a buffer 
containing 20 mM HEPES, pH 7.9 and 150 mM KCl. The diluted deproteinized particle 
was divided into 50 μL aliquots and incubated at the 20, 45, 48, 51, 54, 57, 60, 63, or 
66°C for 5 minutes. Reactions were flash frozen in a dry ice ethanol bath. Samples were 
brought to 20°C and immediately loaded on a 7% 19:1 polyacrylamide, 1x TBE non-
denaturing gel, and separated at 15 mA for 5 hours at 4°C, with recirculating 1x TBE 
running buffer. RNA was transferred to nylon, crosslinked, and U6 snRNA was probed 
for using radiolabeled oligonucleotides.  
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4.3 RESULTS 
4.3.1 Overexpression of U6 bypasses the essential factor, Prp24p 
Previous studies have shown increased levels of U6 snRNA in conditional Prp24p 
mutant strains (Vidaver et al., 1999), suggesting increasing the wildtype levels of U6 can 
compensate for a handicapped Prp24p. Additionally, an upregulation of U6 snRNA was 
noted in the absence the zebrafish ortholog of Prp24p, p110 (Trede et al., 2007).  
To investigate the nature of the relationship between Prp24p and U6, a PRP24 
shuffle strain was obtained. This strain contains a genomic knockout of PRP24 covered 
by a URA3 vector carrying PRP24. Into this strain, the following LEU2-marked plasmids 
were transformed: pRS425 (2μ empty vector), pRS425-SNR6 or pRS425-SNR14. SNR6 
encodes U6 snRNA, while SNR14 encodes U4 snRNA. Transformants were dilution 
plated three times on SD-LEU to allow for loss of the wildtype PRP24 vector. Following 
dilution plating, cells were streaked out on either SD-LEU, SD-URA or SD-LEU + 
5’FOA at 31°C. 5’FOA is a drug that selectively kills any cells harboring a URA gene, 
therefore, any cells still carrying the wildtype PRP24 vector will not grow. As shown in 
the third panel of Figure 4.1A, pRS425-SNR6 can in fact bypass the need for PRP24. To 
test for a growth defect, the strains containing pRS425 or pRS425-SNR6 were serial 
diluted on either SD-LEU, SD-URA or SD-LEU + 5’FOA at 31°C. Serial dilutions 
confirm that the 2μ vector, overexpressing U6 snRNA, can bypass the need for the 
essential nature of PRP24 with only a slight growth defect, while controls including the 
empty vector cannot grow on 5’FOA because they require the PRP24 vector for viability. 
The growth on SD-URA implies that the dilution plating prior to plating on 5’FOA is not 
sufficient for all cells to lose the wildtype copy of PRP24; however, cells growing on 
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5’FOA were then plated on SD-URA to confirm the loss of PRP24. For the remaining 






Figure 4.1 High copy U6 snRNA can bypass the need for PRP24.  
Strains harboring pRS425, pRS425-SNR6, or pRS425-SNR14 were streaked on 
SD-LEU, SD-URA, or SD-LEU + 5’FOA to test for viability. When streaked (A) or 
serial diluted (B) on SD-LEU + 5’FOA, cells harboring the PRP24 gene (which is 
introduced to the cells on a URA3 vector), are not viable. However, those cells that lose 
the URA3, PRP24 vector will grow. In the presence of high copy U6 (pRS425-SNR6), 
PRP24 is not essential, and only shows a slight growth defect (B).  
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4.3.2 U4/U6 base pairing analysis by non-denaturing gel electrophoresis 
The next step was to determine whether or not U4 and U6 could still form a base 
pairing interaction in the Δprp24sup. Total native RNA was harvested from cells 
containing wildtype PRP24 and either pRS425, pRS415-SNR6, or pRS425-SNR6, and 
from the Δprp24sup strain. Extracted native RNA was then either heated to denature the 
U4/U6 base pairing or left on ice, and then run on a native gel, transferred to nylon 
membrane and consecutively probed for U4 and U6 snRNAs to determine the base 
pairing status between U4 and U6.  
As can be seen in the native Northern blots in Figure 4.2, all native samples 
contain levels of U4/U6 base paired; this result indicates that even in the absence of 
Prp24p, U4 and U6 can anneal. This suggests that high levels of U6 can indeed bypass 
the need for Prp24p in facilitating the annealing of U4 and U6, although the levels of 
U4/U6 is reduced by roughly half that of the wildtype .  
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Figure 4.2 U4 and U6 base pair in the absence of Prp24p.  
Native total RNA was extracted from wildtype Prp24p strains in the presence of 
pRS415, pRS415-SNR6, or pRS425-SNR6, and cells with the genomic disruption of 
prp24 containing pRS425-SNR6. RNA was separated on a non-denaturing gel, transferred 
and Northern blotted for U6, U4, and U3, consecutively. The level of U4/U6 in strains 
lacking Prp24p is decreased by roughly one half that of strains carrying a wildtype copy, 
as determined by quantitation of U6 in the band representing U4/U6, and normalization 
to the U3 band.  
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4.3.3 U4/U6 base pairing analysis upon Prp24p depletion 
Immunodepletion of Prp24p defined the function of Prp24p in annealing U4 and 
U6, and in addition showed in vitro splicing defects (Raghunathan and Guthrie, 1998b). 
In light of the results demonstrating that Prp24p is not essential for the base pairing of 
U4/U6 in strains overexpressing U6 snRNA, it was necessary to confirm that Prp24p is 
essential for in vivo U4/U6 base pairing, and characterize any defects caused by depletion 
of PRP24 during growth of cells.  
To do this, a yeast strain that could be metabolically depleted of PRP24 upon 
shifting carbon sources was created. As shown in Figure 4.3A, cell growth is affected 9 
hours after shifting to dextrose. Likewise, levels of Prp24p are not detectable by Western 
blot for the C-terminal HA tag on Prp24p after 4.5 hours in dextrose (Figure 4.3B). This 
indicates that upon depletion of Prp24p, cells do not maintain viability, likely due to the 
lack of recycling of U6 snRNA in the splicing cycle.  
Next, the base pairing of U4 and U6 was analyzed in 1.5-hour timepoints by 
native RNA extraction, followed by non-denaturing gel electrophoresis and Northern 
blotting for U6, U4, and U3, consecutively. As can be seen in Fig 4.3C, U4/U6 levels 
begin to drop 1.5 hours after shifting the carbon source to dextrose, which represses the 
galactose promoter. As U4/U6 levels decrease, there is a concomitant increase in free U4 
snRNA levels until 6 hours, at which point levels begin to drop likely due to overall RNA 
degradation. Interestingly, there is a decrease in levels of U6 snRNA as metabolic 
depletion proceeds, indicating possible degradation of total cellular levels of U6. This is 
contrary to what was initially hypothesized  - that there would be an increase in 
expression levels of U6 as levels of Prp24p decreased. However, the interpretation that 
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U6 levels drop because total cellular RNA is compromised is consistent with drop in 
levels of free U4. 
 Finally, the panel probed for the intron containing U3 snRNA (Figure 4.3C) 
shows an accumulation of unspliced U3 after 4.5 hours of a temperature shift, indicating 
a splicing defect associated with the Prp24p depletion. This data is consistent with 
previous reports (Ghetti et al., 1995; Raghunathan and Guthrie, 1998b), and reflects an in 
vivo U4/U6 annealing defect, concomitant with a splicing defect upon depletion of the 
essential Prp24p protein. The in vivo demonstration that cell viability decreases upon 
depletion of Prp24p (Figure 4.3A), in combination with the previous result showing that 
the functioning of Prp24p in U4/U6 annealing can be bypassed in the presence of high 
levels of U6, lead to the question of whether or not Prp24p is required for another 





Figure 4.3A GAL-HA-PRP24 cells are not viable after 9 hours in repressive media. 
A strain containing a metabolically depletable version of PRP24 was shifted to 
repressive media (dextrose) or maintained in non-repressive media (galactose). The 
optical density was taken every 1.5 hours and plotted versus time. Following a 9-hour 











Figure 4.3B Prp24p is not detectable following shifting to repressive media.  
Whole-cell extract from each timepoint during Prp24p depletion was separated by 
SDS-PAGE and subjected to Western blotting for HA-Prp24p. Prp24p is not detectable 




   
Figure 4.3C. Depletion of Prp24p is concomitant with a decrease in U4/U6 base pairing.   
Total native RNA was extracted from each of the timepoints between the sugar 
shift (T = 0 hrs) and 7.5 hours after the shift, and separated on a native gel. The gel was 
transferred to nylon for consecutive probing for U6, U4, and U3 snRNAs. U4/U6 levels 
decrease as levels of free U4 increase. As shown in the bottom panel probed for U3, there 
is also a splicing defect, which arises as PRP24 is depleted and  U4/U6 levels decrease.  
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4.3.4 Native gel analysis of Prp24p knockout assembly complexes  
 To further understand and characterize the strain lacking Prp24p, splicing 
complex conformations were investigated.  Nuclear extracts, from cells that had either 
been grown at 31°C or 16°C were analyzed by native snRNP-resolving gel 
electrophoresis and Northern blotting for U6 snRNA. The migration of snRNP complexes 
was analyzed from Δprp24sup strain, and wildtype strains harboring no vector, an empty 
vector (pRS425),  or a 2μ vector encoding SNR6 (pRS425-SNR6).  
As seen in Figure 4.4, di-snRNP migrates significantly faster than di-snRNP 
levels from strains carrying a wildtype copy of PRP24. This is interesting considering the 
finding that U4 and U6 can still base pair in the absence of Prp24p (Figure 4.2). 
Additionally, tri-snRNP from Δprp24sup strains at both 31°C and 16°C migrates 
noticeably slower than wildtype tri-snRNP. Native gel electrophoresis separates by both 
size and charge. The slower migration of tri-snRNP resulting from a Δprp24sup strain 
could be due to a change in size or conformation of the complex, which could be 
accounted for by addition of proteins to the tri-snRNP. Another possibility is that there 
could be a significant reduction in levels of exposed RNA. Because RNA is highly 




Figure 4.4 Aberrant migrations of di-snRNP and tri-snRNP in Δprp24sup extracts 
indicate that Prp24p may function in events following the annealing of U4 
and U6.  
Native gel analysis of snRNP complexes from extracts shows that both di-snRNP 
and tri-snRNP migrate with shifted mobilities when Prp24p is knocked out in the 
presence of high copy U6, implying that Prp24p, which has been previously described to 
facilitate the interaction between U4 and U6 (Raghunathan and Guthrie, 1998a), may also 
be acting in another spliceosome assembly event.  
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4.3.5 Biochemical characterization of in vivo purified tri-snRNP from wildtype and 
Δprp24sup strains  
 Native gel analysis demonstrates that in the absence of Prp24p di-snRNP migrates 
significantly faster and a conformational defect in tri-snRNP results, indicating that 
Prp24p may have an additional uncharacterized function in higher order complexes of the 
spliceosome. To specifically understand the consequences of deleting Prp24p, an affinity 
purification strategy was used. 
 
4.3.5.1 Tri-snRNP isolation from wildtype and Δprp24 strains 
In order to assess tri-snRNP, LSm8p was C-terminally TAP tagged in the 
Δprp24sup, and Prp3p was C-terminally TAP tagged in a wildtype Prp24p strain. 
Affinity purifications, as described in Chapter 2, section 2.2.6, were designed specifically 
to purify tri-snRNP. Following cleavage with TEV protease, the elutions were layered 
upon a 10-30% glycerol gradient as described in Chapter 2, section 2.2.6, and centrifuged 
specifically to isolate tri-snRNP. After glycerol gradient fractionation and RNA 
precipitation, native and denaturing Northern blotting was used to analyze the quality and 
assess the migration of the spliceosomal intermediates purified. The native northern blot 
was probed for U6 and U4, consecutively, while the denaturing northern blot was probed 
for all five snRNAs.  
The denaturing Northern blot of spliceosomal intermediates in Figure 4.5A, 
indicates the presence of purified tri-snRNP in fractions 16 – 20 of the gradient. In 
addition, U4/U6 snRNP is observed in fractions 8 - 10 of the glycerol gradient. Non-
denaturing gel electrophoresis of the identical RNA fractions (Figure 4.5B) shows that 
U4 and U6 are base paired in both di-snRNP and tri-snRNP. Upon purification and 
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glycerol gradient sedimentation of tri-snRNP in the strain lacking Prp24p, a similar 
migration of tri-snRNP in lanes 16-18 is observed (Figure 4.5C); however, the peak does 
not extend into fraction 20. This could imply there was less starting material, that there 
was a slight shift in sedimentation, or it may be an indication that there are reduced or 
unstable levels of tri-snRNP formed from strains lacking Prp24p. Additionally, di-snRNP 
is sediments in lanes 8-10, while mono-U6 snRNA sediments in lanes 4-6. These results 
indicate that the LSm complex resides on the U6 snRNA in each of these assembly stages 
of the spliceosome even in absence of Prp24p. The native northern blot in Figure 4.5D 
shows that di-snRNP and tri-snRNP contain U4 and U6 mostly in a base paired form. 
This finding is consistent with previous results (section 4.3.2, Figure 4.2) and 
demonstrates that not only can U4 and U6 base pair in di-snRNP in the absence of 




Figure 4.5 Purified tri-snRNP from Δprp24sup strain (right) shows a similar migration to 
that purified from wildtype Prp24p (left) strains.  
Affinity purifications designed to isolate tri-snRNP from both wildtype (A and B) 
and Prp24p knockout (C and D) strains reveal no significant sedimentation difference 
between the two resulting tri-snRNP particles. Native gel electrophoresis demonstrates 
that assembly intermediates from both wildtype (B) and Δprp24sup strains (D) contain 
mostly base paired U6 and strains form base pairing interactions in both di-snRNP and 
tri-snRNP 
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4.3.5.2 Sedimentation behavior between tri-snRNP from wildtype and Δprp24sup 
strains 
 U4 snRNA was quantitated across the glycerol gradients from both the wildtype 
and Δprp24sup strains to see if there is a detectable difference in sedimentation behavior 
between the two tri-snRNPs. As shown in Figure 4.7, there is a slight sedimentation shift 
in tri-snRNPs produced from a strain lacking Prp24p. This shift is indicates that the tri-
snRNP from Δprp24sup strains is either of lower molecular weight or of a smaller shape 
when compared to tri-snRNP from wildtype strains, implying that there may be 





Figure 4.6 Relative sedimentation of tri-snRNP based on U4 snRNA intensity.  
U4 snRNA was quantitated across the tri-snRNP glycerol gradients (Figure 4.5A 
and C). Tri-snRNP produced from Δprp24sup strains sediments slightly higher in the 
glycerol gradient, suggesting either a compositional difference or a slight conformational 
difference. These results imply that Prp24p may have a role in tri-snRNP formation that 
has been previously uncharacterized. 
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4.3.5.3 Compositional comparison between tri-snRNP formed from wildtype and 
Δprp24sup strains 
The differences observed between wildtype tri-snRNP and Δprp24sup tri-snRNP 
in migration in the native gel (Figure 4.4) and in the sedimentation in glycerol gradients 
(Figure 4.5), could be due to a compositional variance. To test for this discrepancy 
between tri-snRNP particles, protein fractions were pooled of tri-snRNP purified from 
both wildtype and Δprp24sup strains and subjected to mass spectrometry analysis.  
Table 4.4 shows a comparison between the protein composition of tri-snRNP 
purified from wildtype and Δprp24sup strains. Consistent with glycerol gradient 
sedimentation, there are very few differences. Both particles contain the heterotrimer of 
Prp8p, Brr2p, and Snu114p, in addition to the other previously defined tri-snRNP 
components (Stevens and Abelson, 1999). Interestingly, tri-snRNP from Δprp24sup 
purified particle contains Cbf5p. Cbf5p is a component of the H/ACA box snoRNP, 
which is known to pseudouridylate the U2 snRNA (Ma et al., 2005). Though the snRNP 
particle under investigation does not contain the U2 snRNA, it is possible that the 
snRNAs within this tri-snRNP particle are also pseudouridylated. The addition of these 
this factor likely does not account for the migration shift seen in tri-snRNP of the 
Δprp24sup strain (Figure 4.4). Additional differences noted in the Δprp24sup  tri-snRNP 
include the absence of the tri-snRNP-specific factors, Prp38p and Snu23p. While Prp38p 
has been implicated in activation of the spliceosome (Xie et al., 1998), no functional role 
has been assigned to Snu23p.   
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Protein MW (kDa) Wildtype tri-
snRNP (# of 
peptides IDed) 
Δprp24sup tri-
snRNP   (# of 
peptides IDed) 
Prp8p 279 123 74 
Brr2p 246 73 91 
Snu114p 114 44 54 
Prp6p 104 31 44 
Snu66p 66 19 21 
Prp3p 56 26 29 
Prp31p 56 25 28 
Cbf5p 55 - 6 
Prp4p 52 18 15 
Spp381p 34 2 2 
Prp38p 28 1 − 
Snu23p 23 3 − 
SmB1p 22 5 6 
LSm4p 21 3 3 
Dib1p 17 3 8 
SmD1p 16 5 5 
Snu13p 13 1 1 
SmD2p 12 6 4 
LSm8p 12 4 6 
SmD3p 11 7 5 
LSm2p 11 2 5 
LSm5p 10 1 4 
LSm3p 10 3 3 
LSm6p 9 5 6 
SmFp 9 2 3 
Table 4.4 Compositional comparison between tri-snRNPs purified from wildtype 
andΔprp24sup strains reveal no major compositional differences. 
Proteins from tri-snRNP purifications (Figure 4.5) were pooled and subjected to 
mass spectrometry analysis. As shown by bolded text, differences between tri-snRNPs 
purified from wildtype and Δprp24sup strains reveal the absence of Prp38p and Snu23p, 
and the presence of Cbf5p in tri-snRNP from the Δprp24sup strain. 
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4.3.5.4 U4/U6 melting temperature analysis  
The compositional analysis of the tri-snRNP particles suggest that there is no 
substantial change in total molecular weight of the tri-snRNP purified from Δprp24sup 
cells. Native gel analysis of intermediates of the splicing cycle demonstrates that there is 
a defect in tri-snRNP, as implied by the slower migration of tri-snRNP in Δprp24sup 
extract. Since roughly only half of U4/U6 is formed in this strain (Figure 4.2), it could be 
that there is a deficiency in forming each of the stems of the base pairing interaction 
between U4 and U6.  
To test the stability of the duplex, a glycerol gradient fraction of tri-snRNP 
purified from both wildtype and Δprp24sup cells was proteinase K treated in the 
presence of SDS, and then divided. Each sample was incubated at designated 
temperatures ranging from 45°C to 66°C. Wildtype melting temperatures for the U4/U6 
duplex are ~53°C (Brow and Guthrie, 1988); however, previously described mutations 
have lowered this to 40°C (Shannon and Guthrie, 1991). Following temperature 
incubation, the samples were frozen, then brought to ambient temperatures, and separated 
by non-denaturing electrophoresis.  
Figure 4.7 depicts the melting of the U4/U6 duplex from both wildtype tri-snRNP 
and tri-snRNP from Δprp24sup cells. Both deproteinized U4/U6 duplexes melt at 
roughly 54°C, indicating that there is nothing substantial interfering with the U4/U6 
interaction in tri-snRNPs formed from assembly intermediates lacking Prp24p. This 
implies that Prp24p is not required for the maintenance of the remarkable base pairing 




Figure 4.7 Melting of deproteinized U4/U6 purified from wildtype or Δprp24sup strains 
show that there both duplexes melt at ~54°C.  
Glycerol gradient purified particle was deproteinized and incubated at the 
temperature listed. Both U4/U6 duplexes melt at ~54°C, as shown by the lack of U4/U6 
band, and the appearance of a mono-U6 snRNA band. No significant difference between 
wildtype and Δprp24sup U4/U6 is apparent, suggesting that the absence of Prp24p does 




4.3.6 Biochemical analysis of arrested di-snRNP complexes 
U4/U6 is a transient assembly intermediate when compared with the assembly 
species that exist downstream and upstream of this snRNP. Because in vivo levels of 
U4/U6 are low, isolating this intermediate for compositional analysis has proven to be a 
difficult task. Previous studies have compositionally analyzed in vitro assembled U4/U6; 
however, these reconstitution assays do not necessarily represent authentic spliceosomal 
complexes, as they are not on-pathway intermediates. In addition, it is difficult to 
determine the timing of protein additions and removals from snRNP complexes when 
particles are assembled from extract.  
Previously, a U4 snRNA cold-sensitive mutant, U4-G14C, had been characterized 
to stall the assembly pathway of U4/U6 at the Prp24p step (Shannon and Guthrie, 1991). 
This U4 mutant disrupts the base stacking of three G-C intermolecular U4/U6 base pairs, 
and leads to a destabilization between U4 and U6, which lowers the melting temperature 
of the duplex from 53°C to 37°C. Destabilizations such as this often lead to a  
temperature sensitive phenotype; however, this particular destabilization traps a complex 
containing U4, U6, and Prp24p in di-snRNP. In a wildtype background this intermediate 
containing U4, U6, and Prp24p is considered highly transient (Stevens et al., 2001). This 
led to the suggestion that this U4Prp24pU6 complex represents a functional 
intermediate along the assembly pathway (Shannon and Guthrie, 1991). Compositional 
characterization of the U4Prp24pU6 intermediate could provide insight a to whether 
Prp24p potentially acts in a di-snRNP complex in the presence of other di-snRNP factors 
or binds to di-snRNP so as to exclude other di-snRNP proteins from interacting 
prematurely.  
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4.3.6.1 Affinity purification of Prp24p-containing di-snRNP 
To begin, Prp24p was C-terminally TAP tagged in a strain expressing a plasmid 
copy of U4-G14C and a genomic disruption of SNR14. Next, U4-Prp24p-TAPU6 di-
snRNP was affinity purified from cells which had been grown at permissive temperatures 
(31°C) and non-permissive temperatures (16°C). Following the affinity purifications (as 
described in Chapter 2, section 2.2.7), the elutions were layered on di-snRNP-resolving 
glycerol gradients and centrifuged to separate di-snRNP. Gradients were fractionated and 
RNA was extracted from protein. RNA was separated by denaturing electrophoresis and 
transferred to nylon membrane for Northern blotting. Northern blots were probed for all 
five snRNAs.  
As can be seen in Figure 4.8A and B, U4 and U6 are both precipitated by Prp24p 
in this mutant at non-permissive and permissive temperatures, respectively, while a 
purification from a wildtype strain (Prp24p affinity tagged) precipitates only U6 snRNP 
(Stevens et al., 2001). The results also demonstrate that mono-U6 snRNA is present at a 
high sedimentation in the gradient consistent with previous findings that Prp24p 
immunoprecipitates U6 snRNP (Stevens et al., 2001). Additionally, no accumulation of 
snRNAs is apparent in the pellet fraction (fraction 28), indicating that tri-snRNP cannot 
be precipitated by Prp24p; a result consistent aligned with previous immunoprecipitations 




Figure 4.8 Prp24p immunoprecipitates both U4 and U6 in the when U4 is mutated.  
At non-permissive (A) and permissive temperature (B) (16°C and 31°C, 
respectively), affinity purified U4 and U6 cosediment di-snRNP resolving glycerol 
gradients, indicating the presence of a di-snRNP particle containing Prp24p. This particle 
is suggested to be an intermediate in the assembly pathway of tri-snRNP (Jandrositz and 
Guthrie, 1995; Shannon and Guthrie, 1991).  
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4.3.6.2 Stability of the interaction between U4 and U6 in di-snRNP 
The Guthrie laboratory reported that both U4 and U6 immunoprecipitated with 
Prp24p in the U4-G14C mutant strain (Shannon and Guthrie, 1991), posing the question 
of the mechanism of their interaction: is a protein, such as Prp24p, responsible for their 
interaction or do the two snRNAs interact by through base pairing interactions. Jandrositz 
and Guthrie use psoralen crosslinking and protein denaturation in nuclear extract to 
determine that U4 and U6 are in fact base paired in di-snRNP, indicating that their 
interaction is independent of proteins even in the presence of Prp24p (Jandrositz and 
Guthrie, 1995). Non-denaturing electrophoresis (Figure 4.9A) and psoralen crosslinking 
(Figure 4.9B) were used to study the extent of destabilization between U4 and U6.  
Native RNA was extracted from strains containing either a wildtype copy of U4 
or cells containing the U4-G14C mutant. As can be seen in lane 1 of Figure 4.9A, native 
extraction and non-denaturing electrophoresis of total RNA produces a band representing 
a U4/U6 base pairing interaction only in the strain carrying a wildtype copy of U4. Total 
RNA from the U4-G14C mutant shows no detectable amounts of U4/U6 base pairing 
(lane 3 of Figure 4.9A), suggesting a destabilization in the duplex that does not withstand 
standard native extraction and electrophoresis. 
To determine if the lack of base pairing in the U4-G14C mutant strain is a result 
of the preparation of the RNA, a single glycerol gradient fraction of di-snRNP (from 
Figure 4.8 for the U4-C14 mutant, and Figure 4.5A for wildtype) was split and samples 
were incubated either in the presence of both UV and psoralen, in the presence of UV and 
absence of psoralen, in the absence of UV and presence of psoralen, or in the absence of 
both UV and psoralen. U4/U6 base pairing was expected only in the presence of both 
psoralen and UV. RNA from each of the samples was then extracted, precipitated and 
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subjected to electrophoresis on a denaturing gel. The gel was transferred to nylon, and the 
blot was probed for U6. As shown in Figure 4.9B, U4 and U6 do show a base pairing 
interaction only in the presence of both UV and psoralen, indicating that though the 
interaction is not able to withstand a standard native extraction, the two snRNAs are 
indeed participating in base pairing interactions. This is consistent with the data from the 
Guthrie laboratory, and indicates that even in the presence of Prp24p, U4 and U6 are base 




Figure 4.9 U4 and U6 are base paired in the U4-G14CPrp24pU6 particle 
A. Non-denaturing electrophoresis and Northern blotting of total RNA 
from wildtype U4 and U4-G14C cells shows that U4 and U6 are stably 
base paired in wildtype U4 cells (lane 1), but not in U4-G14C cells 
(lane 3). RNA in lanes 2 and 4 was heat-treated as a control.  
B. Glycerol gradient fractions were treated in the absence or presence of 
psoralen and UV light, and extracted RNA was separated on a 
denaturing gel. Northern blotting for U6 demonstrates that treatment 
with psoralen and UV light crosslinks U4 and U6 in affinity-purified 
di-snRNP from both wildtype (lane 5) and U4-G14C (lane 9) strains. In 
the absence of either psoralen or UV light, no base pairing is detected 
(lanes 2-4 and lanes 6-9). Lane 1 serves as an untreated total RNA 
control.   
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4.3.6.3 Compositional analysis of Prp24p-containing di-snRNP 
Protein fractions corresponding to the RNA fractions where U4/U6 was detected 
(from section 4.3.6.1) were precipitated, pooled and subjected to mass spectrometry. 
Table 4.5 shows that the only stable protein components present in this complex are 
Prp24p, the LSm core, and the Sm core. These results are not unexpected; however, it is 
interesting to note that no other di-snRNP components are present, indicating they may 
join in a mutually exclusive manner to Prp24p. It is also possible that the di-snRNP 
components cannot load into this complex when U4 and U6 are destabilized. These data 
suggest that the uncharacterized U4 snRNP, which enters into interactions with U6 
snRNP does not carry or recruit other di-snRNP factors into di-snRNP, at least before it 




Protein MW (kDa) Di-snRNP (# of 
peptides detected) 
Prp24p 51 24 
SmB1p 22 15 
LSm4p 21 11 
SmD1p 16 11 
SmD2p 13 9 
LSm7p 13 3 
LSm3p 12 11 
LSm8p 12 15 
SmD3 11 8 
LSm2p 11 9 
LSm5p 10 12 
SmFp 10 6 
SmEp 10 1 
LSm6p 9 9 
Table 4.5 Factors present in Prp24p-purified di-snRNP include the Sm and LSm 
complex.  
Compositional analysis of proteins found in Prp24p-containing di-snRNP was 
determined by mass spectrometry analysis. All of the core snRNP components of U4 and 
U6 snRNAs, the Sm and LSm complexes, respectively, are present. No other di-snRNP 
factors were identified suggesting they are recruited later in the assembly process, and are 
not brought in by the U4 snRNP.  
 161 
4.3.6.4 Compositional analysis of the di-snRNP contained in Δprp24sup strain 
Di-snRNP found in the Δprp24sup strain is base paired, as demonstrated in non-
denaturing electrophoresis (Figure 4.5D), suggesting that this particle is likely to 
represent the post-Prp24p assembly intermediate. Additionally, as shown by native gel 
electrophoresis in Figure 4.4, di-snRNP migrates comparably different from di-snRNP 
from a wildtype native extract. Using the affinity-purified di-snRNP described in section 
4.3.5.1, protein was precipitated, pooled and analyzed by mass spectrometry analysis to 
determine composition. Proteins identified are presented in Table 4.6.  Indeed, this 
complex contains other di-snRNP factors, including Prp3p, Prp4p and Prp31p. Snu13p 
was not identified despite using an inclusion list specifically for Snu13p peptides; 
however, it cannot be ruled out that total protein is too low for detection of peptides from 
Snu13p. Evidence from the Lührmann laboratory suggests that this factor must join prior 
to Prp31p, Prp3p, and Prp4p forming interactions in the di-snRNP (Nottrott et al., 1999) 
(Nottrott et al., 2002).  
Furthermore, as expected, this particle contains members of the Sm and LSm 
protein cores, as expected. Additionally, several identifications with significant scores 
were made of Brr2p, however, the large molecular weight of Brr2p makes resultant 
peptide identifications plausible even in the event that Brr2p does not specifically interact 




Protein  Molecular 
weight (kDa) 
Δprp24sup di-snRNP (# 
of peptides IDed) 
Brr2p 246 11 
Pab1p 64 11 
Prp31p 56 3 
Prp3p 56 13 
Prp4p 52 17 
LSm4p 21 5 
SmD2p 13 2 
LSm8p 12 5 
LSm2p 11 2 
LSm3p 10 1 
SmFp 10 1 
LSm6p 9 1 
Table 4.6 Compositional analysis of di-snRNP purified from Δprp24sup strain show that 
di-snRNP factors, Prp3p, Prp4p, and Prp31p join to the base paired duplex. 
Mass spectrometry analysis of pooled protein from di-snRNP fractions of 
Δprp24sup purification identify di-snRNP factors not found in the Prp24p containing di-




Previous studies have shown that Prp24p predominantly acts by structurally 
rearranging U6 snRNA into a conformation optimal for the formation of extensive base 
pairing interactions with the U4 snRNA. Recent studies have proposed a mechanism for 
this action whereby RRM2 recognizes precise residues in a bulged central stemloop of 
U6, thus bringing RRM1 of Prp24p into close enough proximity to capture U6 (Martin-
Tumasz et al., 2010). It has not been determined if this rearrangement is concurrent or 
directly preceding U4 annealing, but Prp24p has not been shown to exist in complex with 
U4 snRNA in a wildtype background (Stevens et al., 2001).  
Studies in yeast have shown that cells can compensate for a mutation in Prp24p 
by upregulating steady-state levels of U6 snRNA (Vidaver et al., 1999). This effect is 
conserved in vertebrates (Trede et al., 2007), underlining the significance of the 
observation. This finding begs the question of how increasing steady-state levels of U6 
can compensate for defective Prp24p. While yeast and zebrafish knockouts of Prp24p are 
non-viable, we have demonstrated that by overexpressing U6 snRNA, viability can be 
restored in the absence of Prp24p. Interestingly, U4 and U6 can still base pair in the 
absence of Prp24p; however, Prp24p knockout strains display defects in the assembly of 
higher order spliceosomal intermediates. The results presented here suggest that the 
release of Prp24p may act as a trigger for the assembly of tri-snRNP.  
Prp24p is well characterized to mediate the annealing between U4 and U6, but 
proposed roles for Prp24p function in later steps of the splicing cycle lack biochemical 
support. Using the Prp24p knockout strain, we have shown that the role of Prp24p 
extends beyond U4/U6 annealing. The data presented here suggest that Prp24p is 
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temporally important for tri-snRNP formation, and implying that the timing of Prp24p 
action is critical for cells to maintain a fully functional spliceosome biogenesis pathway.  
We began by overexpressing either U6 snRNA or U4 snRNA in a PRP24 shuffle 
strain to test the hypothesis that the essential nature of Prp24p can be bypassed by driving 
di-snRNP assembly process by mass action. Indeed, it was observed that elevated levels 
of U6 make Prp24p non-essential (Figure 4.1). Molecularly, the increased levels of U6 
snRNA in this strain imply that there is a concomitant increase in the total amount of de 
novo-produced U6 snRNA entering the splicing cycle. As Prp24p has been defined as a 
recycling factor, it is possible that U6 snRNA produced de novo exists in a conformation 
that can readily anneal to U4 snRNA. Another possibility is that the increase in steady-
state levels of U6 snRNA in a cell raises the levels of U6 snRNA in a conformation 
thermodynamically favorable for binding U4 snRNA. A combination of these effects is 
also possible.  
While high levels of U6 snRNA can circumvent the requirement of Prp24p in 
vivo, non-denaturing electrophoresis demonstrated that cells lacking Prp24p could still 
form U4/U6 base pairing interactions, though the total amount of base paired duplex is 
reduced (Figure 4.2). The presence of base pairing is surprising considering the essential 
protein, Prp24p, has been assigned a functional role in annealing U4 and U6 
(Raghunathan and Guthrie, 1998b). Thus, this result suggests that Prp24p may have an 
additional role in vivo.  Instead of observing a complete absence of U4/U6 annealing, 
assembled di-snRNP and tri-snRNP in the Δprp24sup strain have unique migrations in a 
native gel when compared to di-snRNP and tri-snRNP assembled in wildtype cells 
(Figure 4.4). Taken together these data suggest that Prp24p may also be playing a direct 
or indirect role in facilitating downstream assembly events.  
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 In the absence of Prp24p, a reduction in base pairing between U4 and U6 was 
observed; however, the interaction was not completely ablated. To confirm its role in the 
annealing of U4 and U6, Prp24p was metabolically depleted and the extent of base 
pairing between U4 and U6 was assessed. Following a shift to a repressive carbon source, 
Prp24p was not detectable by 4.5 hours (Figure 4.3B), and a concomitant decrease in the 
levels of U4 base paired to U6 was observed (Figure 4.3C). This in vivo data partially 
validates the previously reported function of Prp24p in U4/U6 annealing, but in light of 
our previous finding that Prp24p is not essential in the presence of high levels of U6, our 
results imply that Prp24p is not essential for the interaction. This scenario provides an 
appealing explanation for the finding that high levels of U6 can bypass the need for 
Prp24p.  
To test whether the migration differences noted in native gel electrophoresis of 
the Δprp24sup spliceosomal particles (Figure 4.4) are the result of a previously 
undescribed function for Prp24p in later spliceosome assembly events, we affinity 
purified the tri-snRNP and di-snRNP assembled in vivo in the Δprp24sup strain. Di-
snRNP and tri-snRNP were purified by means of a C-terminal TAP tag on LSm8p in the 
Δprp24sup strain, and large-scale affinity purifications were performed. A comparison of 
the protein composition of tri-snRNPs from wildtype and Δprp24sup revealed very few 
compositional differences. The presence of Cbf5p in the Δprp24sup tri-snRNP is notable, 
as Cbf5p is a component of the box H/ACA snoRNA, which pseudouridylates U2 snRNA 
during U2 snRNP biogenesis (Ma et al., 2005). Other snRNAs have been reported to be 
modified by pseudouridylation, as well (Massenet et al., 1998); however, Cbf5p has only 
been specifically reported for modifying U2.  
More interesting is the absence of Prp38p and Snu23p in the Δprp24sup tri-
snRNP. Both of these factors are reported to be stable components of tri-snRNP (Stevens 
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and Abelson, 1999), and their absence is surprising. Prp38p has been reported to be 
important for unwinding of U4 snRNA during activation (Xie et al., 1998). It is 
interesting to note that the presence of Prp38p, a factor important for unwinding, appears 
to be dependent upon the presence of another factor, namely Prp24p, proposed to 
function in the same activation event. However, the purifications of tri-snRNP described 
here do not answer whether Prp24p directly affects the stability of Prp38p.  
Since no significant compositional changes were observed between wildtype tri-
snRNP and tri-snRNP assembled in Δprp24sup strain, the migration shift in the native 
gel is likely to be due to conformational changes in the U4/U6 interaction. One approach 
to test this hypothesis is to study the thermal stability of the U4/U6 duplex in the presence 
and absence of Prp24p. Melting experiments revealed that the U4/U6 interaction in 
Δprp24sup tri-snRNP is similar to that of wildtype tri-snRNP, suggesting that reduced 
migration in the native gel is not due to incomplete or destabilized base pairing 
interactions between U4 and U6. Native gel analysis separates by both size and charge, 
thus it is possible that the tri-snRNP produced from Δprp24sup strains is structurally 
different or that there are fewer exposed charged residues than that from wildtype cells. 
In either case, these data suggest that Prp24p is important for either tri-snRNP assembly 
or stability, or both, and implicate a previously uncharacterized function for Prp24p in 
later spliceosome assembly events.  
One of the possibilities for the aberrantly migrating tri-snRNP in the Δprp24sup 
strain is that Prp24p may be functioning in assembly of the spliceosome indirectly. The 
role of Prp24p in di-snRNP formation may be kinetically or temporally significant, as 
other factors are known to eventually associate with di-snRNP on the pathway to tri-
snRNP. To investigate the effect that knocking out Prp24p has on di-snRNP, proteins 
specific to di-snRNP were identified by mass spectrometry analysis, and compared to di-
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snRNP isolated from cells containing a mutation U4 snRNA that has been shown to 
accumulate a Prp24p-containing di-snRNP (Shannon and Guthrie, 1991). In the presence 
of Prp24p, di-snRNP is composed of only Sm and LSm complexes, while di-snRNP 
purified from Δprp24sup cells contains other di-snRNP components, including Prp3p, 
Prp4p, and Prp31p, in addition to the Sm and LSm complexes. The absence of Snu13p 
may be significant; however, Snu13p is not easily identified using this method of mass 
spectrometry analysis even in the presence of a Snu13p-specific inclusion list. 
Additionally, Snu13p is thought to recruit the other factors to di-snRNP (Nottrott et al., 
1999; Oruganti et al., 2005), thus the absence of Snu13p is likely an artifact of the 
method of identification.  
The two di-snRNP characterizations suggest that Prp24p may dissociate from di-
snRNP upon the joining of other factors. Perhaps these factors physically remove Prp24p 
from di-snRNP, or it is possible that the other factors induce rearrangements in the 
snRNAs that cause the Prp24p interaction to be disrupted. In either case, it appears that 
Prp24p precedes the entrance of the other di-snRNP factors into the assembly pathway, as 
opposed to their concomitant recruitment as possible U4-interacting factors.  
Finally, as noted above, Prp24p has been implicated in dissociation of U4 during 
activation of the spliceosome (Ghetti et al., 1995; Vidaver et al., 1999), but the viability 
of the Δprp24sup strain containing high levels of U6 snRNA indicate that if Prp24p does 
in fact play a role in activation, it is not an essential function for Prp24p, or less likely 
that it too can be bypassed with high levels of U6 snRNA. Prp24p is essential for the 
recycling of U6 snRNA, but the data proves that this function for Prp24p can be bypassed 
by increasing the cellular levels of U6. Though this strain has a slight growth defect, the 
fact that cells are viable proves that all of functions of Prp24p are non-essential, at least 
in the presence of high copy U6. 
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Chapter 5: Significance and future directions 
5.1 SIGNIFICANCE 
As a highly dynamic RNP, the spliceosome presents a uniquely challenging 
system in understanding the network of RNA and protein interactions. Biochemical 
purifications of long-lived spliceosomal intermediates have characterized novel factors 
and interactions, but because the nature of the splicing cycle is largely in flux, in vitro 
strategies for characterizing the more transient-existing intermediates have remained the 
major source of data. Though these in vitro techniques are invaluable to mechanistic 
studies, the particles produced from in vitro reconstitutions are not assembled along the 
splicing cycle pathway, and thus are not necessarily the most accurate method for 
understanding a dynamic RNP. Additionally, the particles produced are not always 
functional due to the method of isolation and the fact that large populations of 
reconstituted particles are off-pathway, dead-end intermediates. Thus, genetic strategies 
for arresting normally short-lived species of splicing particles, in vivo, provide an 
essential means by which the spliceosome must be studied.  
We have employed these genetic strategies to accumulate normally transient 
spliceosomes, and solve the compositions of each of these particles. Furthermore, we 
have shown that given the appropriate conditions these arrested particles are also 
functional. By testing the functionality of the catalytically arrested spliceosomes, we have 
assigned a mechanistic function to a DEAH-box factor, Prp2p, and found a possible 
secondary consequence of Prp2p action. Additionally, using genetic strategies, we have 
shown that assembly intermediates can be accumulated and analyzed by using assembly-
factor mutants. By linking genetic and biochemical experiments, the data presented in 
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this dissertation provides a means to compositional characterizations of the assembly 
intermediates. From the results, we can conclude that the factor, Prp24p, previously 
narrowed to U6 rearranging, also participates in  spliceosomal assembly events 
downstream of U4/U6 annealing. Moreover, we show that Prp24p is not essential in 
activation of the spliceosome, an event previously ascribed to Prp24p.  
Combining these genetic principles and biochemical methods we present a means 
by which snapshots of the dynamic splicing cycle can be mechanistically pieced together. 
Nevertheless there is still much that remains to be learned about how the spliceosome 
functions in molecular detail. In the following, possible future directions based on the 
work described in this dissertation will be discussed.  
 
5.2 CATALYTICALLY ARRESTED SPLICEOSOMES 
The second chapter of this dissertation describes the genetic approach used for 
isolating normally transiently occurring intermediates in the splicing cycle. Specifically, 
catalytically activated spliceosomes arrested before the first step, before the second step, 
and before message released were purified and compositionally defined by mass 
spectrometry analysis. These analyses revealed a number of interesting protein-addition 
and protein-removal events. The third chapter elaborates upon one of these compositional 
changes using functional analysis to show a mechanistic role for Prp2p in the first step of 
splicing. Further analyses of the compositional differences will be instrumental in 
assigning functions to uncharacterized proteins present during the catalytic steps of 
splicing.   
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5.2.1 Compositional changes between arrested spliceosomes 
Our studies demonstrate that there are many noticeable differences between each 
of the arrested spliceosomes, suggesting that the conformational rearrangements and 
chemical steps of splicing trigger protein additions and removals from the spliceosome. 
We specifically investigated one of these removals. We have tested the functionality of 
the spliceosome to carry out the first step of splicing, and we found that the SF3 complex 
is quantitatively displaced from the spliceosome as a result of ATP-hydrolysis by Prp2p. 
In addition to the displacement of the SF3 complex, we also identified numerous other 
protein and complex changes, suggesting that they too might be displaced or added 
following ATPase function. One of the other removals from the prp2-arrested 
spliceosome is the RES complex, which is known to associate with the pre-mRNA to 
prevent the message from entering into the cytoplasm prematurely (Dziembowski et al., 
2004). However, the mechanism that triggers the removal of this complex has not been 
established. A strategy similar to that described for the displacement of the SF3 proteins 
may allow determination of whether the RES complex or any of the other proteins 
specific to prp2-arrested spliceosomes are removed as a direct consequence of the 
DEAH-box proteins.  
Now that at least one consequence of Prp2p function has been established, it will 
be interesting to determine how Prp2p elicits displacement of the SF3 complex. Previous 
results strongly support Prp2p recruitment to the spliceosome by Spp2p (Roy et al., 
1995); however, where Spp2p and Prp2p interact within the spliceosome remains 
unknown. Our arrested particles provide a system by which protein-RNA interactions can 
be investigated by Crosslinking Analysis of cDNA (CRAC) (Granneman et al., 2009). 
This recently described technique takes advantage of the specific RNA-protein crosslinks 
produced by UV light. Specifically, an affinity-purified particle is exposed to UV light, 
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and the particle is treated with RNases. A denaturing purification of the digested RNP, 
specific to the protein interest is then employed. While bound on resin, linkers are then 
ligated to the RNA of interest on both the 5’ and 3’ ends, which can eventually be used 
for primer annealing sites for reverse transcription and then PCR. This amplifies the 
RNA(s) bound by the protein of interest, and can be used in a high-throughput manner.  
A secondary tag within the mutant prp2 strain, on either Prp2p or potentially RNA-
binding protein of interest, such as Spp2p, may be used for a second purification step of 
the digested RNP to identify the exact points of interaction, whether the interaction is 
with an snRNA or the pre-mRNA.  
Using the CRAC strategy on our purified arrested spliceosomes would provide a 
snapshot of interactions among the factors that remain part of the spliceosome throughout 
the catalytic steps. Proteins of interest within the first and second step-arrested particle 
include Prp8p, Brr2p, and Snu114p. Prp8p, in particular, is considered by at the heart of 
the active site of the spliceosome, thus, understanding the interactions between the 
snRNAs, the pre-mRNA, and Prp8p within each of the catalytically arrested particles 
would help elucidate the mechanistic role of Prp8p in the steps of splicing.  
Comparison between the compositions of the first-, second-, and message release-
arrested spliceosomes also reveal a number of protein additions. For example, Yju2p and 
Cwc25p are only found in the prp16-arrested spliceosome suggesting that they are added 
to the spliceosome sometime after Prp2p function. Our functional analysis suggests that 
neither Yju2p nor Cwc25p are essential for the first step of catalysis; however, both of 
these proteins have been demonstrated to be important for the first step using in vitro-
assembled first step-stalled spliceosomes (Chiu et al., 2009; Liu et al., 2007; Warkocki et 
al., 2009). Determination of where Yju2p and Cwc25p bind in the second step arrested 
spliceosome by CRAC may help elucidate the purposes of these factors. Specifically, the 
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primary tag on prp16 and a secondary tag on either Cwc25p or Yju2p could reveal the 
location of these factors within the spliceosome. We predict that these factors may be 
interacting on and/or around the second step reactive species before the second step of 
catalysis. 
 
5.2.2 Analysis of other particles 
Using genetic strategies to isolate normally transient occurring intermediates, 
provides the means to isolate and analyze in vivo assemble, synchronized, on-pathway, 
functional intermediates. As described in the Chapter 4, genetic strategies can be used to 
isolate assembly intermediates as well. This strategy is valuable in addressing the specific 
consequences of early assembly intermediates affecting later spliceosome assembly 
intermediates and would be useful if applied to other particles, such A complex 
spliceosomes or activated B* spliceosomes, in vivo.  
5.3 CHARACTERIZING THE ASSEMBLY PATHWAY 
Prp24p has been well characterized as a mono-U6 snRNP component (Shannon 
and Guthrie, 1991; Stevens et al., 2001), and the traditional role of Prp24p is to anneal 
U4 and U6 in one of the earliest assembly pathways (Raghunathan and Guthrie, 1998b). 
This event may take place by simply relaxing the U6 secondary structure such that U4 
has the opportunity to form base pairing interactions with U6. It is also possible that 
Prp24p, which contains four RRMs, actually binds U4 snRNA in addition to U6, and that 
this U4-Prp24p interaction has never been isolated due to the transient nature of this 
particle. Using our in vivo-assembled, Prp24p containing di-snRNP, an interaction for 
U4-Prp24p can be explored using the CRAC method described above. An interaction 
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between U4 and Prp24p would help elucidate the formation of the di-snRNP and the 
mechanism by which Prp24p anneals U4 and U6 snRNAs.  
Though our data clearly show that Prp24p is not required for the activation of the 
spliceosome, Prp24p may be involved in stimulating the unwinding of U4 snRNA in a 
non-essential manner. It would be interesting to further investigate this potential role for 
Prp24p by biochemically exploring the existence of Prp24p in a spliceosome-sized 
particle. Previous compositional studies have shown the exclusive binding of Prp24p to 
U6 snRNA (Stevens et al., 2001); however, the transient nature of some of the assembly 
intermediates may not permit biochemical isolation. Using the U4-G14C strain, which is 
known to be defective for Prp24p release, a spliceosome component, such as Brr2p, could 
be affinity tagged. An affinity purification following glycerol gradient sedimentation 
specific for a spliceosome-sized particle, may reveal that Prp24p is prevented from 
release not only during tri-snRNP formation, but also during the activation event, 
implying a function for Prp24p in a fully assembled, B-complex spliceosome. Though 
several reports have provided genetic evidence of a role for Prp24p in the activation step, 
in vivo biochemical data would provide physical evidence for a non-essential role for 
Prp24p just upstream of the catalytic steps of splicing.  
Finally, mass spectrometry analysis of tri-snRNP produced from the Δprp24sup 
strain, identified the snoRNP component Cbf5p. Cbf5p is known to be involved in 
pseudouridylation of U2 snRNA (Ma et al., 2005), and although tri-snRNP by definition 
does not contain the U2 snRNP, it is possible that Cbf5p is involved in modifying one or 
all of the other snRNAs. Using a TAP tag on Cbf5p in the Δprp24sup strain, it would be 
interesting to see if spliceosomal intermediates co-precipitate. 
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Appendix I 
 Mass spectrometry protocol used in Chapter 2 to compositionally characterize arrested 
spliceosomes as described by James Thompson of the Yates Laboratory 
To each lyophilized protein sample, 60 μL of solubilization buffer (8M urea, 10 
mM Tri-HCl, pH 8.5) was added. The subsequent mixture was then reduced by adding 
TCEP to 5 mM. Iodoacetamide (10 mM final concentration) was added to alkylate 
cysteine residues and the samples were subsequently incubated at room temperature in 
the dark for 15 minutes. Reactions were diluted to 2 M urea by the addition of 180 μL of 
100 mM Tris, pH 8.5. Calcium chloride was added to a final concentration of 1 mM. Two 
micrograms of Trypsin were added and the resulting mixtures were shaken for 18 hours 
in the dark at 37°C. Formic acid (90%) was added to a final concentration of 5% formic 
acid. The tubes were centrifuged for 30 minutes at 2°C on a table-top centrifuge.  
The protein digest was pressure-loaded onto a fused silica capillary desalting 
column containing 5 cm of 5 μm Polaris C18-A material (Metachem) packed into a 250 
μm i.d. capillary with a 2 μm filtered union (UpChurch Scientific). The desalting column 
was washed with buffer containing 95% water, 5% acetonitrile, and 0.1% formic acid. 
After desalting, a 100 μm i.d. capillary with a 5μm pulled tip packed with 10 cm 3-μm 
Aqua C18 material (Phenomenex) followed by 3 cm of 5 μm Partisphere strong cation 
exchanger (Whatman) was attached to the filter union and the entire split-column 
(desalting column-filter union-analytical column) was placed inline with an Agilent 1100 
quaternary HPLC and analyzed using a modified six-step separation described previously 
(Washburn et al., 2001). The buffer solutions used were 5% acetonitrile/0.1% formic acid 
(buffer A), 80% acetonitrile/0.1% formic acid (buffer B), and 500 mM ammonium 
acetate/5%acetonitrile/0.1% formic acid (buffer C). Step 1 consisted of a 90 minute 
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gradient from 0 – 100% buffer B. Steps 2-5 had the following profile: 3 minutes of 100% 
buffer A, 2 minute X% buffer C a 10 minutes gradient from 0-15% buffer B and a 97 
minute gradient from 15-45% buffer B. The 2 minute buffer C percentages (X) were 
20%, 40%, 60%, and 80%, respectively, for the seix step analysis. For the final step, the 
elution consisted of: 3 minutes of 100% buffer A, 20 minutes of 100% buffer C, a 10 
minute gradient from 0-15% buffer B and a 107 minute gradient from 15-70% buffer B.  
As peptides were eluted from the microcapillary column, they were 
electrosprayed directly into an LTQ two-dimensional ion trap mass spectrometer 
(ThermoFinnigan) with the application of a distal 2.4-kV spray voltage. A cycle of one 
full-scan mass spectrum (400-1400 m/z) followed by eight data-dependent MS/MS 
spectra at a 35% normalized collision energy was repeated continuously throughout each 
step of the multidimensional separation. Application of mass spectrometer scan functions 
and HPLC solvent gradients were controlled by the Xcalibur data system.  
MS/MS spectra were analyzed using the following software analysis protocol. 
Poor quality spectra were removed from the data set using an automated spectral quality 
assessment algorithm (Bern et al., 2004). MS/MS spectra remaining after filtering were 
searched with the SEQUEST algorithm (Eng et al., 1994) against the SGD S. cerevisiae 
(December 16, 2005) protein database (created on December 17, 2006) concatenated to a 
decoy database in which the sequence for each entry in the original database was 
performed on a Beowulf computer cluster consisting of 100 1.2 GHz Athlon CPUs 
(Sadygov et al., 2002). No enzyme specificity was considered for any search. SEQUEST 
results were assembled and filtered suing the DTASelect (version 2.0) program (Cociorva 
et al., 2006; Tabb et al., 2002). DTASelect 2.0 uses a linear discriminate analysis to 
dynamically set XCorr and DeltaCH thresholds for the entire data set to achieve a user-
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specified false-positive rate. The false-positive rates are estimated by the program from 
the number and quality of spectral matches to the decoy database.  
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Appendix II  
Contaminants from mass spectrometry analysis of mock purification in Chapter 2. 
MOCK control 
Cdc19p Hor2p Shm2p 
Pgk1p Hyr1p Egd2p 
Trx2p Sse1p Rnq1p 
Fba1p Cdc48p Frm2p 
Tef2p, Tef1p Cof1p Glk1p 
Tsa1p Ssc1p Gpd1p 
Eno2p YDL124W Efg20p 
Eno1p Mmf1p Adk1p 
Ahp1p YBR012W-A Arg1p 
Gpm1p YDR098C-A Gcv3p 
Mbf1p YDR210C-C Leu1p 
Hsp26p YDR261C-C Wtm1p 
Pdc1p YMR051C, YDR316W Aro4p 
Bmh1p Gre2p Aro8p 
Hmf1p Sam2p Sis1p 
Tal1 Dps1p Lys21p 
Tpi1p Eft1p, Eft2p Pfk2p 
Tma19p Hyp2p Scl1p 
Pgi1p Act1p Stm1p 
Grx5p YMR090W Cpr6p 
Trx1p Hsp104p Hxk2p 
Hhf2p, Hhf1p Hhp31p Ipp1p 
Rhr2p Cpr3p Erg13p 
Sod1p Imd4p Ser3p 
Ynk1p Tif2p, Tif1p Ser33p 
Bmh2p YLR179C Aha1p 
Ado1p Gly1p Ald6p 
Ntf2p Oye2p Gnd1p 
Hsc82p Guk1p Hem2p 
Trr1p Pre9p Tfp1p 
YNL134C Cys4p Hom6p 
Imd3p Tkl1p Tef4p 
Yef3 Cpr1p Fas2p 
Pnc1p Hsp60p Hsp82p 





Appendix III  
Contaminating polypeptides from arrested particles characterized in Chapter 2. 
prp2-arrested  prp16-arrested prp22-arrested 
Atp1p Air1p Apa1p 
Atp2p Arp9p Arf1p 
Bgl2p Atp1p Arp7p 
Csn12p Cdc33p Atp2p 
Kri1p Eaf3 Cdc22p 
Krr1p Ebp2p Dbp6p 
Lat1p Hsp10p Drs1p 
Loc1p Ilv3p Hpr1p 
Mpd2p Kre33p Krr1p 
Nop12p Med1p Mft1p 
Nop13p Med6p Nog1p 
Pma2p Nog1p Nop1p 
Rpf2p Nop1p Nop58p 
Sbp1p Nop58p Por1p 
 Rfc1p Sbp1p 
 Rpc19p  
 Rsc4p  




Appendix IV  
Mass spectrometry analysis of assembly intermediates characterized in Chapter 4, 
Protein digests were preformed by Michelle Gadush at the Institute for Cellular 
and Molecular Biology Protein Microanalysis Facility. Protein pellets were dissolved in 
25 μL ultrapure, filtered water. To the dissolved pellet, 5 μL of denature solution was 
added (8 M urea, 100 μM DTT, 60 μM CaCl2, 64 mM NH4HCO3). The solutions were 
allowed to denature at room temperature for no less than one hour. To digest the samples, 
10 μL of trypsin solution (Promega) was added (100 ng total enzyme), and digests were 
left shaking at 37°C overnight. To the digests, 3 μL of 5 mM DTT and 7 μL of 10% TFA 
were added.  
Samples number corresponds to the following particles: 
2. Compositional analysis of wildtype Prp3p-TAP purified tri-snRNP 
4. Compositional analysis of tri-snRNP from strain lacking Prp24p 
5. Compositional analysis Prp24p-containing di-snRNP 
6. Compositional analysis of di-snRNP from strain lacking Prp24p 
Protein identification was performed in the ICMB Proteomics and Metabolomics 
Facility by Dr. Maria D. Person (Dennis et al., 2009; Gorini et al., 2010). Tryptic 
peptides were loaded onto a Dionex Switchos µ-precolumn trap cartridge (Acclaim 
Peptrap C18 precolumn) flowing buffer A at 30 µl/min and then separated on an Dionex 
Ultimate HPLC flowing at 240 nL/min with a 73 (sample 2), 80 (4) or 100 (5,6) min 
gradient from 5-60% B (2) or 5-65% B (4-6).  Buffer A consists of 0.05% TFA, 5% 
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acetonitrile, 95% water and Buffer B is 0.04% TFA, 95% acetonitrile, 5% water.  The 
HPLC column used was the Dionex Acclaim PepMap 100 C18 column, with 3 µm, 100 
Å beads, 75 µm inner diameter x 15 cm. The samples were spotted with a Dionex Probot 
spotting robot using 30 sec per spot, on 96 spots (2) or the whole plate of a 192 well 
target (4-6). α-cyano-4-hydroxycinnamic acid matrix (LaserBio Labs) made at 10 mg/ml 
in 80% acetonitrile was deposited simultaneously at a rate of 1.08 µl/min.  Target 
spotting began 12-23 minutes after the start of the HPLC run. 
MS and MS/MS were acquired on a MALDI-TOF/TOF (AB Sciex 4700 
Proteomics Analyzer) running 4000 Series Explorer V3.6.  MS was acquired over a mass 
range of 800-4000.  The LC interpretation method acquired up to 12 MS/MS per spot 
from peaks with MS s/n > 30.  Samples 3-6 had MS/MS exclusion lists with 35 keratin 
peaks and 65 PRP8 peaks (4).  An MS/MS inclusion list was used including peptides 
from proteins Snu13 and 9 (4) or 14 (5,6) other small Sm and LSm proteins (LSm 
2,3,4,5,7,8; Snu23, SmE, SmF, Dib1, SP381, PRP38, SmD2 and SmB).  The spectra were 
processed using GPS Explorer V3.6 with MASCOT V2.2 as the embedded search engine.   
The data was searched against the Swiss Prot (January 19, 2010) all species 
database and a yeast only subset database.  The search parameters included trypsin/P with 
up to 2 missed cleavages, MS mass tolerance was set at 40 or 50 ppm, MS/MS mass 
tolerance of 0.2 Da, and the following variable modifications were specified:  protein N-
terminal acetylation and methionine oxidation.  The MASCOT scores were reported 
according to standard scoring.  The search output combines the scores from MS search 
and the MS/MS search using a probabilistic MOWSE algorithm. The MASCOT score is 
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defined as –10*logP, where P is the probability that the observed match is a random 
event. A score which corresponds to P<0.05 is chosen as the cutoff for a significant hit.  
For the Swiss Prot all species search, a score of greater than 40 for individual MS/MS 
was the significant cutoff.  Human keratin proteins and bovine serum albumin carryover 
were detected in the all species search, along with yeast complex proteins.  The yeast 
database search was used to restrict the identifications to complex proteins. 
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Appendix V  
Protein contaminants from mass spectrometry analysis of assembly intermediates 













Hsp75p Rnq1p Hsp75p Rtg2p 
 Rps5p Hsp72p Fun12p 
 Pab1p Adh1p Hsp71p 
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